The validation of profluorescent nitroxides as potential probes to monitor mitochondrial oxidative stress by Chong, Kok Leong
 THE VALIDATION OF 
PROFLUORESCENT NITROXIDES 
AS POTENTIAL PROBES TO 
MONITOR MITOCHONDRIAL 
OXIDATIVE STRESS  
[Kok Leong CHONG] 
[Bachelor of Science (Hons) Biotechnology] 
 
 
 
Submitted in fulfilment of the requirements for the degree of 
[Doctor of Philosophy] 
 
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology 
School of Chemistry, Physics and Mechanical Engineering 
Queensland University of Technology 
 
 
2016
 3 
Keywords 
 
3,-(4,5-Dimethylthazol-2-yl)-2,5-Diphenyltetrazolium Bromide, Adenocarcinomic 
Alveolar Basal Epithelial Cells, Antimycin, Antioxidant, Ataxia-Telangiectasia, 
Carbonyl Cyanide m-Chlorophenyl Hydrazine, Cerebellum Cells, Cervical Cancer 
Cells,  Dulbesco’s media, Flow Cytometry, Fluorescein, Fluorescence, Fluorescent 
Probe, Fluorophore, Free Radicals, hTERT Immortalized Human Fibroblast Cells, 
Hydroxylamine, Immortalized Retinal Cells, Intraocular Pressure, Ischaemia, 
Isoindoline,  LysoTracker Blue, Microscopy,    Mitochondria, MitoSox, MitoTracker 
Green, Nitroxide, Oxidation, Oxidative Stress, Paramagnetic, Retinal Cells, Probe, 
Profluorescent, Reactive Oxygen Species, Redox, Reduction, Retina, Rhodamine, 
Rotenone, Sprague-Dawley Rats, Tetramethylrhodamine Methyl Ester 
 4 
Abstract 
Profluorescent nitroxides (PFNs), in which redox sensitive nitroxide moieties are 
coupled to a fluorophore, have been reported to be effective probes to monitor cellular 
redox status. Based on this, several PFNs have been developed and trialled, in order to 
develop a biologically relevant probe that allows the assessment of cellular redox 
status.  
 
 
Structurally modified PFNs possessing greater steric bulk around the nitroxide moiety 
are harder to reduce than less hindered probes. Extra steric hindrance around the 
radical centre within the PFN, is also helped by the extra electron-donating character 
of four ethyl versus four methyl groups beta to the nitroxide group. The greater steric 
bulk along nwith the extra steric hindrace in ethyl-based PFNs result in a slower 
reduction rate compare to methyl-based PFNs. This enables ethyl-based probes to 
better reflect the redox status within the systems under study as ethyl-based probes are 
not as rapidly reduced by the many biological reductants present in viable cells. The 
slower reduction rate of ethyl-based probes gives a more measured response to 
metabolic factors.   
 
Fluorescein-chromophore based PFNs (tetraethylfluorescein nitroxide, TEF) are less 
stable to changes in the pH of the environment than rhodamine-chromophore based 
PFNs (tetraethylrhodamine nitroxide, TER). The rhodamine chromophore gives a 
constant fluorescent response over the pH range of 3-12. On the other hand, 
fluorescence intensity varies with pH in the case of TEF, due to structural changes that 
occur with fluorescein from pH 3-12.  
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In this study, fluorescence imaging was undertaken to investigate cellular localization 
of fluorescein-based and rhodamine-based PFNs. This provided the background for 
assessing each probe’s possible role in monitoring redox status within specific cellular 
compartments.  
 
TEF undergoes predominantly lysosomal localisation while TER is present mostly in 
the mitochondria. As mitochondria are one of the main sites for the generation of 
reactive oxygen species (ROS), TER is a better probe for analysis of oxidative stress 
within cells.  
 
The fluorescence-based response of TER was shown to be reversible and therefore 
reflects cellular redox status in real time. Based on microscopy and flow cytometry 
investigations, it was determined that TER responded to changes in intracellular redox 
environment, especially those driven by the mitochondria. To validate this, cells 
incubated with TER were stressed with rotenone (ROT) and antimycin (AMC). 
Fluorescence emission of TER decreases with increasing levels of ROT and AMC 
additives.   
 
In an attempt to increase the uptake of TER type probe in the mitochondria, TER was 
esterified to give a probe with more positive charge. This methyl-ester tetraethyl-
isoindoline linked rhodamine molecule (ME-TER) gave significantly increased 
mitochondrial localization. 
 
Flow cytometry demonstrated that ME-TER responded to changes in intracellular 
redox environment induced by ROT and AMC. In addition,   ME-TER was shown to 
be able to assess redox status for a number of cell lines. ME-TER was also potentially 
able to assess redox status for Ataxia Telangiectasia (A-T) cell lines and within the 
retina of ischaemic rat model. Both A-T and ischaemic retinas are recognized as 
involving significant levels of oxidative stress. 
 
As determined by cell counting and MTT (3,-(4-5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay, both TER and ME-TER do not appear to affect 
cell viability, even over extended incubation periods up to 3 days.  
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Together, these results establish the feasibility of a rhodamine-based PFN probe as 
effective real time analytical tools to determine redox status within the mitochondria 
of cellular systems. 
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mitochondrial localization of ME-TER relative to MitoTracker Green 
in normal human fibroblast cell line (left) and Ataxia Telangiectasia, 
A-T diseased human fibroblast cell line (right) were shown. 
173 
Figure 5.4.2 Figures showing percentage changes in fluorescence intensity of 
sample, Fs (compounds) relative to control, Fc (DMSO) upon 
treatment with A) 45 minutes incubation with 10 nM ME-TER; B) 45 
minutes incubation with 5µM MitoSox; C) 30 minutes incubation 
with 10 nM of MT-ME-TER; D) 30 minutes incubation with 20 nM 
TMRM probe. Results were normalized to mitochondrial density as 
measured by 30 minutes incubation with Mitotracker Green (100 
nM). (Result were significantly different between normal and A-T 
diseasesd cells with P values < 0.1 under different treatment 
conditions, as determined by T-test). 
175 
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Figure 5.5.1 Localization of 10 nM methyl ester-tetraethylrhodamine nitroxide 
(ME-TER) and its non-radical alkylated derivative, methyl trap 
methyl ester tetraethylrhodamine (MT-ME-TER) along with 100 nM 
MitoTracker Green in A) immortalized retinal cells; B) DAOY, 
cerebellum cell; C) HeLa, cervical cancer cell; D) A549, 
adenocarcinomic alveolar basal epithelial cells. Pearson Coefficient 
of Correlation plots between nitroxide and MitoTracker Green were 
shown. 
179 
Figure 5.5.2 Percentage reduction in fluorescence intensity of treated 
immortalized mouse retinal cells, Fs [cells incubated with 
probes for 45 minutes, followed by treatment with varying 
concentrations of rotenone (ROT) or antimycin (AMC)] for 15 
minutes relative to blank, Fc [cells incubated with  probes for 
45 minutes, followed by treatment with DMSO for 15 minutes] 
. A) Cells treated with 10 nM ME-TER. B) Cells treated with 
10 nM MT-ME-TER. C) Cells treated with 1 µM MitoSox. 
[Each data point are mean values. Data were analysed using 
Kruskal Wallis test with pos hoc testing using the Dunn’s 
multiple comparison test where P < 0.05 means results are 
significantly different to blank. Results in both Figures A and C 
showed a P value < 0.05 (significantly different to blank), 
while Figure B showed a P value > 0.05 (non-significantly 
different to blank)]. 
182 
Figure 5.6.1 Chemical structure of lutein. 185 
Figure 5.6.2 A) Spinning disk microscopy images of 25 nM ME-TER 
treated cells upon subjection to different treatments; B) 
Spinning disk microscopy overlay images of 25 nM ME-TER 
with 100 nM MitoTracker Green. 
187 
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Figure 5.7.1 The change in methyl ester tetraethylrhodamine nitroxide (ME-
TER, 2 µM) fluorescence intensity in the retina during 
reperfusion following an acute ischaemic insult in Sprague-
Dawley rats. A) Fluorescent fundus images. B) Quantification 
of ME-TER fluorescence: Comparing fluorescence intensity 
between control and ischaemic reperfusion (I/R) treatment. 
(The data was fitted with a linear model and subsequently 
ANOVA statistical test was carried out. Relative to control, P 
values < 0.05 were obtained. Results are therefore significantly 
different to control). (Figure was taken from Nigel
175
 with 
permission). 
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List of Abbreviations 
8-OHdG  8-oxodeoxyguanosine  
A549  adenocarcinomic alveolar basal epithelial cells  
AMC  antimycin 
Asc  ascorbate 
A-T  Ataxia Telangiectasia 
ATM  Ataxia Telangiectasia mutated 
ATP  Adenosine Triphosphate 
CCCP  carbonyl cyanide m-chlorophenyl hydrazone 
DAOY   cerebellum cells 
DCFH-DA 2’,7’-dichlorodihydrofluorescein diacetate 
DMEM  Dulbeco’s modified eagle media 
DMSO  dimethyl sulfoxide 
EPR  electron paramagnetic resonance 
ETC  electron transport chain 
FSC  forward scatter 
HeLa  cervical cancer cells 
IOP  intraocular pressure 
I / R  ischaemic / reperfussion treatment 
hTERT  human telomerase reverse transcriptase 
ME-TER methyl ester tetraethylrhodamine nitroxide 
Mn-SOD manganese superoxide dismutase 
MT-ME-TER methyl trap methyl ester tetraethylrhodamine nitroxide  
MT-TEF methyl trap tetraethylfluorescein nitroxide 
MT-TER methyl trap tetraethylrhodamine nitroxide 
MTT  3,-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NADH  nicotinamide adenine dinucleotide 
NADPH  nicotinamide adenine dinucleotide phosphate 
NFF  neonatal foreskin fibroblast cells 
NMR  nuclear magnetic resonance 
PBS  phosphate buffered solution 
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PFN  profluorescent nitroxide 
RNS  reactive nitrogen species 
ROS  reactive oxygen species 
ROT  rotenone 
RPMI  Roswell Park Memorial Institute 
SOD  superoxide dismutase 
SSC  side scatter 
TEMPO  2,2,6,6-tetramethylpiperidin-2-yloxyl 
TEF  tetraethylfluorescein nitroxide 
TER  tetraethylrhodamine nitroxide 
TEIO  1,1,3,3-tetraethylisoindoline-2-yloxyl 
TMIO  1,1,3,3-tetramethylisoindoline-2-yloxyl  
TMR  tetramethylfluorescein nitroxide 
TMRM  tetramethylrhodamine methyl ester 
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CHAPTER 1 
Introduction & Literature 
Review 
 
The significance of oxidative and reductive redox processes as an integral part of our 
daily life is increasingly being recognized. Redox chemistry has a significant role in 
key biological processes, namely cell signalling,
1,2
 cell fate determination
3,4
 and 
supporting the body’s defence systems.5,6 These key biological processes contribute 
significantly to the overall well-being of living organisms.  
 
Free radicals generated by daily factors such as ultraviolet (UV) radiation, drug 
ingestion and other exogenous stress have been shown to alter the balance between 
oxidative and reductive processes. This may lead to physiological and pathological 
abnormalities such as cancer,
7
 vascular diseases,
8 
and neurodegenerative diseases.
9
 
Understanding the chemistry of free radicals is crucial in order to assess and control 
the damaging effects of these reactive species.  
 
1.1 What are free radicals? 
Free radicals are chemical species that have an unpaired electron in their outer or 
valence orbitals. The presence of an unpaired electron renders these species highly 
reactive. Free radicals readily accept electrons from surrounding molecules within the 
biological environment such as lipids and deoxyribonucleic acid (DNA), subsequently 
oxidizing these molecules as the free radicals are reduced.
8,10
  
 
Free radicals that are particularly relevant to biological systems can be generalized 
into two categories i) reactive oxygen species (ROS) and ii) reactive nitrogen species 
(RNS).
11,12 
 
 
ROS is a collective term used to describe oxygen containing free radicals such as 
superoxide (O2•
-
), hydroxyl (OH•) and peroxyl (RO2•) radicals. ROS also includes 
non-radicals which exist either as oxidizing agents and/or are easily converted into 
 29 
radicals such as hydrogen peroxide (H2O2).
13
 RNS on the other hand, includes radicals 
such as nitric oxide (NO•), peroxynitrite (ONO2
-
) and dinitrogen trioxide (N2O3).
14,15  
 
Many studies have shown that free radicals contribute significantly to the overall 
health deterioration and disease progression in humans. Free radicals may be 
responsible for the general deterioration that comes with aging.
15,16
 This occurs as a 
result of unstable free radicals reacting with major components of the body such as 
lipids, proteins and carbohydrates.
17 
These unstable free radicals initiate uncontrolled 
chain reactions generating further radicals from the molecules being attacked, thereby 
damaging the normal processes of living cells.
15,17,18 
Despite their negative effects, free 
radicals play an important part in the body’s defence mechanisms. Free radicals are 
generated endogenously by neutrophiles in response to pathogens.
19
  
 
A balance in the amount of free radicals within any biologically variable system is 
crucial.
20
 Oxidative stress results when the level of free radicals exceeds the 
endogenous redox defences within the system. This may lead to oxidative damage, 
which is associated with more than 50 diseases, such as Parkinson’s disease,21 
myocardial ischemia,
22
 diabetes,
23
 cancer
11
 , Ataxia-Telangiectasia,
24
 retinal 
ischaemia
25
 and in severe cases, organ dysfunction.
26   
 
It is crucial that the production of free radicals within the biological system is 
rigorously controlled by redox defences. One such defence is a group of molecules 
known as antioxidants. 
 
 
1.2 Antioxidants  
Antioxidant is a collective term for molecules that preferentially oxidize in the 
presence of other oxidisable substrates. The oxidisable substrates could be lipids, 
polyunsaturated fatty acids, proteins, carbohydrates and DNA. Antioxidants are 
preferentially oxidised even when present at a lower concentration when compared to 
the oxidisable substrate.
27 
 
 
Antioxidants therefore play a vital role in stabilizing, deactivating, delaying and 
preventing oxidation of molecules within biological systems or biomolecules. This 
prevents or at least limits oxidative damage.
28  
 30 
 
Antioxidants generally play two major roles: i) acting through preventive measures or 
ii) acting through repairing or reduction measures. Based on their mode of action, 
antioxidants are classified as being either a) primary or b) secondary antioxidants.
29 
 
a) Primary Antioxidants 
Primary antioxidants act in a preventative manner prior to the occurrence of oxidative 
damage. This is carried out by donating electrons or hydrogen atoms, scavenging free 
radicals or converting free radicals into more stable products. Examples include 
enzymes such as superoxide dismutase
30
, catalase,
30
 and small molecules such as 
vitamins, lutein, phenols and flavonoids.
31
 
 
b) Secondary Antioxidants 
Secondary antioxidants function in repairing or reducing sustained oxidative damage. 
Secondary antioxidants retard the formation of more free radicals by sequestering 
metal ions. This reduces hydroperoxyl (HO2•) radicals and H2O2 formation as well as 
quenches O2•
- 
and singlet oxygen. Examples of secondary antioxidants include 
glutathione and oxidoreductase.
32 
 
 
A method for assessing the redox status within a biological system is therefore crucial 
to monitor metabolic health. This would not only provide an assessment of the free 
radical status within biological systems, but could also serve as a means to determine 
the efficacy of the administration of an antioxidant treatment.   
 
Although free radicals have been studied since the 1950’s33 the development of a 
method for assessing the amount of free radicals within the biological system has been 
deemed challenging due to several factors. Firstly, the short lifetime of most free 
radicals, secondly, the presence of antioxidants in vivo and thirdly, the capability of 
the method to capture free radicals.
34
 Despite these factors, several techniques for 
assessing the amount of free radicals or the redox status have been explored over the 
last 64 years. 
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1.3 Oxidation reduction detection   
1.3.1 Spectroscopic techniques 
One of the most common and simplest redox status assessment techniques is 
spectroscopy using visually responsive probes. Such spectroscopic probes are 
substances (usually exogenous) which, upon reacting with free radicals, change their 
light absorption or emission characteristics.
34
 Changes in light absorption or emission 
characteristics can be measured by a spectrophotometer, where such changes reflect 
the redox status being measured. 
 
A widely used spectroscopic technique involves measuring the changes in absorbance 
intensity of the system under study upon the application of Nitro Blue Tetrazolium 
(NBT). NBT (initially colourless to yellow) is commonly used for the detection of O2•
-
 
radicals. NBT is reduced by O2•
-
 to a tetrazoinyl radical. The tetrazoinyl radical is 
subsequently reduced to the blue insoluble formazan (Figure 1.1).
34,35
 The change in 
spectroscopic properties, from NBT to formazan can be quantified using UV/Visible 
spectroscopy. 
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_____________________________________________________________________ 
Figure 1.1: Reduction of Nitro Blue Tetrazolium (NBT
2+
) to formazan.
34
 
 
Other spectroscopic techniques used for assessing the concentration of free radicals 
involve the reduction of Fe
3+
 in Cytochrome C protein by free radicals.  The reduction 
of Cytochrome C protein from Fe
3+
 to Fe
2+
 by free radicals gives rise to an increased 
absorption which can be measured by UV/visible spectroscopy (Figure 1.2).
34
 The 
reduction of Cytochrome C protein is commonly used for detecting O2•
-
, which results 
in an increased absorbance at 550 nm.
34,36,37    
 
 
 
_____________________________________________________________________ 
Figure 1.2: Reduction of Cytochrome C protein by free radicals.
34
 
 
The use of spectroscopic probes is advantageous because of simplicity and low cost, 
requiring only commonly available spectrophotometers. However, the probes are 
usually less sensitive compared to other analytical techniques as they can suffer from 
non-specific reactions. For example, apart from O2•
–
 radicals, NBT is also reduced by 
cellular reductases.
38
 Cytochrome C protein can also undergo re-oxidation in the 
presence of biological oxidants such as peroxidase thereby underestimating the actual 
redox level.
34
 
 
1.3.2 Chemiluminescence techniques 
Chemiluminescence is another commonly used antioxidant detection technique. 
Chemiluminescence involves chemical reactions which give rise to luminescence. 
Similar to spectroscopic techniques, chemiluminescent probes react with free radicals, 
resulting in a change of light emission characteristics. 
 
A commonly used chemiluminescence probe is 5-amino-2,3-dihydro-1,4-
phthalazinedione or luminol. The use of luminol as a free radical detector was first 
investigated in 1960 by Totter et al.
39
 The technique relies on a one-electron oxidation 
by H2O2 in the presence of peroxidase.  The theory behind this technique is that upon 
oxidation of H2O2, a luminol radical is produced. The luminal radical subsequently 
 33 
reduces oxygen (O2) to O2•
-
 radicals. The O2•
-
 radicals react with additional luminol 
radicals which results in the generation of an endoperoxide. Being unstable, the 
endoperoxide decomposes yielding nitrogen (N2) and aminophthalate. The 
aminophthalate is in an electronically excited state and hence emits a photon to return 
to the ground state. The emission of the photon is measured as luminescence (Figure 
1.3).
34 
 
   
_____________________________________________________________________ 
Figure 1.3: Reaction pathway of luminol derived chemiluminescence.
34
 
                                                                                                                                                                                                             
Another chemiluminescence probe commonly used is 2-methyl-6-(p-methoxyphenyl)-
3,7-dihydroimidazo (1,2-α) pyrazin-3-one or MCLA. MCLA is used mainly for 
detecting O2•
-
 radicals. MCLA has been covalently bound with fluorescein to 
synthesize 6-[4-[2-[N(`)-(5-fluoresceinyl)thioureido]ethoxy]phenyl]-2-
methylimidazo[1,2-alpha] pyrazin-3(7H)-one or FCLA (Figure 1.4). Upon interacting 
with the O2•
-
 radicals, the MCLA moiety transfers the singlet-excitation energy 
generated to fluorescein. This energy subsequently excites the fluorescein molecule. 
Upon losing energy and returning to the ground state, fluorescein emits a green 
luminescence.
34 
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_____________________________________________________________________ 
Figure 1.4: Chemical structure of 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo(1,2-α) 
pyrazin-3-one (MCLA) and 6-[4-[2-[n(`)-(5-fluoresceinyl)thioureido]ethoxy]phenyl]-2-
methyllimidazo[1,2-alpha]pyrazin-3(7H)-one (FCLA).
34
      
 
Other chemiluminescence probes include bis-N-methylacridinium, commonly known 
as lucigenin.
40
 Lucigenin is frequently used in the detection of O2•
-
 radicals. Li et al. 
have demonstrated that lucigenin monitors intramitochondrial O2•
-.
. Upon uptake into 
the mitochondria, lucigenin is reduced to a cation radical. This radical then reacts with 
O2•
- 
yielding an unstable dioxetane intermediate. The dioxetane intermediate 
subsequently decomposes producing 2 molecules of N-methylacridone which upon 
relaxation to the ground state, emits a photon (Figure 1.5).
34  
 
 
_____________________________________________________________________ 
Figure 1.5: Reaction pathway of lucigenin.
34
  
 
Similarly, the glycoprotein derived from the chemiluminescence mollusc Pholas 
dactylus, has been adapted as a detector for free radicals.
41
 Although the mechanism 
contributing to the chemiluminescence remains unclear, the glycoprotein, known as 
Pholasin has been used in the monitoring of loss of antioxidants and changes in the 
type of oxidants in plasma under oxidative stress.
42,43,44
 Glebska et al. deduced that 
upon reacting with peroxynitrite, Pholasin forms a reversible peroxynitrite-protein 
adduct. The protein adduct subsequently undergoes a series of unknown reactions, 
leading to the formation of an excited second intermediate. The second excited 
intermediate decays and return to ground state via the emission of light.
41
 Changes in 
the light intensity, is therefore an indication of the amount of peroxynitrite present.  
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Chemiluminescence although being simplistic in its application, suffers from low 
sensitivity. In some cases such as with luminol, chemiluminescence is inhibited by 
other substrates such as catalase and superoxide dismutase. MCLA on the other hand, 
suffers from low luminescence intensity and from light, temperature and pH 
sensitivity.
 
Other chemiluminescence probes are prone to auto-oxidation, giving rise to 
free radicals artificially as in the case of lucigenin. Another drawback associated with 
lucigenin is its slow response time. Lucigenin requires another cellular-reducing 
system such as NADPH (nicotinamide adenine dinucleotide phosphate-oxidase) 
oxidase to generate a chemiluminescence response which not only slows response 
time but may complicate the interpretation of the results.
34
 
 
 
1.3.3 Electron Paramagnetic Resonance (EPR) or Electron Spin Resonance (ESR)  
Electron Paramagnetic Resonance (EPR) or Electron Spin Resonance (ESR) enables 
the specific detection of the unpaired spins or paramagnetic nature within free radicals. 
This technique is based on the application of electromagnetic (microwave) radiation to 
excite electron populations from a low energy state to a high energy state. The 
concurrent application of an external magnetic field during microwave excitation 
causes the unpaired electrons to align at a low energy state or misalign at a high 
energy state, relative to the applied field.  The net absorption of electromagnetic 
radiation results in the generation of a spectrum, which indicates the presence of free 
radicals.
34
 
 
The short lifetime along with the degree of electron delocalisation, the presence of 
electron acceptor molecules in the environment as well as the mobility of the free 
radicals give rise to an issue where the free radicals do not generally accumulate in 
high enough amounts to be detectable by EPR.
45
 Hence, spin traps often have to be 
used to trap these species as longer lived derivatives. Spin traps are non-paramagnetic 
substances such as organic nitrone or nitroso compounds which react with free radicals 
providing radical adducts which are more stable and longer lasting.  The use of spin 
traps therefore, results in the accumulation of semi-stable paramagnetic compounds at 
detectable concentrations.
46
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The most commonly used nitrone or nitroso spin traps are 5,5-dimethyl-1-pyrroline N-
oxide (DMPO),  N-t-butyl-α-phenylnitrone (PBN) and 2-methyl-2-nitrosopropane 
(MNP) (Figure 1.6).
34,46  
 
 
_____________________________________________________________________ 
Figure 1.6: Examples of spin traps.
34,46 
 
EPR has been used in the detection of O2•
-
 and OH• radicals with the use of spin traps 
enabling the detection of more stable ascorbyl and tocopheroxyl radicals as well as 
heme-nitroxyl complexes.
47,48
 
 
The conversion of an hydroxylamine species back into a nitroxide results in the 
generation of an EPR signal and has been used as a means for the detection of ROS.  
Using 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine (Tempone-H) as probes, this 
technique has been used for the detection of O2•
- 
as well as ONOO
-
 radicals (Figure 
1.7).
34
 
 
 
_____________________________________________________________________ 
Figure 1.7: Detection of free radicals using 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine 
(Tempone-H).
34
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EPR has also been use to monitor the signal decay of stable radicals upon reaction of 
such radicals with other reactive free radicals. A commonly applied probe for this 
technique is TAM OX063 (Figure 1.8) which has been proposed for the detection of 
O2•
-  
radicals.
34
 The rate of loss of the stable radical signal via EPR correlates to the 
amount of free radicals present in the system under study.  
 
 
_____________________________________________________________________ 
Figure 1.8: Chemical structure of TAM OX063.
34
  
 
Although EPR has the advantage of being specific, in that it directly interacts with the 
paramagnetic nature of free radicals, EPR does possess several limitations. For 
example with the use of nitrone spin traps, reaction can also occur with the carbon 
atom adjacent to the incipient nitroxide group which is distant from the molecular 
orbital containing the unpaired electron. This can give rise to spectra with complicated 
hyperfine couplings, which in turn makes analysis of the observed spectra difficult.
49
 
 
Even with the use of spin traps, hydroxylamines or stable free radicals as probes, EPR 
still suffers from a lack of spatial resolution in assessing redox status in cells. This is 
probably due to the inability of the system to correct the EPR linewidth for distortion 
cause by uneven shapes among cells. This limitation makes it difficult to monitor 
processes at the subcellular level.
50  
 
1.3.4 Fluorescence techniques 
Fluorescence probes can be categorized into two types i) positive and ii) negative. 
Positive fluorescence probes consist of non-fluorescent or weakly fluorescent 
compounds, which increase in fluorescence intensity upon reacting with free radicals. 
Conversely, negative probes consist of inherently bright fluorescent compounds, 
 38 
which upon reacting with free radicals switch off fluorescence or reduce in 
fluorescence intensity.
51 
The most commonly used approach is the positive 
fluorescence probe.  
 
An example of a positive fluorescence probe is p-hydroxyphenylacetic acid (PHPA) 
(Figure 1.9).   PHPA has been used for the detection of H2O2 in the presence of 
peroxidase. The probe is oxidized by H2O2 to a dimer with absorption and emission 
maxima at 300 and 400 nm respectively. It has been reported that the dimer fluoresces 
optimally at pH > 10. However, the limitation of PHPA is the generation of spectra 
that overlaps with the absorption of common cellular components such as 
Nicotinamide Adenine Dinucleotide Phosphate (NADPH).
52 
 
 
_____________________________________________________________________ 
Figure 1.9: Chemical structures of p-hydroxyphenylacetic acid.
53
 
 
Apart from PHPA, another example of a positive fluorescence probe is 
dichlorodihydrofluorescein diacetate, known as DCFH-DA (Figure 1.10). DCFH-DA 
is a frequently applied probe for the intracellular detection of free radicals such as 
H2O2.
54
 DCFH-DA is a cell permeable ester which crosses the cell membrane and is 
hydrolysed by intracellular esterase to the DCFH anion. Subsequent two-electron 
oxidation of DCFH gives rise to DCF (dichlorofluorescein) which can be monitored 
via fluorescence.
54, 55 
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_____________________________________________________________________ 
Figure 1.10: Dichlorodihydrofluorescein diacetate (DCFH-DA) in the detection of hydrogen 
peroxide (H2O2). GSH- Glutathione; GSSG- Glutathione Disulfide; NADH- Nicotiamide 
Adenine Dinucleotide.
55
 
 
Although DCFH-DA is commonly used, this probe is of limited value because of auto-
oxidation and the loss of probe from the intracellular to extracellular environment via 
diffusion.
56
 DCFH-DA does not directly react with H2O2 and hence DCF fluorescence 
cannot be used as a direct measure of H2O2 content.
55
 DCFH-DA also lacks 
specificity. For example when detecting H2O2, the DCF radical can react with oxygen 
giving rise to O2•
-
 which will distort the results obtained.
55
 In addition, the presence of 
transition metals and heme peroxidase catalyse the oxidation of DCFH-DA which 
further falsifies fluorescence results.
55
  
 
7-Hydroxy-6-methoxy-coumarin (scopoletin) and 9,10-dimethylanthracene (DMA) 
(Figure 1.11) are examples of commonly used negative fluorescence probes.
51
 
Scopoletin have been widely used for the detection of H2O2 in leukocytes
56
 and 
eosinophils
57
 while DMA used for O2•
-
 detection.
51 
The reduction in fluorescence 
observed in scopoletin results from oxidation of the probe while that of DMA results 
from the generation of a non-fluorescent endoperoxide. Assessment of redox status by 
both negative probes is hence based on an inverse fluorescence measurement.   
 
 
 40 
 
_____________________________________________________________________ 
Figure 1.11: Chemical structures of A) 7-hydroxy-6-methoxy-coumarin (scopoletin) and B) 
9,10-dimethylantracene (DMA).
51 
 
Similar to their positive counterparts, these negative fluorescence probes also present 
several drawbacks. Scopoletin has excitation and emission spectra which are 
susceptible to autofluorescence from biological samples. Apart from that it has a low 
fluorescent emission and hence requires significant signal amplification leading to 
increased background signal. Scopoletin also suffers from pH and temperature 
sensitivity.
51
 DMA, on the other hand, is not located in a preferential depth within the 
membrane
58
 and hence may have issues crossing the cell membrane to assess 
intracellular redox status.  These limitations have possibly led to the low adoption of 
negative fluorogenic probe technology.  
 
Current fluorescence techniques are limited by sensitivity to pH variation (changes in 
fluorescence intensity upon subjection to varying pH conditions) and photobleaching 
(loss of fluorophore molecules upon illumination). However, because the fluorescence 
technique is able to provide a sensitive response with a wide range of free radicals it is 
a preferred technique. Fluorescence detection is versatile through incorporation of 
biological relevant systems such as microtiter plate readers and microscopes as well as 
advanced and more sensitive detection systems such as flow cytometry. The use of 
confocal microscopy makes studies of cellular topography relating to free radical 
generation possible.
 
In addition, fluorescence techniques have been frequently used in 
cell culture and tissue due to their ability to provide biologically relevant excitation 
and emission profiles.
51,59
   
 
A 
B 
 41 
Recent research has led to harnessing the paramagnetic nature of radicals, one of 
which is nitroxide, NO• in the development of improved fluorescence techniques.  
 
1.4 Nitroxides 
N,N-disubstituted nitric oxides or nitroxides [R(NO•)R’] are stable free radicals. Two 
main factors contribute to their stability: 1) resistance towards dimerization and 2) the 
nature of the substituents attached to the radical centre. 
 
Dimerization requires the formation of a weak R2NO-ONR2 bond which is 
thermodynamically unstable. However, if an aromatic ring is attached to the nitrogen 
atom of the nitroxide moiety, this results in bimolecular degradation. Delocalization of 
the radical into the aromatic system stabilizes the molecule by creating a new reaction 
centre for biomolecular degradation by increasing the radical character of the carbon 
atoms within the aromatic ring. Most stable nitroxides, hence possess bulky functional 
groups such as the alkyl groups of 1,1,3,3-tetramethylisoindolin-2-yloxyl (TMIO) and 
2,2,6,6-tetramethylpiperidin-1-yloxyl (TEMPO) (Figure 1.12).
60
 
 
 
_____________________________________________________________________ 
Figure 1.12: A) Pathway showing the biomolecular degradation of a phenyl-substituted 
nitroxide. B) Chemical structures of TMIO and TEMPO.
60
  
 
The application of nitroxides to assess redox status of biological systems is 
increasingly being recognized. A nitroxide may undergo a one-electron reduction 
giving rise to a hydroxylamine after the addition of H
+
. On the other hand, nitroxides 
can also undergo a one-electron oxidation giving rise to oxoammonium ions (Figure 
1.13).
50,59,61
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_____________________________________________________________________ 
Figure 1.13: Oxidation and reduction of a nitroxide. 
 
The ability of nitroxides to shuttle between redox states has enabled nitroxides to be 
modified into redox sensing probes. The coupling of nitroxides to fluorophores has 
created a new class of analytical tool given the name profluorescent nitroxides or 
PFNs. 
 
1.5 Profluorescent nitroxide (PFN) probes  
Due to the potential of nitroxides to act as both reductants and oxidants, the idea of 
combining a fluorophore with a nitroxide in a single molecule as a redox probe, was 
first described in 1965 by Stryer and Griffith.
62
 The significance of this technology 
was subsequently realized by Likhtenstein et al.
63
 and Bystryak et al.
64
  
 
A paramagnetic nitroxide moiety covalently linked in close proximity to a fluorophore 
efficiently quenches the excited state of the fluorophore, suppressing fluorescence. 
The suppression of fluorescence occurs as a result of inter- and intra- molecular 
quenching of the singlet excited state of the fluorophore. The unpaired electron within 
the nitroxide is capable of quenching the excited singlet state which normally leads to 
fluorescence. Consequently, reduction of the nitroxide to a diamagnetic 
hydroxylamine, oxidation to an oxammonium ion, or radical trapping removes this 
quenching effect, and hence restores the fluorescence emission of the fluorophore 
(Figure 1.14).
59
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_____________________________________________________________________ 
Figure 1.14: Coupling a fluorophore to a nitroxide to generate a profluorescent nitroxide 
(PFN) probe.
59
 
 
Several terms have been used to describe the system of combining a nitroxide with a 
fluorophore such as fluorophore-nitronyl probes,
65 
double spin and fluorescence 
sensors,
66
 prefluorescent
67 
and profluorescent probes.
68
 Among the terms used, the 
most appropriate term would be that with the prefix “pro” as this describes the 
fluorescence of a fluorophore being masked or hidden.
59
 Such a term also aligns with 
other pro-system terms used in literature such as pro-drug. Coupled to a nitroxide, the 
profluorescent system can be conveniently termed a profluorescent nitroxide or PFN 
probe.  
 
Blough et al. have provided significant evidence showing the profluorescent nature of 
a nitroxide coupled to a fluorophore. Upon comparing a series of paramagnetic 
nitroxide-napthalene adducts with their diamagnetic analogues (Figure 1.15), the 
fluorescence quantum yields of the paramagnetic derivatives were recorded by Blough 
et al. to be 2.9-6.0 or 30-55 fold (depending on the solvent). Such quantum yield is 
lower than the corresponding diamagnetic derivatives. Alternatively, reduction of the 
nitroxide moiety to the diamagnetic hydroxylamine restores the fluorescence yield to a 
level that parallels the effect of nitroxide radical loss from the system.
69
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Figure 1.15: Paramagnetic nitroxide-napthalene adduct and their diamagnetic analogues.
69
 
 
Further studies by Green and Blough et al. reported that the absorption and emission 
energies of attached fluorophores are not affected by the presence of the nitroxide. In 
addition, the residual emission that is observed from the PFN arises from the excited 
fluorophore and not from charge recombination.
61
 An understanding of the underlying 
mechanism contributing to the suppression of fluorescence is therefore of importance. 
 
1.6 Underlying mechanism contributing to profluorescence 
The underlying mechanism contributing to the observed reduction in fluorescence 
intensity of the PFN, is based mainly on the electron exchange between the nitroxide 
and the fluorophore moiety, which occurs both inter- and intra-molecularly.
70,71,72
   
 
Fluorescence involves the excitation of a singlet ground state (S0) electron to one of 
the vibration levels (S2) of the excited state, upon receiving energy from a photon 
(Figure 1.16). 
A 
B 
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______________________________________________________________ 
Figure 1.16: Jablonski diagram of electron transition.
59
 
 
The excited electron subsequently returns to ground state via a two-step process. The 
first step is through the dissipation of energy to the surrounding environment via 
vibrational relaxation (VR). This is followed by an internal conversion (IC) until the 
energy within the molecule reaches the lowest vibrational level of the first excited 
singlet state, S1. The second step on the other hand, involves several mechanisms 
depending on the difference in energy between the ground (S0) and excited state (S1). 
In cases where the energy difference is large, energy is either lost via emission of a 
photon through a process commonly known as fluorescence (F). Alternatively, energy 
can be lost by intersystem crossing (ISC), which is a process involving changes in the 
spin angular momentum of the excited electron. If the energy difference is relatively 
small, energy loss can occur via non-radiative internal conversion.
59
 
 
In the typical case of fluorescence (F), the emitted photon is detected within the visible 
or ultraviolet spectrum range. In the case of ISC, it results in changes in multiplicity, 
giving rise to a triplet excited state (T1).
59
 
 
The relaxation of the excited electron from the first excited triplet state, may result in 
the emission of a photon through a process known as phosphorescence. Similar to 
fluorescence, phosphorescence involves the emission of light, but over a longer time 
 46 
scale and longer wavelength compared to fluorescence. In most cases however, the 
energy loss occurs in a non-radiative manner, arising from various chemical and 
physical interactions of the molecule with the surrounding owing to the long lifetime 
of the triplet state.
59
  
 
ISC therefore reduces fluorescence emission, and it is via facilitating this electronic 
interaction that paramagnetic species quench fluorescence when coupled to 
fluorophores. In summary, upon coupling to fluorophores, the unpaired spin of the 
nitroxide radical interacts with the electron of the conjugated system within the 
fluorophore. This in turn results in a change in multiplicity, giving rise to the triplet 
excited state.
59,73
 
 
Owing to the antiparallel spin of the radical, the singlet ground state and the lowest 
singlet excited state, S0 and S1, become doublet states, D0 and Dn respectively (Figure 
1.17). The triplet state, T1 (Figure 1.16) is represented by D1 (Figure 1.17). 
 
 
_____________________________________________________________________ 
Figure 1.17: Electronic transition occurring upon coupling of a nitroxide radical to a 
fluorophore.
59
 (SOMO- single occupied molecular orbital) 
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Such a change in electronic transition, indicates that the previously S1 to T1 transition 
which occurs during ISC, and subsequently the T1 to S0 transition becomes spin-
allowable within double state transitions. This then results in the lost of 
fluorescence.
59,73
  
 
The extent to which fluorescence quenching occurs is related to the proximity of the 
nitroxide radical to the fluorophore within the coupled molecule. Effective quenching 
is known to only occur within the distance of 0-25Å. In most synthesized PFN probes, 
this is achieved via a short spacer unit coupling both the radical and the fluorophore.
74
  
 
Such an electron-transition quenching mechanism makes the PFN a powerful 
analytical tool to follow redox chemistry. The use of PFN as redox probes allows 
several unique analytical capabilities. 
 
1.7 Advantages of profluorescent nitroxide (PFN) probes 
Combining the properties of a nitroxide and fluorophore provides advantages such as: 
 
1) Allowing the measurement of EPR and fluorescence information simultaneously 
from the system being studied.  
2) Monitoring redox processes in systems of low optical density and those giving a 
weak EPR signal. This is due to the higher sensitivity of fluorescence spectroscopy, 
which may be deemed to be two or three orders more sensitive compared to optical 
absorption spectroscopy and EPR.  
3) Enabling the photochemical and photophysical nature of a system to be studied by 
comparing EPR and fluorescence data. 
 
A wide range of studies have been undertaken involving the use of PFN probes. These 
studies range from physical applications, such as monitoring the formation of 
polymers as well as the degradation of aging materials
68,69,70 
and the dectection of 
radical in pollutants,
71,72
 through to the analysis of biological systems. 
 
Exploring the applications of PFN’s to assess biological systems forms the basis of 
this research project. Since the discovery of PFN probes, past studies have discussed 
the one-electron reduction of nitroxide to hydroxylamine involving biological relevant 
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reductants such as uric acid, quercetin, glutathione as well as cysteine.
65,75,76,77
 Among 
all the reductants, the reduction of the PFN probes by ascorbate has been most studied.  
  
1.8 Past studies of profluorescent nitroxides (PFN’s) probes in biological systems 
In one of the earliest studies in this field, Blough and Simpson reported of the 
reduction of naphthalene probes by ascorbate (Figure 1.18). These researchers 
reported an increase in fluorescence quantum yield along with a reduction in EPR 
signal intensity.
69 
 
 
_____________________________________________________________________ 
Figure 1.18: Naphthalene PFN probes.
69 
 
 
Similar studies involving the reduction of a PFN with ascorbate were carried out by 
Medvedeva et al. almost two decades later. Medvedeva et al. synthesized a pyrene-
nitroxide adduct, 4,4,5,5-tetramethyl-2-(1-pyryl)-2-imidazoline-1-oxyl-3-oxide or 
FNO. FNO demonstrated the capability to detect O2•
-
 and to quantitatively estimate 
the antioxidant activity of compounds such as ascorbic acid and quercetin within 
biological systems (Figure 1.19). Similar to the findings of Blough and Simpson, the 
reduction of FNO gave a reduction in EPR signal intensity, accompanied by an 
increase in fluorescent quantum yield. Medvedeva et al. also reported that using the 
FNO as probe, the presence of O2•
-
 radical could be determined when generated at 
rates as low as 10 nM per minute.
65 
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_____________________________________________________________________ 
Figure 1.19: Reduction pathyway of 4,4,5,5-tetramethyl-2-(1-pyryl)-2-imidazoline-1-oxyl-3-
oxide (FNO).
65
 
 
Recent experiments by Yamasaki et al. involving piperidine nitroxides, agree with 
previous results by Blough, Simpson and Medvedeva. In an attempt to study the 
structure-reactivity relationship of piperidine nitroxides, Yamasaki et al. documented 
the rate of reduction in EPR signal intensity upon reacting several piperidine 
nitroxides (Figure 1.20) with ascorbate. It was concluded that the redox potentials of 
piperidine nitroxides were influenced by the electronic effect of substitutents at 2 and 
6 positions of the piperidine ring.
78 
 
 
_____________________________________________________________________ 
Figure 1.20: Piperidine nitroxides with varying substituents.
78 
 
 
Lozinsky et al. proposed the use of two PFN probes (Figure 1.21) for quantitative 
analysis of ascorbic acid in biological and chemical solutions. By performing a series 
of reactions between the PFN probes and ascorbic acid, a calibration curve for analysis 
was obtained. Based on the calibration curve, the ascorbic acid concentration of 
samples was determined. Lozinsky et al. reported that the PFN probes allow for 
determination of ascorbic acid content ranging from 0.01 to 0.8 mM and higher.
79 
 50 
 
_____________________________________________________________________ 
Figure 1.21: PFN probes used in quantitative analysis of ascorbic acid content.
79
 
 
Further experiments by Lozinsky et al.
79
 reported that the reduction of the dansyl PFN 
probe (Figure 1.21A) was influenced by large biomolecules. Bovine serum albumin 
(BSA) was observed to affect the kinetics of ascorbate reducing the dansyl PFN probe. 
It was postulated that such an observation was a result of the adsorption of both, the 
PFN probe and ascorbate into the protein molecule. This in turn enabled a more 
efficient reduction process.
80
  
 
Similarly, Saphier et al. reported that a piperidine-based PFN probe, 5-
dimethylaminonapthalene-1-sulfonyl-4-amino-2,2,6,6-tetramethyl-1-piperidine-oxyl is 
adsorbed to the outer surface of erythrocytes (red blood cells).
81 
Within the scope of 
human blood sample,  Saphier et al. further reported that the only natural reducing 
agent that reacts with the piperidine-based probe is ascorbate. 
 
The first obervation of an increase in fluorescence intensity and a decrease in EPR 
signal in umbelliferone-nitroxide PFN probes (Figure 1.22) upon reduction by 
ascorbic acid was reported by Sato et al. Both umbelliferone-nitroxide PFNs A and B, 
have longer wavelength (443 and 450 nm) compared to those developed by 
Medvedeva et al., Yamasaki, et al., Lozinsky et al. and Saphier et al. These longer 
wavelength PFNs, have been used for assessing both the presense of OH• radicals in 
biosystems and Fe(II) in solution.
82 
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_____________________________________________________________________ 
Figure 1.22: Umbelliferone-nitroxide adducts.
82
 
 
On the basis of Nitric Oxide Cheletropic Traps (NOCTs), Sustmann et al. successfully 
developed a system which traps nitric oxide (NO) into cyclic nitroxide radicals which 
in turn give rise to a PFN in situ.
83,84,85,86
 Several derivatives of phenanthrene-based 
cheletropic traps were developed and were given the term fluorescent nitric oxide 
cheletropic traps (FNOCTs) (Figure 1.23).  
 
 
_____________________________________________________________________ 
Figure 1.23: Phenanthrene-based fluorescent nitric oxide chelotrophic traps (FNOCTs).
86
 
 
Further changes on the FNOCTs traps were carried out by Sustmann et al. The 
previous phenanthrene fluorophore within FNOCTs was replaced with a pyrene group 
(Figure 1.24). Among the different FNOCTs in Figure 1.23, FNOCT A which has a 
A B C 
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higher NO trapping rate, has been used in NO trapping studies in cell culture systems 
and in tissue model, namely pig aorta.
86
     
 
 
_____________________________________________________________________ 
Figure 1.24: Pyrene-based fluorescent nitric oxide chelotrophic traps (FNOCTs).
86
 
 
On a genetic biomolecular level, a PFN has been applied in the development of a 
nucleoside. Barhate et al.
87
 and Cekan et al.
88
 reported of the development of 
Nucleoside C, consisting of the attachment of an isoindoline nitroxide to a nucleoside 
(Figure 1.25). Nucleoside C is able to base pair with the guanine nucleotide within 
deoxyribonucleic acid (DNA). The nitroxide moiety within Nucleoside C is reduced 
by sodium sulphide (Na2S) in DNA to the corresponding hydroxylamine, yielding a 
fluorescent probe that enables the study of the base pairing and hence structure of the 
DNA double helix.   
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_____________________________________________________________________ 
Figure 1.25: Attachment of isoindoline profluorescent nitroxide to nucleoside.
88
 
 
Derivatives of PFNs have also been reported as a means for the detection of urushiol 
from poison oak.
89
 Urushiol is the collective term given to compounds consisting of 3-
substituted catechols, which have a long linear hydrophobic, C15 or C17 alkyl group 
chain (Figure 1.26). Urushiol is the causative agent of dermatitis, a type of skin 
inflammation, which in severe cases leads to fatal systemic anaphylaxis.  
  
 
_____________________________________________________________________ 
Figure 1.26: Structure of most abundant urushiol.
 89
 
 
Braslau et al. developed a PFN probe which reacts with B-n-butylcatecholboronate 
ester (Figure 1.27). The ester is formed in situ as a result of the reaction between the 
catechol uroshiol and n-butylboronic acid. The PFN probe is reduced by the ester to an 
N-alkoxyamine which is fluorescent.
89
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_____________________________________________________________________ 
Figure 1.27: Fluorescent N-alkoxyamine formed from reaction between catechol and n-
butylboronic acid via Dansyl-TEMPO PFN probe.
89
 
 
 In addition, Mito et al. have synthesized two PFN probes (Figure 1.28) in an attempt 
to monitor the aggregation process of amyloid-ß fibrils, the main constituents 
suspected to lead to Alzheimer’s disease. It was reported that among the two PFN 
probes, the fluorescence of PFN probe A increased in a concentration-dependent 
manner after incubation with 100 µM amyloid-ß peptide for 24 hours. PFN probe B on 
the other hand, showed a decrease in fluorescence intensity with increasing 
concentration of probe after incubation with 100 µM amyloid-ß peptide. The 
difference in observation was proposed to possibly be due to the distance between the 
nitroxyl radical and the fluorophore.
90
  
 
 
_____________________________________________________________________ 
Figure 1.28: PFN probes for monitoring aggregation process of amyloid-ß fibrils.
90
 
 
Synthetic chemistry has enabled alteration and advancement to be made to the 
chemical structure of these probes, tethering a variety of spacers to the fluorophore 
and/or nitroxide segments which alters the absorption, fluorescence and EPR signals. 
Such alteration has enabled a better understanding of redox processes occurring in 
biological environments.
59
 One such environment is within the mitochondria. Being 
one of the main sites of ROS generation, monitoring the redox status within the 
mitochondria is of utmost importance as it determines the overall well-being of the 
biological system.  
A B 
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1.9 Mitochondria- important ROS generation site within biological systems 
The mitochondrion is a small organelle (0.5-1µm in diameter) located within 
eukaryotic cells (cells with nuclear membranes). This membrane bound organelle can 
be divided into three compartments, i) outer membrane, ii) intermembrane space and 
iii) inner membrane. Each compartment functions synergistically in the generation of 
energy, in the form of Adenosine Trisphosphate (ATP) via a process known as 
oxidative phosphorylation. 
 
As the name suggests, oxidative phosphorylation involves the oxidation of nutrients 
taken up by cells and subsequently phosphorylation of an Adenosine Diphosphate 
(ADP) unit. Oxidative phosphorylation involves the transfer of electrons along several 
protein complexes (Complex I, II, III and IV), collectively known as the electron 
transport chain (ETC) (Figure 1.29).  
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_____________________________________________________________________ 
Figure 1.29: A) Layout of a mitochondria; B) Schematic of electron transport chain. 
 
Catabolic processes within the biological system breaks down food molecules to form 
Nicotiamide Adenosine Dinucleotide (NADH), succinate and ADP. Electrons flow 
from NADH to Complex I (NADH Dehydrogenase). The flow of these electrons is 
accompanied by the flow of positively charged hydrogen ions (H
+
) into the 
intermembrane space.
91 
 
 
Succinate on the other hand, loses electrons to Complex II forming fumarate. The 
electrons are subsequently transferred to Complex III (Cytochome C Reductase) via 
Ubiquinone (Coenzyme Q). These electrons are then transferred to Complex IV 
A 
B 
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(Cytochrome C Oxidase) via Cytochrome C, involving the pumping of H
+
 from the 
matrix into the intermembrane space. The pumping of H
+ 
generates an electrochemical 
proton gradient. This proton gradient aids in the generation of ATP, powered by the 
flow of H
+ 
down the gradient via ATP synthase. The electrons from Complex IV 
subsequently interact with oxygen forming water molecules.
91
 
 
Although the ETC is essential to cellular energy generation, the transduction of 
electrons which occur during ATP generation may be a significant source of damaging 
ROS, especially O2•
-
 and H2O2 as the electrons escape from the ETC. Such 
phenomena has been described as ROS “leakage”.92,93  
 
Complex I and Complex III are the main sites for ROS production and therefore ROS 
leakage. Complex I and Complex III generates strongly oxidizing compounds such as 
reduced flavin mononucleotide and semiquinone, which has redox potential below 
than that of O2•
-
.
92
 Having redox probes that target or are able to detect redox changes 
within the mitochondria, focusing on both Complex I and III is therefore of significant 
value. 
 
Several techniques have been explored to investigate mitochondrial redox status. Such 
techniques range from the use of EPR, to liquid chromatography tandem mass 
spectroscopy and fluorescence analysis.  
 
1.9.1 Electron Paramagnetic Resonance (EPR) techniques for the analysis of 
mitochondrial redox status  
It was reported that Hardy et al. (2007) successfully modified a cyclic nitrone with an 
attached triphenylphosphonium group, to form Mito-5-diethoxyphosphoryl-5-methyl-
1-pyrroline N-oxide (DEPMPO). Mito-DEPMPO covalently bonds with O2•
-
 
producing a stable product, Mito-DEPMPO-OOH which is EPR detectable (Figure 
1.30).  Despite the mitochondrial specificity of Mito-DEPMPO, the probe suffers from 
several drawbacks. A high concentration of Mito-DEPMPO is required, around 50 
mM for good detectable EPR signal. Such large amounts may affect normal 
functioning of the mitochondria due to accumulation of lipophilic cations within the 
mitochondrial membrane. This in turn affects the proton gradient within the ETC, 
which in turn affects ATP generation.
94,95 
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_____________________________________________________________________ 
Figure 1.30: Formation of mitochondrial targeted 5-diethoxyphosphoryl-5-methyl-1-pyrroline 
N-oxide (Mito-DEPMPO-OOH).
94
 
 
Similarly, Dikalov et al. reported of the use of the cyclic hydroxylamine mito 
TEMPO-H (1-hydroxy-4-[2-triphenylphosphonio-acetamido]-2,2,6,6 
tetramethylpiperidine) as a means of assessing ROS within the mitochondria (Figure 
1.31). The hydroxylamine in its reduced state is oxidized by ROS into EPR detectable 
stable nitroxide. An increase in EPR signal, hence serves as a measure of possible 
oxidative stress within the biological system under study. Superoxide dismustase 
activity however, has been reported to inhibit mito TEMPO-H signal caused by the 
mitochondrial toxin, rotenone.
96,97,98 
 
 
_____________________________________________________________________
 
Figure 1.31: Cyclic hydroxylamine, mito TEMPO-H used in assessing reactive oxygen species 
(ROS) within the mitochondria.
96,97,98
 
 
One of the earliest methods for detecting O2•
-
 is via spin trapping with 5,5-dimethyl-1-
pyrroline-N-oxide (DMPO) (Figure 1.32).
99 
 Immunospin trapping techniques which 
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couple spin trap and immunology have been used to detect free radical adduct 
formation in the mitochondria.
100
 Using immunospin trapping, DMPO adducts formed 
from reaction with O2•
-
 within the ETC have been detected.
101
 DMPO reacts with 
protein radicals resulting in the formation of DMPO-protein radicals. These DMPO-
protein radicals reacts with antibodies which can subsequently be identified via 
immunostaining, western blot analysis and immunofluorescence.
99 
 Despite the 
versatility of this technique, it is limited to the detection of radical protein adducts and 
the development of antibodies to react with the DMPO-protein radicals can be 
costly.
55,102 
 
 
_____________________________________________________________________ 
Figure 1.32: Chemical structure of DMPO.
103
 
 
Owing to their advantage of a direct interaction with ROS in assessing redox status 
within the mitochondria, these EPR probes minimize possible artifacts generated from 
multistep reactions. However, a down-side to this technique is that it requires the use 
of relatively expensive and complex EPR instrumentation.  
 
Apart from EPR, liquid chromatography techniques have also been explored in 
assessing redox status within mitochondria. 
 
1.9.2 Liquid chromatography tandem mass spectroscopy techniques for the 
analysis of mitochondrial redox status 
Cocheme et al. (2011) described a liquid chromatography tandem mass spectrometry 
probe targeting the mitochondria by the name MitoBoronic acid or MitoB.
104 
As 
suggested by its name, MitoB consists of an arylboronic acid conjugated to a 
triphenylphosphium group. This species reacts with hydrogen peroxide (H2O2) and 
peroxynitrite (ONOO
-
) to form a phenol product, MitoP (Figure 1.33). Quantification 
of MitoP/MitoB ratio by liquid chromatography tandem mass spectroscopy provides 
quantification of the H2O2 and ONOO
-
 levels within the system studied.  Although this 
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technique of quantifying MitoP/MitoB is sensitive, it requires rather laborious effort 
and specialized instrumentation.  
 
 
_____________________________________________________________________ 
Figure 1.33: Reaction of MitoBoronic acid (MitoB) with hydroxyl radicals.
104
 
 
Owing to its sensitivity and easily assessable instrumentation, much focus has been 
placed in developing fluorescent techniques for assessing redox status within the 
mitochondria. 
 
1.9.3 Fluorescence techniques for the analysis of mitochondrial redox status 
MitoSox
 
which consists of dihydroethidium with an attached triphenylphosphonium 
group, is a commonly used fluorescent probe.
105,106,107
  This probe was initially 
developed for O2•
-
 detection. However, it has been reported that two products are 
formed from the use of MitoSox, i) 2-hydroxyethidium which is formed from reaction 
with O2•
-
 and ii) ethidium, formed from non-specific redox reactions (Figure 1.34).
108
  
 
MitoSox has been used to assess redox status within patients suffering from Wolf-
Hirschborn syndrome (a genetic disorder which results in a complex set of 
developmental phenotypes ranging from growth restriction to intellectual 
disability).
109
 MitoSox has also been used to monitor oxidative stress in myocardial 
ischemia- reperfusion injuries,
110
 to detect ROS in obesity,
111
 to monitor the 
production of ROS in B cell immune response,
112 
to assess genetic oxidative stress in 
cancer
113,114
 and to monitor regulation of oxidative stress in cells resulting from 
radiation stress.
115 
 
Despite being a commonly used probe, MitoSox suffers from several drawbacks. 
MitoSox is somewhat unstable. It suffers from potential interference from heme 
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enzymes
116 
and is prone to auto-oxidation as well as being light sensitive. In addition, 
the chemical transformation involves a free radical intermediate which can be 
scavenged by antioxidants, thereby compromising results.
117
  
 
 
_____________________________________________________________________ 
Figure 1.34: Detection of reactive oxygen species (ROS) by MitoSox.
108
 
 
Analogous to MitoSox, boronate based probes have also been developed. An example 
of such a boronate probe involves the conjugation of a boronate based peroxy-yellow 
1 moiety with a triphenylphosphonium group. This probe known as MitoPY1 has been 
used to detect H2O2 within the mitochondria (Figure 1.35).
118,119 
Boronate suppresses 
the fluorescence of the peroxy-yellow 1 fluorophore. Upon nucleophilic attack the 
boronate is cleaved, restoring the fluorescence of the fluorophore.
55 
Boronate based 
probes however, suffer from a lack of specificity as they have to compete with fast 
reacting substrates such as peroxiredoxin and gluthatione peroxidase for H2O2.
120 
Change in the fluorescence intensity of MitoPY1 is therefore an estimate of the degree 
of oxidative stress within the studied biological system.
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Figure 1.35:  Detection of hydrogen peroxide by MitoPY1.
55
 
 
Although much effort has been undertaken to investigate mitochondrial redox status, 
many of the described techniques and probes are unable to provide an on-going or 
reversible dynamic real time assessment of redox status. 
 
Attempts to address this short-coming, have led to the development of redox sensitive 
proteins. These proteins involve the integration of genetic codes within plasmid 
constructs, via adenoviruses into the genome of host cells. The genetic codes within 
the plasmid are transcribed and translated into redox sensitive proteins within host 
cells. A subsequent change in fluorescence intensity of the redox proteins within host 
cells is hence an indication of intracellular redox status.
55
  
 
One such protein is the mitochondrial targeted protein is pHyPer-dMito. pHyPer-
dMito is derived from the yellow fluorescent protein, cpYFP. It has been used in 
assessing H2O2 within human uterine cancer cells (HeLa).
121
  
 
Other examples include a class of redox sensitive protein derived from green 
fluorescent proteins conjugated to redox sensitive reporter (roGFP). Meyer et al. 
reported a redox sensitive reporter (roGFP2) conjugated with a H2O2 sensor (Orp1).
122 
H2O2 oxidizes Orp1, upon which Orp1 is reduced by roGFP2. The oxidized species of 
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roGFP2 subsequently emits fluorescence which can be measured as an indication of 
oxidative stress.
123
   
 
These redox sensitive proteins have the advantage of allowing real time measurement 
of varying ROS fluxes within cells, as they are constantly being produced within cells. 
The drawback of the application of these proteins is the possibility of over-production 
of redox sensitive proteins within cells. Over production may in turn act as a precursor 
to initiate an increase in ROS generation, giving false positive results.
55 
A possible 
solution to this drawback is the application of redox sensitive proteins along with other 
small molecule fluorescence probes.
124
  
 
Recently, Hirosawa et al. (2012) reported a TEMPO-conjugated profluorescent probe, 
MitoRP which enables dynamic reversible monitoring of mitochondrial redox status. 
The TEMPO (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl moiety is coupled to the 
fluorophore coumarin 343 (Figure 1.36). The monocationic coumarin fluorophore aids 
in the localization of the probe into the mitochondria. The probe, however, was 
reported to only show specifity towards monitoring dynamic changes of electron flow 
within Complex I of the ETC and not other protein complexes.
125 
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Figure 1.36: Reduction of MitoRP.
125
 
 
Despite the many techniques explored and developed for assessing mitochondrial 
redox status, much remains to be discovered. A need to develop reversible and easily 
applicable small molecule fluorescent probes is of much importance.  
 
Previous work by Morrow
126
 has successfully developed two isoindoline 
profluorescent fluorescein nitroxides, which will be referred to as tetramethyl- and 
tetraethyl-fluorescein profluorescent nitroxides in this study (Figure 1.37). Initial 
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studies on the tetraethylfluorescein nitroxide (TEF) by Morrow
126 
reported that in the 
prescence of the nitroxide radical, the fluorescence of the chromphore fluorescein was 
suppressed from ɸf 0.94 to 0.11, an almost 90% suppression.  
 
 
_____________________________________________________________________ 
Figure 1.37: Tetramethyl- and tetraethyl-fluorescein nitroxide synthesized by Morrow.
126
 
 
Using flow cytometry, Morrow showed that both TMF and TEF have the capability to 
assess overall cellular redox environment. It was reported that normal fibroblast cells 
treated with rotenone and 2-deoxyglucose, resulted in an oxidizing cellular 
environment which was displayed by a lack of reduction of both TMF and TEF. Both 
TMF and TEF were also shown to be more effective than the widely used redox 
sensing probe, 2’,7’-dichlorohydrofluorescein diacetate.126 
 
The study presented here serves as a follow up to the initial study by Morrow, 
focusing on comparing and assessing the application of varying PFN probes in 
monitoring biological redox status, especially in the mitochondria. 
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Research Objectives 
In summary, the previously described spectrophotometry and chemiluminescence 
techniques for assessing biological redox status, although inexpensive and simple, 
suffer from several limitations namely low sensitivity and undergo non-specific 
reactions. EPR on the other hand, although specific in detecting unpaired spin within 
free radicals, is expensive and involve complex instrumentation setup and application. 
In addition, most of the redox sensing techniques up-to-date are not reversible in their 
detection and hence are not able to provide a dynamic assessment of the redox status 
within biological systems. 
 
The main objective of this study is therefore to validate an inexpensive, simple, 
sensitive, and reliable as well as mitochondrial specific fluorescence based redox 
sensing techniques based on the use of PFN probe. In achieving this objective, the 
capabilities of fluorescein- and rhodamine-based profluorescent nitroxide (PFN) as 
potential probes to monitor the redox state of the mitochondria will be explored. 
Several factors will be assessed namely: 
 i) The reduction rate of the PFN.  
ii) The influence of changing pH conditions on the fluorescence characteristics of the 
PFN.  
iii) The localization of the PFN in cells (intracellular localization of the PFN). 
iv) The reversible characteristics of the PFN. 
v)  The applicability of the PFN within biological systems. 
 
Probes which are easily reduced or oxidized can deliver a rapid response to the overall 
redox status within the biological system studied. However, such a response can be a 
limitation when assessing the redox status within highly redox active intracellular 
organelles such as the mitochondria. The rapid response of the probe gives rise to 
difficulties in differentiating the probe response to additives and changing redox 
conditions before reaching the mitochondria. Ideally the best probes for such cellular 
environments should not react prior to reaching the organelle. This enables any 
response detected to reflect the conditions within the targeted organelle better, where 
in this case the highly reactive mitochondria. 
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In this study, the effect of increasing steric bulk of ethyl- over methyl-groups around 
the radical centre on reduction rate of PFN will be assessed. The reduction rate of 
tetramethylfluorescein (TMF) and tetraethylfluorescein (TEF) (Figure 1.37) will be 
compared through fluorescence measurement of solutions containing TMF or TEF, 
upon reacting the PFN solutions with ascorbate.    
 
The pH stability of the chromophore molecules attached to the nitroxde moiety in PFN 
probes will also be assesed. As fluorescence intensity has been reported to change with 
the surrounding pH,
50,126
 a probe which exhibits stable fluorescence over a biologically 
relevant pH range is therefore desired. The pH stability of fluorescein- compared to 
rhodamine-based PFN probes will also be determined in order to validate the 
usefulness of the probe.  
 
Another important criteria in validating biological relevant redox probes, is the 
localization of the PFN probe within cells or the intracellular localization of the PFN 
probe. It is crucial that the PFN probe localizes to redox relevant sites such as the 
mitochondria. Following the initial development of fluorescein- and rhodamine -based 
PFNs by Morrow,
126
 the localization of both these PFNs will be explored. Rhodamine 
chromophores are known to exhibit great photostability, high water solubility, possess 
excitation and emission profiles free of interference from biological molecules and 
capable of localizing into the mitochondria.
127,128
  
 
In addition, the reversibility of PFN will also be explored. Such reversible detection 
methodologies would enable a dynamic assessment of the redox status within 
biological systems. Redox probe having such reversible detection capability has the 
potential to be used to assess the efficacy of antioxidant therapies provided to patient 
by comparing the oxidative stress level within diseased models both prior and after 
antioxidant treatment.    
 
Flow cytometry as well as microscopic techniques will also be used to determine the 
capability of the PFN probes to assess intracellular redox status on a variety of cell 
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lines including Ataxia-Telangiectasia (A-T) diseased cells, which are known to be 
under oxidative stress.  
 
In summary the key objectives are:    
1) To compare the reduction rate of methyl- and ethyl- based PFN probes. 
2) To compare the pH stability of fluorescein- and rhodamine-based PFN probes. 
3) To monitor the localization of PFN probes within biological cells. 
4) To assess the reversibility characteristics of PFN in providing a dynamic assessment 
of biological redox condition. 
5) To assess the capability of the developed PFN probes to detect redox changes 
within biological systems and oxidative stress associated diseases, namely Ataxia 
Telangiectasia (A-T).  
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CHAPTER 2 
Materials and Methods 
 
A general outline of the reagents and chemicals, initial cell preperation procedures and 
statistical analysis carried out in this study are described below. Any deviations from 
these described procedures are outlined in the experimental section of the subsequent 
results and discussion chapter. Concentrations of the probes and drugs used were 
based on previous work carried out by Morrow.
126
  
 
2.1 Reagents and chemicals 
All reagents and chemicals are of analytical grade and were purchased from Ajax 
Finechem, BDH Chemicals, Sigma-Aldrich or Invitrogen. All experimental work 
described were carried out in Queensland University of Technology (QUT), 
Queensland Medical Research (QIMR), Queensland Eye Institute (QEI) and 
University of Queensland Centre for Clinical Research (UQCCR). 
 
Acknowledgement goes to Dr. Benjamin Morrow and Dr. Benjamin Chalmers for 
developing and synthesizing the PFN probes used in this study. The PFN probes were 
tetramethylfluorescein (TMF), tetraethylfluorescein (TEF), tetraethylrhodamine 
(TER), methyl ester tetraethylrhodamine (ME-TER) nitroxides along with their 
respective non-radical alkylated derivatives (Figure 2.1.1). Synthesis steps were 
developed based on work by Morrow, et al.
50,126 
The probes were kept as solids at -
20
o
C with minimum light exposure.  
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_____________________________________________________________________ 
Figure 2.1.1: Chemical structures of different PFN probes used in this study. 
 
2.2 Cell lines and animal model 
The cell lines used in this study were as listed below: 
a. Immortalized Human Telomerase Reverse Transcriptase (hTERT) fibroblast cells 
b. Normal human fibroblast cells 
c. Ataxia Telangiectasia diseased human fibroblast cells 
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d. Human cerebellum cells (DAOY) 
e. Human cervical cancer cells (HeLa) 
f. Adenocarcinomic human alveolar basal epithelial cells (A549) 
g. Rat immortalized retinal cells  
   
Cell lines a to f were supplied by Lavin research group from QIMR, while cell line g 
was supplied through the Barnett research group from QEI/UQCCR. Cells were 
cultured either from a biopsy human sample or purchased. In all cases, stock solution 
of cells were cultured and maintained in Dulbecco’s modified eagle medium (DMEM) 
added with fetal calf serum (final concentration 12% v/v) and penicillin / streptomycin 
(final concentration 1% v/v). hTERT fibroblast cells were used to compliment a 
follow up study to previous work by Morrow.
126
 
 
Studies on Sprague-Dawley rats were carried out by Miss Cassie Rayner from 
UQCCR using the methyl ester tetraethylrhodamine (ME-TER) probe. Further details 
of these animal experiments are described in the experimental section of the 
subsequent chapter. 
  
2.3 Cell culture 
All cells were incubated and maintained at 37
o
C, under incubation condition of 37
o
C, 
with 95% air and 5% carbon dioxide (CO2). Cell lines a to g mentioned previously 
were cultured in Dulbecco’s Modified Eagle medium (DMEM). The medium DMEM 
was supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v). All cell lines were subcultured 
when they reached 80-90% confluency by washing the cells with 1-5 mL of 10% v/v 
versene (depending on the size of the flask) followed by 0.5-5 mL of 0.5% v/v trypsin 
(depending on the size of the flask). The cells were left to detach for approximately 1 
minute under incubation condition of 37
o
C, with 95% air and 5% CO2. 10 mL of 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] were subsequently 
added to deactivate the trypsin. Cells were subcultured from the trypsinized stock 
according to the required dilution using DMEM [supplemented with fetal calf serum 
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(final concentration 12% v/v) and penicillin streptomycin antibiotics (final 
concentration 1% v/v)].  
 
Cell morphology as well as viability was monitored by microscopic examination and 
cells were assessed for possible Mycoplasma infection.  
 
In assessing Mycoplasma infection, cells were cultured unto a coverslip within a petri 
dish at an initial concentration of approximately 5x10
4
 cells per mL for 7 days. The 
cells were cultured within DMEM supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin antibiotics (final concentration 1% 
v/v). The coverslip containing cells were carefully removed from the petri dish and the 
cells were fixed by fully submerging the coverslip containing cells into 3% 
paraformadehyde (PFA) for 15 mins. The fixed cells were then washed twice with 
1xPBS and subsequently stained by adding 3 µL of VectorShield (DAPI) dye. The 
coverslip of cells were then fixed unto a glass slide and the fluorescence of the cells 
were imaged under a fluorescence microscope excited at wavelength 372-408 nm and 
emission detected at wavelength 417-453 nm. Imaging was carried out at room 
temperature (27
o
C, normal atmospheric condition).  Based on assessment, cells used 
were free from Mycoplasma contamination. 
 
2.4 Cell counting 
Cells were treated with 1 mL of 10% v/v versene, followed by 0.5 mL of 0.5% v/v 
trypsin and left to detach for approximately 1 minute from the flask under incubation 
condition of 37
o
C, with 9% air and 5% CO2 into a 5 mL FALCON tube. Trypsinized 
cells were centrifuged (1200xg for 4 mins) and the supernatant removed. The cells 
were resuspended in 1x phosphate buffer solution (PBS) and taking into consideration 
the dilution factor, cell solution were stained with 0.4 % Trypan Blue in a 1:1 ratio. 
Total cell numbers were determined via the use of Countess Automated Cell Counter. 
The Countess Automated Cell Counter is a benchtop automated cell counter which 
uses optics and image analysis to quantify cell number within a cell sample. The use of 
an automated cell counter was chosen over the standard haemocytometer to improve 
accuracy of cell count. 
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In quantifying the cells number using the Countess Automated Cell Counter, 10 µL of 
cell sample mixed with 10 µL of 0.4% Trypan Blue. 10 µL of the mixture was then 
added to the cell counter slide and the image of the cells optimize by using the focus 
knob to adjust the image for analysis and the number of cells quantified.  
 
2.5 Fluorescence measurements 
Fluorescence was measured using the Cary Eclipse fluorometer. Depending of the 
probes, each treatment was excited and fluorescence emission measured at different 
wavelengths.  
 Excitation wavelength Emission wavelength 
Tetramethylfluorescein 491 nm 519 nm 
Tetraethylfluorescein 491 nm 519 nm 
Tetraethylrhodamine 556 nm 575 nm 
Non-radical alkylated derivative 
of Tetraethylrhodamine nitroxide 
556 nm 575 nm 
 
Measurements were carried out at room temperature with voltage set at 550V and 
samples were mixed to ensure a homogenous solution prior measuring the 
fluorescence intensity of the solution.  
 
Fluorescence measurement was used:  
i) To assess the reduction rate of methyl- and ethyl-based PFN probes. 
ii) To compare the pH stability of fluorescein- and rhodamine-based PFN probes. 
iii) To assess the reversibility characteristics of PFN in providing a dynamic 
assessment of biological redox condition. 
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Assessing the reduction rate of PFN probes 
Reduction rates were determined by measuring the change in fluorescence intensity 
(using Cary Eclipse fluorometer) over time upon subjecting the PFN probes, TMF, 
TEF and TER (each of concentration 0.5 µM, prepared from a 1 mM dimethyl 
sulfoxide, DMSO stock solution) to reduction by ascorbate at a concentration of 375 
µM. The concentration of ascorbate was added at an excess of 750 times to that of the 
PFN probes (1:750) in a final volume of 4 mL of 1x PBS. 
 
Experiments were carried out in argon-bubbled 1xPBS (pH 7) to minimize residual 
oxygen from re-oxidizing hydroxylamine back to nitroxide. The PFN probes were 
excited at wavelength 491 nm and fluorescence emission was measured at 519 nm in 
the case of TMF and TEF. However, in the case of TER, an excitation at wavelength 
556 nm, followed by measuring the emission fluorescence intensity at wavelength 575 
nm was applied. Changes in fluorescence intensity of the PFN solutions were recorded 
over time by recording the change in fluorescence intensity of PFN every 3 minutes 
over 600 minutes within the fluorometer. The reduction rates of the PFN probes were 
calculated (based on the slope of the graph of percentage fluorescence intensity against 
time) and compared. 
  
Comparing the pH stability of fluorescein- and rhodamine-based PFN probes 
Solutions of varying pH were prepared from a 10 M hydrochloric acid (HCl) solution 
through serial dilution. 10 M HCl was diluted 100-fold to give a solution of pH 1. 
Subsequently, an aliquot of the pH 1 solution was further diluted 10-fold to give a 
solution of pH 2. An aliquot of the pH 2 solution was further diluted 10-fold to give a 
solution of pH 3. Successive 10-fold dilutions were carried out until a pH 7 solution 
was obtained.  
 
On the other hand, a 10 M sodium hydroxide (NaOH) solution was diluted 100-fold to 
give a solution of pH 14. An aliquot of the pH 14 solution was further diluted 10-fold, 
providing a solution of pH 13. Successive 10-fold dilutions were carried out until a pH 
8 solution was obtained. 
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Stock solutions of TEF and TER at a concentration of 1 mM were prepared in DMSO 
and added to the different pH solutions, to give a final probe concentration of 0.5 µM. 
The prepared solutions were mixed and the fluorescence intensity of the mixture was 
obtained via the fluorometer. An excitation wavelength of 491 nm and an emission 
wavelength of 519 nm were applied to assess the fluorescence intensity of TEF in 
varying pH solutions, while an excitation wavelength of 556 nm and an emission 
wavelength of 575 nm were applied to assess the fluorescence intensity of TER.  
 
Assessing the reversible characteristics of PFN in providing a dynamic assessment of 
biological redox condition 
1 µM of TER and Rhodamine B was prepared in a cuvette from 4 mM DMSO stock in 
a final volume of 4 mL 1xPBS solution (Concentration was selected based on previous 
study to previous work by Morrow.
126
). The PBS solution was previously bubbled 
with N2 to minimize residual O2, hence preventing initial oxidation. Fluorescence 
intensity of TER solution was measured in a fluorometer (Cary Eclipse) at time point 0 
minute (excite: 556nm, emit: 575nm). The reductant, hydrazine hydrate (N2H2.H2O) 
was subsequently added in excess (200 mM) and fluorescence intensity was measured 
immediately. Fluorescence of TER was then measured every 3 minutes, for a total of 
15 minutes. Reduction by N2H2.H2O was carried out in a sealed environment to avoid 
oxidation by atmospheric O2. 
 
The solution was subsequently oxidized by bubbling O2 into the solution for 
approximately 15 minutes. Concurrent changes in fluorescence intensity within the 
solution were measured every 3 minutes within the fluorometer. The whole reduction 
and oxidation cycle was repeated while the changes in fluorescence intensity within 
the solution were measured accordingly. The observed fluorescence changes were 
displayed as a plot of change in fluorescence intensity (a.u.) at 580 nm against time 
(minutes).  
 
2.6 Fluorescence imaging 
Fluorescence imaging was carried out based on the use of i) Deltavision Microscope 
and ii) Spinning Disk Microscope. In both cases, live cells were imaged under an 
atmospheric condition of 37
o
C and 5% CO2 in air. Depending on the probes in which 
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the cells were incubated with, each treatment was excited and fluorescence emission 
measured at different wavelengths.  
 
 Excitation wavelength Emission wavelength 
Tetramethylfluorescein nitroxide 
(TMF) 
447-503 nm 487-559 nm 
Tetraethylfluorescein nitroxide 
(TER) 
447-503 nm 487-559 nm 
 
MitoTracker Green 
(commercially available 
Mitchondria dye) 
 
 
 
447-503 nm 
 
 
487-559 nm 
LysoTracker Blue (commercially 
available lysosome dye) 
372-408 nm 417-453 nm 
Tetraethylrhodamine nitroxide 
(TER) 
515-569 nm 549-639 nm 
Non-radical alkylated derivative 
of TER  
(MT-TER) 
515-569 nm 549-639 nm 
Methyl Ester 
Tetraethylrhodamine Nitroxide 
515-569 nm 549-639 nm 
 
Non-radical alkylated derivative 
of MT-ME-TERe 
 
 
515-569 nm 
 
549-639 nm 
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Hoechst 33258 372-408 nm 417-453 nm 
 
Samples were mixed to ensure a homogenous solution by carefully pipetting the 
solution several times, while taking care to avoid detaching cells from the culture dish.  
 
i) Deltavision microscope imaging 
1.5x10
5
 cells per mL of hTERT immortalized human fibroblast cells were cultured 
overnight in IBIDI slides in DMEM containing fetal calf serum (final concentration 
12% v/v), penicillin streptomycin antibiotics (final concentration 1% v/v) and phenol 
red.  
 
The cells were subsequently incubated with different compounds [1 µM TMF, 1 µM 
TEF, 1 µM TER and MT-TER (Figure 2.1.1), 1 µM or 5 nM ME-TER and MT- ME-
TER, 1.6 µM Hoechst 33258, 100 nM MitoTracker Green or 50 nM LysoTracker Blue 
(Figure 2.6.1)] by replacing previous medium within each well with 2 mL of phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)], containing the 
different compounds. 
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Figure 2.6.1: Chemical structures of several compounds used in Deltavision 
microscope imaging. 
__________________________________________________________________ 
 
 The cells were incubated for 45 minutes (an incubation period of 45 minutes was 
chosen to coincide with previous studies by Morrow
126
) at 37
0
C under an atmosphere 
of 5% CO2 in air.  Upon incubation, the cells were washed once with 2 mL of phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)]. A new batch of 2 mL 
phenol red free DMEM [supplemented with fetal calf serum (final concentration 12% 
v/v) and penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to 
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each well prior imaging. Imaging conditions were maintained at 37
o
C under an 
atmosphere of 5% CO2 in air.  
 
ii) Spinning disk microscopy 
Conventional fluorescence microscopy involves exciting the sample under observation 
with a broad stream of light. The fluorescence given off by the sample, both within 
and out of focal plane were subsequently collected and imaged. In the case of confocal 
fluorescence microscopy, a pinhole is used to block out light which is out of focus. 
This improves the resolution of image.  
 
A commonly used confocal fluorescence microscopic technique is the confocal laser 
scanning microscope. Such a laser scanning microscope uses a laser of distinct 
wavelength governed by the nature of the sample to rapidly scan the sample at several 
different points. The light returning from each point is quantified by a photomultiplier 
tube and a digital image is reconstructed.
129
  
 
Although the confocal laser scanning microscope is able to provide a fast response, the 
microscope however suffers from a trade off between image resolution and imaging 
speed. In order to obtain a significantly good resolution in a short period of time, 
relatively intense laser power has to be used. Such intense power can result in 
photobleaching and even phototoxicity in live cell imaging.
130
 
 
Another technology that has the potential to overcome this limitation is a spinning disk 
instrument where the microscope is equipped with multiple pin holes. A spinning disk 
containing rapidly rotating pinhole disk enables thousands of light points to scan the 
sample simultaneously and can achieve frame rates up to 1000 frames per second 
(Figure 2.6.2). This enables the use of a lower intensity laser power and multiple point 
detection simultaneously, giving high resolution images in a short period of time.
130
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_____________________________________________________________________ 
Figure 2.6.2: Layout of a spinning disk microscopy (Figure adapted from Stehbens et al., 
2012)
130
 (CCD- cooled charged-coupled device cameras). 
 
Due to its sensitivity and low phototoxicity, spinning disk microscopic techniques was 
used in this study to: A) assess the effect of PFN probes on cells by incubating cells 
with PFN probe ME-TER and imaging the condition of the cells every 3 minutes over 
time; B) to assess the efficacy of lutein as an antioxidant therapy in reducing oxidative 
stress. The CV1000 spinning disk microscope was used in this study.  
 
A) Assessing the effect of PFN on cells 
The effect of ME-TER on cells was assessed. 4x10
5
cells per mL of hTERT 
immortalized human fibroblast cells were cultured in IBIDI slides overnight in 
DMEM media [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)]. The cells were 
subsequently incubated with 25 nM of ME-TER (prepared in 2 mL of phenol red free 
DMEM media supplemented with fetal calf serum (final concentration 12% v/v) and 
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penicillin streptomycin (final concentration 1% v/v) and localization of probe was 
imaged under the CV1000 spinning disk microscope every 3 minutes for over 24 
hours. Imaging conditions were maintained at 37
o
C and 5% CO2. The probe was 
excited at wavelength 561 nm and emission detected at wavelength 582 nm.  
 
B) Assessing the efficacy of lutein as an antioxidant therapy in reducing oxidative 
stress 
4x10
5
 cells per mL of hTERT immortalized human fibroblast cells were cultured in 
IBIDI slides overnight in DMEM media [supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin antibiotics (final concentration 1% 
v/v)]. The cells were subsequently incubated with 300 µL of 25 nM ME-TER 
(prepared from a 10 mM DMSO stock,  in 2 mL of phenol red free DMEM media 
supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v) for 45 minutes. The media was 
then replaced with a fresh batch of media (300 µL) that does not contain ME-TER (but 
supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v). The ME-TER treated cells were 
subsequently imaged and the change in fluorescence intensity was imaged every 
minute for 3 minutes.  
 
During imaging, the cells were then subjected to different treatments as follow. 
Different compounds were added to the cells within IBIDI slides between imaging 
intervals. 
 
a) 45 minutes incubation with 25 nM of ME-TER (as described), followed by a 20 µM 
AMC treatment (prepared from a 100 mM DMSO stock) in a final volume of 300 µL. 
In addition to ME-TER, cells were also incubated with 100 nM MitoTracker Green 
(prepared from a 100 µM DMSO stock, in 2 mL of phenol red free DMEM media 
supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v) for 30 minutes. 
 
b) 45 minutes incubation with 25 nM of ME-TER (as described), followed by a 2 mM 
lutein treatment (prepared from  a 0.6 M DMSO stock) in a final volume of 300 µL.  
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c) 45 minutes incubation with 25 nM of ME-TER (as described), followed by a 20 µM 
AMC treatment (prepared from a 100 mM DMSO stock) and 2 mM lutein treatment 
(prepared from  a 0.6 M DMSO stock) in a final volume of 300 µL. 
  
d) A blank solution was prepared where upon 45 minutes incubation with 25 nM of 
ME-TER (as described), cells were incubated with DMSO in place of AMC and 
lutein, in a final volume of 300 µL. 
 
Fluorescence intensity of ME-TER treated cells subjected to the different treatment 
were imaged and compared accordingly. An excitation at wavelength 515-569 nm and 
emission detection at wavelength 549-639 nm was applied in the case of ME-TER, 
while in the case of MitoTracker Green, an excitation at wavelength 447-503 nm and 
emission detection at wavelength 487-559 nm was applied. Imaging conditions were 
maintained at 37
0
C under an atmosphere of 5% CO2 in air in phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. 
 
2.7 Flow cytometry 
Flow cytometry enables the fluorescence of each cell in a cell suspension to be 
measured. PFN treated individual cells are excited based on the PFN specific 
wavelength and subsequently passed through a detector where the intensity of the light 
emited are measured. On average, the fluorescence intensity of 10000 cells can be 
measured within minutes. This technique therefore provides a fast as well as accurate 
cell flouorescence measurement. 
 
The flow cytometer used was BD LSRFortessa. Changes in PFN fluorescence 
intensity upon subjecting PFN treated cells to different treatment were analysed via 
flow cytometry. In all cases, live cells were pass through the detector at a flow rate of 
60 µL per min. Measurements were carried out at room temperature and cells were 
suspended in 500 mL of 1xPBS within 1 mL tubes. Cells were kept in dark to avoid 
photobleaching of PFN probe prior measruement. Between each run, the system was 
rinsed and cleaned with bleach (70% v/v) to avoid cross-contamination. Details of 
each fluorescence measurement carried out were outline in the subsequently chapters.   
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 A histogram representation and a typical scatter plot obtained from the flow 
cytometer, displaying cells incubated with TER is shown below. 
 
     
 
 
 
Figure 2.7.1: A) A histrogram representation (log scale) and B) a scatter plot of hTERT 
immortalized human fibroblast cells incubated with tetraethylrhodamine nitroxide (TER) as 
obtained from the BD LSRFortessa flow cytometer.  
 
In analysing flow cytometry data, light scattering and fluorescence data were collected 
from a total of 10000 cells. Light scattered in the forward direction, in line with the 
beam (FSC, X-axis on Figure 2.7.1B) relates to cell size. Light scattered in the side 
direction, 90
o
 to the incident beam (SSC, Y-axis on Figure 2.8.1B) is an indication of 
the surface roughness of the cells.
131 
 
Each data point on the scatter plot (Figure 2.7.1B) represents data from a single cell. 
The eclipse surrounding the set of data points represents the cell population of interest 
as these cells are of the correct size and shape. Data points nearer to the Y axis on the 
other hand, represent cellular debris and are, therefore, excluded from analysis. Such 
methodology of excluding cellular debris is commonly known as “gating”. The mean 
fluorescence data obtained from gating of cells was used to plot the histogram (Figure 
2.7.1A). Unless otherwise stated, all fluorescence data were gated and in each 
histogram, the fluorescence intensity were given on the X-axis (log scale) while the 
number of cell count were given on the Y-axis. 
A B 
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A stock culture of hTERT immortalized human fibroblast cells were prepared as 
described in 2.3. From the stock culture hTERT immortalized human fibroblast cells 
were seeded at an initial concentration of approximately 5x10
4
 cells per mL in 6-well 
plates. The cells were cultured in DMEM, supplemented with fetal calf serum (final 
concentration 12% v/v), penicillin streptomycin antibiotics (final concentration 1% 
v/v) and phenol red over a period of approximately 48 hours (final cell concentration 
approximately 2x10
5
 cells per mL). Within different wells, the cells were treated 
differently as follows. Details of each experiment will be described further in the 
experimental section in subsequent chapter.   
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with different probes [TER or MT-TER (1 µM for 
45  / 360 minutes), MitoSox (1 µM for 45 minutes), ME-TER or MT-ME-TER (1 µM 
/ 5 nm / 10 nm for 45 minutes), TMRM (20 nM for 30 minutes)] at 37
o
C, 5% CO2, in 
1 mL of DMEM [supplemented with fetal calf serum (final concentration 12% v/v), 
penicillin streptomycin antibiotics (final concentration 1% v/v) and phenol red].  The 
medium containing probes was subsequently removed by pipette and a fresh batch of 
DMEM containing varying concentration of ROT (0.01, 0.1, 1, 10, 100 µM) in a final 
volume of 1 mL was added to each of the 6 well respectively. The cells were incubated 
with ROT for 15 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
 
ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of AMC treatment. Upon treatment with TER, the cells were incubated with AMC (0, 
0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a final volume of 1 mL of DMEM for 
15 minutes.  
 
Blanks were carried out by replacing ROT or AMC with DMSO in a final volume of 1 
mL of DMEM, followed by15 minutes incubation at 37
0
C under an atmosphere of 5% 
CO2 in air. 
  
Upon treatment, the cells were washed with 1 mL of 10% v/v versene, treated with a 
stock solution of trypsin (adding 0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 
1200xg, time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells 
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were resuspended in 1 mL 1xPBS. Fluorescence readings for approximately 10000 
cells were subsequently obtained via the BD LSRFortessa flow cytometer. The cells 
incubated with TER were excited around wavelength 556 nm and emission collected 
at wavelength 575 nm. 
 
2.8 MTT assay 
An understanding on the cytotoxic effect of TER provides a greater understanding on 
the applicability of the PFN probe. A commonly used assay for assessing the 
cytotoxicity of compounds is the MTT or (3,-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. 
 
MTT (3,-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)  cell 
proliferation assay is a widely used assay for assessing cytotoxicity of a compound in 
cells. It involves the conversion of the water soluble MTT (3,-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) by the enzyme mitochondria reductase to an 
insoluble formazan which can be measured by UV absorption.
132
  
 
 
_______________________________________________________________________________________________ 
Figure 2.8.1: The conversion of water soluble MTT (3,-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) by the enzyme mitochondria reductase to an insoluble formazan 
which can be measured by UV absorption. 
 
hTRET immortalized human fibroblast cells were cultured in 96-well plate at a 
concentration of 2x10
4
cells per mL over a period of 24 hours. The cells were then 
incubated with compounds namely, TER, MT-TER and MitoSox (1 µM each) as well 
as ME-TER, MT-ME-TER (25 nM each). DMSO was used in place of the compounds 
as blank.  
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Cells were incubated with the compounds for 45 minutes, washed and replaced with 
100 µL of fresh phenol red free DMEM supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin (final concentration 1% v/v).   
 
A 12 mM stock solution of MTT was prepared by adding 1 mL of 1xPBS to a 5 mg 
vial of MTT (commercially available). 10 µL of the 12 mM MTT stock solution was 
added to each well within the 96-well plate. A negative control was prepared by 
adding of 10 µL of the 12 mM MTT stock solution to 100 µL media.  
 
The mixtures were incubated at 37
o
C for 4 hours. After which, 85 µL of the solution 
was removed and 50 µL of DMSO was added to each well. The mixtures were 
thoroughly mixed and incubated for a further 10 minutes at 37
o
C. 
 
The mixtures within the 96-well plate were subsequently mixed to form a homogenous 
solution and absorbance within each well was obtained at 540 nm using the BioTek 
Synergy plate reader.  
 
 2.9 Statistical analysis 
Statistical analysis was carried out using the GraphPad version 6 program. One-way 
ANOVA or Kruskal Wallis test with pos hoc testing using the Dunnett’s multiple 
comparison test as well as T-test were used to analyse the results in this study. Data 
used in statistical analysis were mean values of replicated experiments. 
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CHAPTER 3 
Optimizing Mitochondrial Redox 
Probe 
 
Assessing Bioreduction of Redox Probes 
The rate at which redox probes react with the changing oxidation-reduction conditions 
within cells determines the potential application of the probe. Redox probes which are 
easily reduced provide a rapid response to the redox status within the biological 
system studied. Although a rapid response can be desirable for certain conditions, this 
can prove to be a limitation when applied to a highly redox active intracellular 
organelles such as the mitochondria. An ideal mitochondrial redox probe should not 
react prior to reaching the organelle. This will ensure that any response given off by 
the probe reflects the redox status within the mitochondria. 
 
In an attempt to validate a mitochondrial redox sensing PFN, the rate at which 
nitroxides are reduced to hydroxylamines (Figure 3.1A) was assessed. As previously 
described, the groups attached to the nitroxide radical centre play an important role in 
determining the rate of reduction of the PFN.
133,134
 The attachment of a large group 
around the radical centre increases steric bulk around the radical centre. This increased 
in steric bulk hinders or slows down the reduction of the radical. Two PFNs of varying 
groups of different sizes attached to the nitroxide radical centre, tetramethylfluorescein 
(TMF) and tetraethylfluorescein (TEF) nitoxides (Figure 3.1B) were subjected to 
ascorbate reduction. The increase in fluorescence intensity of the PFNs upon reduction 
were subsequently measured and compared.  
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_____________________________________________________________________ 
Figure 3.1: A) Reduction and oxidation of nitroxide. B) Chemical structure of 
tetramethylfluorescein nitroxide (TMF) and tetraethylfluorescein nitroxide (TEF). 
 
3.1 Comparing reduction rate of tetramethyl- and tetraethyl-based PFN probes 
Past studies have reported that ethyl-based probes have a slower reduction rate 
compared to methyl-based probes. Marx et al. carried out an EPR comparative study 
of the reduction rate between 1,1,3,3-tetramethylisoindolin-2-yloxyl (TMIO) and 
1,1,3,3-tetraethylisoindolin-2-yloxyl (TEIO) (Figure 3.1.1) with ascorbic acid. It was 
reported that at a concentration of 25 equivalents of ascorbic acid, TEIO 2a did not 
undergo any reduction as observed in the case of TMIO 1a. In addition, upon reacting 
TMIO 1b and TEIO 2b (both probes at a concentration of 1x10
-3
M) with ascorbic acid 
(at a concentration of 1x10
-1
M), the initial concentration of TMIO 1b decreased by 50 
% within 0.5 minutes while TEIO 2b has a much longer half life of 13 minutes.
135 
 
 
 
 
B 
A 
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_____________________________________________________________________ 
Figure 3.1.1: Chemical structure of 1,1,3,3-tetramethyl-isoindolin-2-yloxyl (TMIO) and 
1,1,3,3-tetraethyl-isoindolin-2-yloxyl (TEIO) nitroxides.
135
 
  
A similar result was reported by Bobko et al. upon comparing the reduction rate of a 
pyrrolidine nitroxide with a tetraethyl-substituted nitroxide both reacted with ascorbate  
in de-oxygenated aqueous solution (Figure 3.1.2).  EPR results carried out by Bobko et 
al. reported that the tetraethyl-substituted nitroxide demonstrated a remarkable ability 
to resist reduction up to a 100 fold excess of ascorbate.
134
 
 
 
_____________________________________________________________________ 
Figure 3.1.2: Chemical structure of a pyrrolidine nitroxide and a tetraethyl-substituted 
nitroxide.
134
 
 
Kinoshita et al.
 
successfully synthesized a 2,2,6,6-tetraethylpiperidine nitroxide radical 
(Figure 3.1.3). Compared to other tetramethyl-substituted compounds such as 4-oxo-
2,2,6,6-tetramethylpiperidine-N-oxyl (oxo-TEMPO) and hydroxyl-TEMPO, the 
2,2,6,6-tetraethylpiperidine nitroxide radical showed increased stability towards 
reduction by ascorbic acid. Using EPR, the reduction rate constant (derived from the 
slope of a graph where the area under the low-field EPR signal of the first derivative 
spectrum was plotted against time after the addition of redox probe) of the tetramethyl-
substituted compounds was compared to that of the tetraethyl piperidine radical.
136
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Both oxo-TEMPO and hydroxyl-TEMPO were found to give a similar rate of 
reduction. The rate constants were found to be 0.427 ± 0.034 per min and 0.381 ± 
0.0076 per min, respectively. These rates are much higher than that of 2,2,6,6-
tetraethylpiperidine nitroxide radical (0.003 ± 0.0005 per min). This indicates that the 
tetramethyl-substituted compounds have a faster reduction rate compared to that of the 
tetraethyl-substituted nitroxide radical. 
  
 
_____________________________________________________________________ 
Figure 3.1.3: Chemical structures of 4-oxo-2,2,6,6-tetramethylpiperidine-N-oxyl (oxo-
TEMPO), hydroxyl-TEMPO and 2,2,6,6-tetraethylpiperidine nitroxide radical.
136
 
 
Using the biologically relevant reductant ascorbate, the reduction rates of the PFN 
probes, tetramethylfluorescein (TMF) and tetraethylfluorescein (TEF) (Figure 3.1.4) 
were compared. A 0.5 µM solution of PFN probes in DMSO/PBS buffer was treated 
with a 750 fold excess of ascorbate in PBS buffer and the fluorescence emission at 519 
nm was measured every 3 minutes for 10 hours.    
 
 
____________________________________________________________________________ 
Figure 3.1.4: Comparing the chemical structures of two fluorescein-based profluorescent 
(PFN) nitroxides, tetramethylfluorescein (TMF) and tetraethylfluorescein (TEF). 
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Experimental 
The experimental procedures used in this study are fully described in Materials and 
Methods, Section 2.5 (page 73). 
 
Results and discussion 
 
 
 
 
      
 
 
A 
C 
B 
D 
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_____________________________________________________________________ 
Figure 3.1.5: Comparing the reduction rate between tetramethylfluorescein (TMF) and 
tetraethylfluorescein (TEF) nitroxides using ascorbate as a reductant. A) Percentage (%) 
change in fluorescence intensity over time relative to fluorescence intensity at time point 0 
minutes, upon reacting TMF  (0.5 µM) with ascorbate (375 µM). B) Chemical structure of 
TMF. C) Percentage (%) change in fluorescence intensity over time relative to fluorescence 
intensity at time point 0 minutes, upon reacting TEF  (0.5 µM) with ascorbate (375 µM). D) 
Chemical structure of TEF. E) Comparing reduction rate of TMF and TEF, upon reacting with 
the PFN probes with ascorbate. The result was displayed as percentage (%) change in 
fluorescence intensity per min. [Results are average of replicated experiments. Data analysed 
using T-test where a P value < 0.05 was obtained, indicating significant difference in 
percentage (%) change in fluorescence intensity per min between TMF and TEF]. 
 
As previously mentioned (Figure 1.14), the attachment of a paramagnetic nitroxide 
moiety in close proximity to the chromophore efficiently quenches the excited state of 
the chromophore, suppressing its fluorescence. Consequently, the reduction of the 
nitroxide by ascorbate to a diamagnetic hydroxylamine (Figure 3.1.6), removes this 
quenching effect and restores the fluorescence of fluorescein.
50,59
 The rate at which the 
fluorescence of the PFN increases, therefore provides an indication of the reduction 
rate of the PFN.  
 
* 
E 
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_____________________________________________________________________ 
Figure 3.1.6: Reduction of nitroxide by ascorbate. 
 
As can be seen in Figure 3.1.5A and C, the fluorescence intensity of TMF reaches 
peak approximately 50 minutes into the reduction process. The fluorescence of TEF 
on the other hand, took over 600 minutes to reach its peak. These observations suggest 
TMF was being reduced at a faster rate compared to TEF. In addition, the fluorescence 
response of TMF reflects a slow reoxidation by oxygen or air where the fluorescence 
of TMF remained relatively stable after peaking at approximately 50 minutes up to 
600 minutes. 
 
Triplicate results showed that the reduction of TMF occurs at an average rate, 
0.37±0.03 per min compared to that of TEF, an average rate of 0.05±0.02 per min 
(Figure 3.1.5E).  The observed result agrees with that reported by Marx et al.
135
 and 
Bobko et al.
134
, concluding that the reduction of methyl-based probes occur at a faster 
rate compared to ethyl-based system. The slower reduction rate of ethyl-based probes 
hence makes these probes a more appropriate redox probe for assessing mitochondrial 
redox status as such probe will not react prior reaching the mitochondria. This will 
ensure that any response given off by the probe reflects the redox status within the 
mitochondria. 
. 
A possible reason for the decreased reduction rate of TEF compared to TMF is thought 
to be due to the enhanced steric bulk around the nitroxide radical centre within TEF. 
This is contributed by the greater size of the ethyl groups around the radical centre 
within TEF compared to its methyl counterpart, TMF (Figure 3.1.4). The enhanced 
steric bulk in TEF hinders or slows down the rate at which the radical centre reacts. 
The ethyl groups in TEF also increase the electron donating effect around the nitroxide 
centre within TEF. Such an increase in electron density increases shielding around the 
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radical centre. Hence, both increased steric bulk and shielding effects within TEF, led 
to a decreased reduction rate of the PFN. 
126,136,137,138 
 
Observations and results obtained from measuring the fluorescence response of 
ascorbate treated TMF and TEF (Figure 3.1.5) suggest that apart from EPR techniques 
used previously by Marx et al.
135
, Bobko et al.
134
 and Kinoshita et al.
136
, fluorescence 
measurement is a convenient means to follow the reduction response of PFN. 
 
In conclusion, upon comparing the reduction rate between TMF and TEF, ethyl-based 
probes have a slower reduction rate compared to methyl-based probes. The slower 
reduction rate of TEF makes it possibly a more relevant redox probe for assessing 
redox status within the redox active mitochondria where TEF will not react prior 
reaching the mitochondria. This will ensure that any response given off by the probe 
reflects the redox status within the mitochondria. 
. 
Apart from reduction rate, other factors such as effect of pH on fluorescence of PFN 
probe as well as localization of the probe serve as critical factors in determining the 
relevance of TEF as a mitochondrial redox probe. These factors will be explored in the 
next section.  
 
 
3.2 Assessing the pH stability and intracellular localization of 
tetraethylfluorescein nitroxide (TEF) in cells 
 
Compared to TMF, TEF has a slower reduction rate, making it potentially a more 
appropriate probe for assessing mitochondrial redox status. However, apart from 
reduction rate, other factors such as the pH stability of TEF and the actual localization 
of TEF into the mitochondria still need to be determined to assess the value of TEF as 
a mitochondrial redox sensing probe.  
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In assessing the pH stability of TEF, an understanding of biological pH in the 
locations where the probe is present is of importance. The steady state maintanence of 
pH 7.4 is critical for normal cellular function.
139,140,141,142
 However, it has been 
reported that disorders such as mucolipidosis (a metabolic disorder),
143
 neuronal 
ceroid lipofuscinoses (a neurodegenerative disorder)
144
 and cancer
145
 can impact on 
the pH of certain cells and tissues. 
 
In validating PFN probes to be used to assess redox status within both normal and 
diseased cells, pH stability of the PFN is crucial. Previous work by Morrow et al. 
reported that changes in pH affect the fluorescence intensity of TMF.
50,126
 Studies 
were hence carried out to assess the pH stability of TEF by measuring the change in 
fluorescence intensity of TEF under different pH conditions.  
 
The possible localization of TEF into the mitochondria was also assessed. This serves 
as a crucial factor to quality the use of TEF as a mitochondrial redox probe.  
 
Previous studies concluded that the localization of probes into the mitochondria is 
largely dependent on the charge present on the probe. Hardy et al. (2007)
94
 reported 
the successful use of a cyclic nitrone with an attached cationic triphenylphosphonium 
group to form Mito-5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide (DEPMPO). 
DEPMPO was used to access mitochondrial redox status via EPR (Figure 1.30). 
Similarly, Dikalov et al.
 96,97,98
 reported of the use of the cyclic hydroxylamine mito 
TEMPO-H (1-hydroxy-4-[2-triphenylphosphonio-acetamido]-2,2,6,6 
tetramethylpiperidine). Being cationic in nature, mito TEMPO-H was reported to 
successfully assess ROS level within the mitochondria via EPR (Figure 1.31).  
 
Further studies by Cocheme and Murphy et al. (2011)
104
 through the use of MitoB 
which consists of an arylboronic acid conjugated to a triphenylphosphium group 
(Figure 1.33)
 
confirmed the localization of cationic probes into the mitochondria. 
Recently, Hirosawa et al. (2012)
125
 reported the mitochondrial localization of the 
probe MitoRP which consist of a TEMPO (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl 
moiety coupled to the monocationic chromophore coumarin 343 (Figure 1.36).  
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The intracellular localization of both TMF and TEF nitroxides was observed via 
Deltavision fluorescence microscopy. hTERT immortalized human fibroblast cells 
were used in an attempt to study the behaviour of the PFN probes within human 
biological conditions. Details of the experiment to assess the pH stability of TEF and 
the localization of TMF and TEF are described below. 
 
Experimental  
Assessing the pH stability of  tetraethylfluorescein nitroxide (TEF) 
A 10 M hydrochloric acid (HCl) solution was prepared and diluted 100-fold to give a 
solution of pH 1. Subsequently, an aliquot of the pH 1 solution was further diluted 10-
fold to give a solution of pH 2. Similarly, an aliquot of the pH 2 solution was further 
diluted 10-fold to give a solution of pH 3. Successive 10-fold dilutions were carried 
out until a pH 7 solution was obtained.  
 
On the other hand, a 10 M sodium hydroxide (NaOH) solution was prepared and 
diluted 100-fold to give a solution of pH 14. An aliquot of the pH 14 solution was 
further diluted 10-fold, providing a solution of pH 13. Successive 10-fold dilutions 
were carried out until a pH 8 solution was obtained. 
 
Stock solutions of TEF at a concentration of 1 mM were prepared in DMSO and added 
to the different pH solutions, to give a final probe concentration of 0.5 µM. The 
prepared solutions were mixed and the fluorescence intensity of the mixture was 
obtained via fluorometer. The actual pH of the solution upon addition of probe was 
subsequently measured using a pH meter. The experiment was carried out in triplicate 
and the results obtained presented as graphs of relative fluorescence intensity against 
measured pH values. Fluorescence intensities were measured using the Cary Eclipse 
fluorometer on which an excitation wavelength of 491 nm and an emission wavelength 
of 519 nm were applied to assess the fluorescence intensity of TEF in varying pH 
solutions.  
 
Assessing the intracellular localization of probes 
hTERT immortalized human fibroblast cells at a concentration of 1.5x10
5
 cells per mL 
were cultured overnight in IBIDI slides. The cells were cultured in 2 mL of DMEM 
 98 
within each well, containing fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red.  
 
The cells were subsequently incubated with TMF or TEF by replacing previous 
medium within each well with 2 mL of phenol red free DMEM [supplemented with 
fetal calf serum (final concentration 12% v/v) and penicillin streptomycin antibiotics 
(final concentration 1% v/v)] containing 1 µM of either TMF or TEF. The cells were 
incubated for 45 minutes (an incubation period of 45 minutes was chosen to coincide 
with previous studies by Morrow
126
) at 37
0
C under an atmosphere of 5% CO2 in air. 
Care was taken to avoid rigorous movement in handling the slides to avoid detachment 
of cells from the slide.  
 
Upon completion of the incubation period, the cells were washed once with 2 mL of 
phenol red free DMEM [supplemented with fetal calf serum (final concentration 12% 
v/v) and penicillin streptomycin antibiotics (final concentration 1% v/v)] and were 
subsequently co-stained with the nucleus specific probe,  known as Hoechst 33258 to 
aid in the imaging of cells. This was achieved by adding 2 mL of phenol red free 
medium [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] containing 1.6 µM of 
Hoechst  to the cells in each well and the cells were incubated for 15 minutes at 37
0
C 
under an atmosphere of 5% CO2 in air.  
 
Similarly, another batch of cells was incubated with the commercially available 
mitochondrial specific probe, MitoTracker Green. Cells were incubated with 100 nM 
of MitoTracker Green in 2 mL of phenol red free medium [supplemented with fetal 
calf serum (final concentration 12% v/v) and penicillin streptomycin antibiotics (final 
concentration 1% v/v)]. The cells were incubated for 30 minutes at 37
o
C under an 
atmosphere of 5% CO2 in air. 
 
The cells were subsequently washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and a new batch of 2 mL phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
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penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to each 
well prior imaging. 
 
The localization of the PFN probes was imaged under an Applied Precision 
Deltavision fluorescence microscope. The PFN probes were excited at wavelength 
447-503 nm and emission detected at wavelength 487-559 nm. In the case of Hoechst 
33258, an excitation wavelength of 372-408 nm and an emission wavelength of 417-
453 nm were applied, while in the case of MitoTracker Green, an excitation 
wavelength of 447-503 nm and an emission wavelength of 487-559 nm was applied. 
Imaging conditions were maintained at 37
o
C under an atmosphere of 5% CO2 in air.  
 
Results and discussion 
 
______________________________________________________________ 
Figure 3.2.1: Changes in fluorescence intensity of tetraethylfluorescein nitroxide (TEF) at 
varying pH.   
 
Based on Figure 3.2.1, TEF shows significant fluctuations in fluorescence intensity 
over a pH range of 3-12. At pH ≤ 6, there is hardly any fluorescence emission.  
 
Previous work by Morrow
50,126
 showed that the coupling of a nitroxide moiety with 
the chromophore fluorescein does not affect the pH stability of the overall compound. 
The fluorescence changes observed were primarily due to the nature of the 
chromophore fluorescein.  
 100 
Fluorescein has been reported to exist in different forms under different pH conditions, 
namely cationic, neutral, anionic as well as dianionic derivatives (Figure 3.2.2). Each 
of these derivatives varies in their fluorescence characteristics and the conversion 
between these species is largely pH dependent.
146,147 
 
 
_____________________________________________________________________ 
Figure 3.2.2: Protolytic equilibria of fluorescein. (Figure taken from Morrow
126
 with 
permission). 
 
Analysis derived from Figure 3.2.1 hence concluded that TEF is not stable to changes 
in the pH of the environment. Slight fluctuation in pH results in a significant change in 
the fluorescence intensity of TEF. 
 
Subsequent localization experiment as displayed on Figure 3.2.3 revealed that both 
TMF and TEF seemed to localize within the lysosome. This was due to the fact that 
the localization patterns observed in the case of TMF and TEF are different from that 
of MitoTracker Green. Such observations support previous work by Morrow,
126
 who 
observed the lysosomal localization of TMF via co-staining of cells with LysoTracker 
Red (Figure 3.2.4). Morrow et al. reported that TMF was initially taken up by 
endocytotic vesicles (within 15 minutes) before migrating to the lysosomes (within 45 
minutes and 120 minutes).  A similar localization pattern was observed in the case of 
TEF compared to TMF (Figure 3.2.3A) suggesting similar lysosomal localization of 
TEF. The internal environment of lysosomes has a relatively low pH (ranging from 4-
5) and based on Figure 3.2.1, the fluorescent is decreased under such acidic 
conditions. Whilst it is likely that these probes accumulate in the lysosomes as part of 
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the excretion from the cell, it is important to note that lower observed fluorescence can 
occur despite accumulation within cellular organelles of the fluorescein based PFN 
probes depending on the pH of the microenvironment. Further work would be 
necessary to definitively confirm co-localization of these probes within lysosomes. 
However, these results do not provide any evidence that there is localization within 
mitochondria with these probes.  
 
 
 
 
 
A 
B 
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_____________________________________________________________________ 
Figure 3.2.3: A) Localization of tetramethylfluorescein nitroxide (TMF) and 
tetraethylfluorescein nitroxide (TEF) (concentration 1 µM respectively, in hTERT 
immortalized human fibroblast cells) co-stained with Hoechst 33258 (1.6 µM) to aid in 
imaging in hTERT immortalised human fibroblast cells. Cells were also incubated with the 
mitochondrial specific probe, MitoTracker Green. B) Chemical structure of TMF, TEF, 
Hoechst and MitoTracker Green. (Triplicate life cell images were taken, only one image is 
being displayed). 
 
 
 
 
 
A 
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Figure 3.2.4: A) Localization of tetramethylfluorescein nitroxide (TMF) (1 µM, in hTERT 
immortalized human fibroblast cells) co-stained with LysoTracker Red over time. (Figure 
taken from Morrow
126
 with permission). B) Chemical structure of TMF and LysoTracker Red. 
 
Results from these experiments indicate that fluorescein-based probes (both the 
tetramethyl- and tetraethyl-systems) suffer from pH instability. The drastic change in 
fluorescein fluorescence intensity with slight changes in pH, limits their potential as 
redox probes for assessing the changing pH condition within biological system.  
 
In addition, although both TMF and TEF are able to provide an assessment of the 
redox status within intracellular lysosomes,
 
lysosomes are not active sites for redox 
processes in cells. A PFN probe which localizes to the main redox active site, the 
mitochondria, is desirable. A possible candidate was the tetraethylrhodamine nitoxide 
(TER) (Figure 3.3.1). The commercially available chromophore, rhodamine has been 
used as an effective probe for staining mitochondria since the 1980’s.148 Coupling a 
tetraethylisoindoline nitroxide with rhodamine could therefore potentially give rise to 
an effective redox probe for assessing the redox condition within the mitochondria.   
 
 
3.3 The use of rhodamine chromophore as an improvement over fluorescein 
  
As discussed in Chapter 3.2, TEF has a slow reduction rate making it a potential probe 
for assessing mitochondrial redox status. However, further studies revealed that TEF 
suffers from pH instability and does not localize into the mitochondria. An alternative 
mitochondrial redox sensing probe is therefore required. This probe should potentially 
B 
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be ethyl-based, stable to changes in the pH of the environment and show significant 
localization into the mitochondria. Tetraethylrhodamine nitroxide (TER) was deemed 
to be the possible candidate. Since the 1980’s, rhodamine has been used as an effective 
probe for staining mitochondria. Chen et al.
148 
reported the use of rhodamine 123 in 
monitoring mitochondrial distribution within cells following transformation of cells 
with Rous sarcoma virus. TER, a tetraethylisoindoline nitroxide coupled with 
rhodamine could potentially be an effective mitochondrial redox probe.  
 
TER consists of an ethyl-based PFN system which incorporates the chromophore 
rhodamine with an isoindoline nitroxide (Figure 3.3.1).  Being an ethyl-based system, 
TER therefore has a reduction rate similar to that of TEF.  The incorporation of 
rhodamine would potentially render TER a mitochondrially targeted redox probe. 
   
 
_____________________________________________________________________ 
Figure 3.3.1: Chemical structure of tetraethylrhodamine nitroxide (TER). 
 
Effort was therefore carried out to assess the pH stability and cellular localization of 
TER.  In an attempt to assesss the properties of TER, similar experimental procedures 
to determine the reduction rate, pH stability and intracellular localization as described 
previously for TEF were carried out. Details of the experimental procedures are listed 
below. 
 
Experimental 
a) Assessing the reduction rate of tetraethylrhodamine nitroxide (TER) 
TER at a final concentration of 0.5 µM was prepared from a 1 mM DMSO stock 
solution in a final volume of 4 mL of 1xPBS (argon-bubbled PBS). The solution 
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containing 0.5 µM of TER was subsequently subjected to reduction by the addition of 
375 µM of ascorbate (an excess of 750 times to that of TER).  
 
The solution containing TER was excited at the wavelength of 556 nm and emission 
collected at wavelength 575 nm. Changes in fluorescence intensity of TER within the 
solution were recorded over time. The reduction rate of TER was subsequently 
determined based on the slope of the graph of percentage fluorescence intensity 
against time. 
 
b) Assessing pH stability and cellular localization of tetraethylrhodamine nitroxide 
(TER) 
Assessing pH stability 
The preparation of solutions with varying pH was carried out as described on page 97. 
As in the case of TEF, stock solutions of TER at a concentration of 1 mM were 
prepared in DMSO. An aliquot of the TER stock solution was added to the different 
pH solutions to give a final probe concentration of 0.5 µM. Solution was mixed and 
the fluorescence intensity of the mixture was obtained along with its pH. Fluorescence 
intensities were measured using the Cary Eclipse fluorometer based on an excitation 
wavelength of 556 nm and emission wavelength of 575 nm. Triplicates were carried 
out and the results presented as graphs of relative fluorescence intensity against pH 
values.  
  
Localization of TER 
In place of TMF and TEF, hTERT human fibroblast cells were incubated with 1 µM of 
TER for 45 minutes. Instead of Hoechst, co-staining with the mitochondrial specific 
probe, MitoTracker Green was carried out. 
 
hTERT immortalized human fibroblast cells at a concentration of 1.5x10
5
 cells per mL 
were cultured overnight in IBIDI slides as previously described on page 97. The cells 
were subsequently treated with 1 µM of TER by replacing previous medium within 
each well with 2 mL of phenol red free DMEM [supplemented with fetal calf serum 
(final concentration 12% v/v) and penicillin streptomycin antibiotics (final 
concentration 1% v/v)]. The cells were incubated with TER for 45 minutes at 37
0
C 
with 5% CO2 in air. 
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 Upon incubation, the cells were washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and were co-stained with 100 
nM of MitoTracker Green in 2 mL of phenol red free medium [supplemented with 
fetal calf serum (final concentration 12% v/v) and penicillin streptomycin antibiotics 
(final concentration 1% v/v)]. The cells were incubated for a further 30 minutes at 
37
0
C under an atmosphere of 5% CO2 in air.  
 
Subsequently, the cells were washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and a new batch of 2 mL phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to each 
well prior imaging. 
 
An excitation wavelength of 515-569 nm and an emission wavelength of 549-639 nm 
was applied for imaging the localization of the TER under the Applied Precision 
Deltavision fluorescence microscope. In the case of MitoTracker Green, an excitation 
wavelength of 447-503 nm and an emission wavelength of 487-559 nm were applied. 
Imaging conditions were maintained at 37
o
C under an atmosphere of 5% CO2 in air. 
 
Results and discussion 
 
 
 
A B 
 107 
__________________________________________________________________ 
Figure 3.3.2: Comparing the reduction rate between tetramethylfluorescein (TMF), 
tetraethylfluorescein (TEF) and tetraethylrhodamine (TER) nitroxides using ascorbate as a 
reductant. A) Percentage change in fluorescence intensity over time relative to fluorescence 
intensity at time point 0 minutes, upon reacting TER  (0.5 µM) with ascorbate (375 µM). B) 
Comparing the reduction rates of TMF, TEF and TER (0.5 µM each) upon reacting the PFN 
probes with ascorbate (375 µM). The result was displayed as change in fluorescence intensity 
per min. (Data analysed using T-test where a P value of < 0.05 was obtained, indicating a 
significant difference in percentage change in fluorescence intensity per min between TMF, 
TEF and TER). 
 
Figure 3.3.2A (measured at a higher gain than Figure 3.1.5) showed that reacting TER 
with ascorbate increases the fluorescence of the PFN. As previously described, the 
reduction of the nitroxide by ascorbate to hydroxylamine, removes the quenching 
effect which arose from the coupling of the PFN with the chromophore moiety. The 
removal of the quenching effect, restores the fluorescence of chromphore,
50,59
 which in 
the case of TER, the fluorescence of rhodamine. The rate at which the fluorescence of 
TER reaches peak upon reacting with ascorbate, provides an indication of the 
reduction rate of TER.   
 
Figure 3.3.2A shows that the fluorescence intensity of TER takes over 400 minutes to 
reach peak fluorescence and comparing the rate of reduction between all three PFN, 
TMF, TEF and TER (Figure 3.3.2B), reveals that TER has the slowest reduction rate 
among all three PFN probes. TMF has a reduction rate of 0.37 ± 0.03 per min, 
followed by TEF 0.05 ± 0.02 per min and lastly TER with a reduction rate of 0.0017 ± 
0.0007 per min. The reduction rate of TER re-confirms that ethyl-based probes have a 
slower reduction rate compare to methyl-based systems due to reasons 
aforementioned.      
 
Although the slow reduction rate potentially qualifies TER as a probe for assessing the 
mitochondrial redox status, the pH stability as well as the actual localization of TER 
into the mitochondra remains to be discovered. In terms of pH stability, it can be 
observed that compared to TEF, TER gave a relatively constant fluorescent response 
over the pH range of 3-12 (Figure 3.3.3). Rhodamine shows consistent fluorescence 
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response over a pH range that encompasses cellular systems (pH 6-7). Fluorescein 
fluorescence response on the other hand, shows a significant drop as the pH decreases 
from neutral (pH = 7) to slightly acidic (pH = 6). As rhodamine is less affected by pH 
change, PFN probes based on this structure would, therefore, provide better response 
than fluorescein analogues. Hence, this makes TER the more favourable PFN probe 
relative to TEF. 
 
 
______________________________________________________________ 
Figure 3.3.3: Comparing change in relative fluorescence intensity of tetraethylrhodamine 
nitroxide (TER) and tetraethylfluorescein nitroxide (TEF) at varying pH.   
 
Subsequent experiment to assess the intracellular localization of TER (Figure 3.3.4) 
shows that TER localizes predominantly within the mitochondria. An overlayed image 
for TER treated and MitoTracker Green treated cells (Figure 3.3.4A) suggests 
localization of TER within the mitochondria. However, the localization of TER is not 
specific only towards the mitochondria as TER was observed to localize within 
globular structures which lacked staining by MitoTracker Green. This finding was 
confirmed by a coefficient of correlation colocalization plot (Figure 3.3.4B). The 
colocalization plot shows how two intensities (in this case TER and MitoTracker 
Green) correlate on a pixel-by-pixel basis (where each spot represents a pixel). The 
plot was derived from the image analysis program SoftWorx where a complete 
localization would result in a coefficient correlation of 1 or 100% correlation. Based 
on the coefficient of correlation of TER relative to MitoTracker Green, a value of 
0.7269 was obtained. It can therefore be concluded that approximately 73% of the total 
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amount of TER localizes into the cell, coincides with that of MitoTracker Green, 
leaving 27% of the probe within the globular structures. 
 
 
 
 
                         
 
 
 
 
           
A 
B 
C 
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Figure 3.3.4: A) Localization of tetraethylrhodamine nitroxide (TER) (1 µM) along with co-
staining with MitoTracker Green (100 nM) in hTERT immortalised human fibroblast cells. B) 
Colocalization plot for TER (1 µM) relative to MitoTracker Green (100 nM) within 
mitochondria. C) Chemical structure of TER and MitoTracker Green. (Triplicate life cell 
images were taken, only one image is being displayed). 
 
The globular structures were suspected to be lysosomes. Subsequent co-staining 
experiment between TER with the lysosome specific probe, LysoTracker Blue was 
hence carried out. Details of the LysoTracker Blue co-staining experiment are as 
follows. 
 
Experimental  
Similar experimental procedures to that of co-staining hTERT cells with TER and 
MitoTracker Green were carried out. hTERT immortalized human fibroblast cells 
were cultured in IBIDI slides as described on page 97.  
 
The cells within IBIDI slides were subsequently incubated with 1 µM of TER by 
replacing previous medium within each well with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)]. The cells were incubated with 
TER for 45 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
 
Upon incubation, the cells were washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)], followed by co-staining with 50 
nM of LysoTracker Blue in 2 mL of phenol red free medium [supplemented with fetal 
calf serum (final concentration 12% v/v) and penicillin streptomycin antibiotics (final 
concentration 1% v/v)] for 30 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
 
The LysoTracker Blue treated cells were subsequently washed once with 2 mL of 
phenol red free DMEM [supplemented with fetal calf serum (final concentration 12% 
v/v) and penicillin streptomycin antibiotics (final concentration 1% v/v)] and a new 
batch of 2 mL phenol red free DMEM [supplemented with fetal calf serum (final 
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concentration 12% v/v) and penicillin streptomycin antibiotics (final concentration 1% 
v/v)] was added to each well prior imaging. 
 
The localization of the the different probes was imaged under the Applied Precision 
Deltavision fluorescence microscope. An excitation at wavelength 515-569 nm and 
emission detected at wavelength 549-639 nm was applied for imaging localization of 
TER while in the case of LysoTracker Blue, an excitation wavelength of 372-408 nm 
and an emission wavelength of 417-453 nm were applied. Imaging conditions were 
maintained at 37
o
C under an atmosphere of 5% CO2 in air.  
  
Results and discussion 
An overlayed image for TER treated and LysoTracker Blue treated cells reveals that 
the localization of TER coincides with lysosome partially (Figure 3.3.5A). Other 
globular structures are suspected to be endosomes. Despite the slight discrepancy, 
most of the fluorescence given off from cells incubated with TER (70% as determined 
from the coefficient of correlation between TER and MitoTracker Green, Figure 
3.3.5B) were predominantly from the mitochondria. This therefore entitles TER as a 
potential probe for assessing mitochondrial redox status.   
 
 
 
 
 
 
 
 
A 
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Figure 3.3.5: A) Localization of tetraethylrhodamine nitroxide (TER) (1 µM) and LysoTracker 
Blue (50 nM) within hTERT immortalised human fibroblast cells. B) Chemical structure of 
TER and LysoTracker Blue. (Triplicate life cell images were taken, only one image is being 
displayed). 
 
The localization of TER into the mitochondria is attributed by the positive charge 
present within the molecule (Figure 3.3.6).  
 
_____________________________________________________________________ 
Figure 3.3.6: Redox potential of tetraethylrhodamine nitroxide (TER). 
 
The uptake of TER, a cationic molecule into the mitochondria agrees with findings 
from several past studies as decribed previously. Hardy et al. (2007) reported the 
successful use of DEPMPO or Mito-5-diethoxyphosphoryl-5-methyl-1-pyrroline N-
oxide, a cyclic nitrone with an attached cationic triphenylphosphonium group, to 
determine mitochondrial redox status via EPR (Figure 1.30).
94
 Similarly Dikalov et al.
 
96,97,98
 reported the use of the cationic mito TEMPO-H or (1-hydroxy-4-[2-
triphenylphosphonio-acetamido]-2,2,6,6 tetramethylpiperidine) to assess ROS within 
the mitochondria via EPR (Figure 1.31).  
 
B 
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Subsequent studies by Cocheme and Murphy et al. (2011)
104
 on MitoB, which consists 
of a cationic triphenylphosphium group conjugated to an arylboronic acid (Figure 
1.33) shows
 
significant uptake of MitoB into the mitochondria as determined by mass 
spectroscopy. Recent work by Hirosawa et al. (2012)
125 
on MitoRP, a TEMPO 
(2,2,6,6-tetramethyl-piperidin-1-yl)oxyl moiety coupled to the monocationic 
chromophore coumarin 343 (Figure 1.36), further confirms the localization of cationic 
probes into the mitochondria. Using isolated mitochondria, Hirosawa et al. (2012) 
demonstrated the capability of MitoRP to monitor electron flow within the 
mitochondria via fluorescence measurement.
125
  
  
As described in the introduction, the generation of energy within the mitochondria 
involves a process known as the oxidative phosphorylation. Oxidative phosphorylation 
involves the transfer of electrons along several protein complexes, collectively known 
as the electron transport chain (ETC) (Figure 1.29). The transfer of electrons generates 
a proton gradient which results from the pumping of H
+
 ions out of the mitochondrial 
matrix. The net negative charge across the mitochondrial membrane generated during 
ETC, attracts the positively charged TER.
,149,150
  
 
Findings from the experiments described in this chapter hence concluded that TER 
have a slow reduction rate, is stable to changes in the pH of the environment and 
localizes predominantly in the mitochondria. These criteria make TER an ideal probe 
for assessing mitochondrial redox status. One criterion however remains in qualifying 
TER as a viable probe for assessing mitochondrial redox status. Due to the changing 
redox condition within biological systems, a redox probe with reversible sensing 
capacity is desirable. In an attempt to determine the capacity of TER to provide 
dyamic mitochondrial redox measurement, the reversible sensing capacity of TER was 
assessed.  
 
3.4 Assessing reversibility of TER 
The ability of the nitroxide to act as both a reductant and an oxidant, should 
theoretically enable TER to respond reversibly as the oxidation or reduction conditions 
within the system changes. Such change is indicated by a change in fluorescence 
intensity of the PFN. An experiment was carried out to assess the reversible nature of 
TER by subjecting the probe to varying oxidation and reduction cycles. The parent 
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chromophore analogue, Rhodamine B was used as a control. The details of the 
experiment are described as below. 
 
Experimental 
The experimental procedures used in this study are fully described in Materials and 
Methods, Section 2.5 (page 73). 
 
Results and Discussion 
 
    
 
A B 
C D 
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Figure 3.4.1: A) Changes in fluorescence intensity of tetraethylrhodamine nitroxide (TER) and 
Rhodamine B (parent chromophore, control) upon subjection to varying oxidation-reduction 
cycle. B) Chemical structure of tetraethylrhodamine nitroxide (TER). C) Close-up view of 
changes in fluorescence intensity of TER upon subjection to varying oxidation-reduction 
cycle. D) Chemical structure of Rhodamine B. E) Close-up view of changes in fluorescence 
intensity of Rhodamine B upon subjection to varying oxidation-reduction cycle. F) Reduction 
and oxidation reaction of TER. G) Reacting Rhodamine B with hydrazine hydrate 
(N2H2.H2O). 
  
Based on Figure 3.4.1C, TER displayed a cycle of increasing and decreasing 
fluorescence intensity upon being subjected to reduction and oxidation. Such cycle of 
 
F 
G 
E 
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increasing and decreasing fluorescence was missing from the control, Rhodamine B 
(Figure 3.4.1E). The difference in the change of fluorescence observed between TER 
and Rhodamine B was due to the difference in chemical structures between TER and 
Rhodamine B. 
 
Rhodamine B consists of just a chromophore which lacks the isoindoline nitroxide 
attachment as observed in TER (Figure 3.4.1B and 3.4.1D). The presence of the 
isoindoline nitroxide moiety, quenches the fluorescence of the chromophore 
rhodamine. Reaction with N2H2.H2O reduces the nitroxide to hydroxylamine, causing 
the nitroxide to lose its radical nature. The lost of the radical nature of the nitroxide, 
removes the fluorescence quenching effect on the rhodamine chromophore thereby 
restoring the fluorescence of TER. Subsequent oxidation of the reduced TER by O2, 
oxidizes the hydroxylamine back to the nitroxide. The oxidation of the hydroxylamine 
back to the nitroxide, reinstates the fluorescence quenching effect on the rhodamine 
chromophore. The fluorescence quenching effect decreases the fluorescence of TER. 
These observations indicated the reversible nature of TER.  
 
N2H2.H2O being a strong basic reductant, causes a general loss of fluorescence over 
time as indicated by a gradual decrease in peak fluorescence intensity of both TER and 
Rhodamine B over time (Figure 3.4.1A and E).   
 
It can therefore be concluded that TER being an ethyl-based PFN has a slower 
reduction rate relative to methyl-based PFN namely TMF. In addition, TER is stable to 
changes in the pH of the environment compared to TEF and TMF due to the 
attachement of a rhodamine chromophore instead of fluorescein to the isoindoline 
nitroxide in TER. The attachment of the chromophore rhodamine also aids in the 
localization of TER into the mitochondria.  Being a nitroxide-based redox sensing 
probe, TER shows reversible nature as indicated by a change in fluorescence intensity 
of the probe in varying oxidizing and reducing cycles.  
 
The aforementioned characteristics of TER, entitles the potential use of TER as a 
mitochondrial redox sensing PFN. Experiments were therefore undertaken in the 
subsequent chapter, to assess the capability of TER to monitor changes in the 
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mitochondrial redox status within hTERT immortalized human fibroblast cells, based 
on flow cytometry techniques. 
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CHAPTER 4 
The Application of PFNs within 
Biological Systems 
 
Findings from previous chapters have shown that TER exhibits characteristics that 
favor its potential use as a probe to assess mitochondrial redox status. TER undergoes 
a slow reduction rate. Such slow reduction rate prevents TER from being easily 
reduced by other biological reductants prior reaching the mitochondria. In addition, 
TER is stable to changes in the pH of the environment, shows mitochondrial 
localization and is reversible in its detection. This therefore enables TER to provide a 
dynamic measurement of the redox status within the active mitochondria. 
 
Despite studies from previous chapters which confer that TER exhibit promising 
characteristics as a potential mitochondrial redox probe, the actual capability of TER 
to assess mitochondrial redox condition remains crucial. This chapter hence serve as a 
preliminary studies to assess the ability of TER to measure redox changes within the 
mitochondria, was carried out by comparing the fluorescence change of normal and 
oxidative stressed diseased cells, both treated with TER, incubated within the 
fluorometer over time.  
 
4.1 Comparing redox status between normal and Ataxia Telangiectasia, A-T 
diseased cells using TER as redox probe  
 Ataxia Telangiectasia, A-T is a neurodegenerative disease characterized by poor 
motor coordination and small dilated blood vessels. The disease results from the lack 
of a functioning ATM (Ataxia Telangiectasis Mutated) protein. This protein is 
involved in regulating cell cycle, maintaining chromosomal integrity as well as 
controlling deoxyribonucleic acid (DNA) damage responses within the cells.
151
 ATM 
is required for DNA repair during DNA replication. Although not fully understood, a 
defect in the gene results in heightened levels of oxidative stress, possibly due to an 
increase in the accumulation of free radical during DNA replication.
24
 A-T patients 
suffer from abnormalities particularly in the development of neurons. Such 
abnormalities result in poor motor coordination among A-T patients.
152,153
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The potential use of TER along with afluorometer to assess mitochondrial redox status 
within biological systems presents a simple and inexpensive method monitor 
mitochondrial redox status. TER treated normal and A-T disease cells were incubated 
within fluorometer and the change in fluorescence intensity were measured over time. 
Details of experiment are as follow. 
 
Experimental 
Immortalized hTERT human normal and A-T diseased fibroblast cells were cultured 
in a 25 mL flask to a final concentration of approximately 1x10
6
 cells per mL. The 
cells were cultured over 4 days at 37
o
C under an atmosphere of 5% CO2 in air. RPMI 
(Roswell Park Memorial Institute) medium, supplemented with fetal calf serum (final 
concentration 12% v/v), penicillin streptomycin antibiotics (final concentration 1% 
v/v) and phenol red was used to culture the . 1 mL of each cells line was pipetted into 
4 different cuvettes and subjected to one of the following treatment. 
 
Cuvette 1: Normal cells + DMSO blank (negative control)  
Cuvette 2: A-T cells + DMSO blank (negative control) 
Cuvette 3: Normal cells + 0.1 µM of TER 
Cuvette 4: A-T cells + 0.1 µM of TER 
 
TER was prepared from a 4 mM DMSO stock and added to the cells to a final 
concentration of 0.1 µM (a low probe concentration was used to minimize 
intermolecular quenching of fluorescence between TER molecules).  The cuvettes 
were left within the fluorometer with conditions maintained at 37
o
C and 5% CO2 
bubbled into the surrounding within the machine at a rate of approximately 1 bubble 
every 2 seconds. Fluorescence readings were obtained every 30 minutes via the use of 
the fluorometer (Cary Eclipse, excite: 556 nm, emit: 575 nm) and the cell solutions 
were mixed throughout measurements.  
 
A graph of change in TER fluorescence intensity of normal and A-T treated cells 
against time was subsequently plotted.  
 
 
 
 120 
Results and Discussion 
 
 
 
A 
B 
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Figure 4.1.1: Change in TER fluorescence intensity over time upon incubating normal 
and A-T diseased cells with 0.1 µM of TER. A) Comparing fluorescence intensity of 
hTERT human normal and A-T fibroblast cells without addition of TER. Triplicate 
results comparing the fluorescence intensity of normal and A-T cells upon addition of 
0.1 µM TER was showed in (B), (C) and (D).  
 
Figure 4.1.1A shows that without TER treatment, both normal and A-T cells have 
similar fluorescence response. However, with TER treatment and under similar 
experimental setup, varying responses were obtained upon comparing fluorescence 
response of TER treated cells in Figure 4.1.1B, C and D.  In Figures 4.1.1 B and D, A-
T cells were observed to have a higher fluorescence compared normal cells. However, 
C 
D 
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in Figure 4.1.1C, both normal and A-T cells were observed to have similar 
fluorescence response over time. Such varying response renders the results from this 
experimental setup in-conclusive.  
 
Possible reason for such an observation could be due to experimental setup. Due to 
possible contamination and inefficient control of experimental condition, it was 
observed that at the end of the experimental period (approximately 80 hours), the cells 
were clumping (possibly signifying changes in the extracellular matrix or cell 
membranes). Such experimental setup is therefore, not a good representation of the 
actual oxidative condition within biological systems.  However, results from this 
preliminary study shows that TER has the ability to be used over extended period of 
time to assess mitochondrial redox status.  
 
As an alternative method, flow cytometry technique was adapted. Flow cytometry has 
long been used in studies from measuring apoptosis of cell thymocytes
154
 and 
determination of lymphocyte division
155
 to study of immune cells
156
. Flow cytometry 
enables the fluorescence of each cell in a cell suspension to be measured where 
individual cells treated with TER are excited at the specific wavelength and 
subsequently passed through a detector where the intensity of the light emited are 
measured. 
 
The ability to incorporate the application of PFN probes with flow cytometry, 
promises a sensitive and accurate tool where redox measurements in terms of 
fluorescence intensity of PFN within tens of thousands of cells can be made in 
relatively short period of time.  
 
Having established the potential use of TER as a mitochondrial redox probe, attempts 
were made to assess the capability of TER to monitor redox changes within the 
mitochondria. This was achieved by altering mitochondrial redox status using 
mitochondrial toxins. Given that Complex I and III within the mitochondrial ETC are 
the main sources of basal reactive ROS production (as discussed in the introduction, 
Section 1.8),
157,158
 the ROS production within both complexes were altered.  Rotenone 
(ROT) was used to induce ROS production within Complex I, while antimycin (AMC) 
to induce ROS production within Complex III (Figure 4.1.2).  It was reported that 
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Complex I produces ROS into the matrix of the mitochondria while Complex III 
produces ROS in both the matrix as well as the intermembrane space of the 
mitochondria.
159
 
 
 
_____________________________________________________________________ 
Figure 4.1.2: Chemical structure of mitochondrial toxins, rotenone (ROT) and antimycin 
(AMC) used in inducing mitochondrial oxidative stress. 
 
The capability of TER to assess mitochondrial redox status was compared to that of 
MitoSox, which serve as a control. As described in the introduction, MitoSox consists 
of a dihydroethidium with an attached triphenylphosphonium group (Figure 4.1.3). 
MitoSox is a commonly available and used commercial fluorescent redox 
probe.
105,106,107
   
 
Apart from MitoSox, a second control was set in place using tetramethylrhodamine 
methyl ester (TMRM). TMRM is a widely used commercial probe to assess 
mitochondrial membrane potential (Figure 4.1.3) and was used alongside TER and 
MitoSox as a means to assess the effect of ROT and AMC treatment on mitochondrial 
membrane potential. 
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Figure 4.1.3: Chemical structure of MitoSox and tetramethylrhodamine methyl ester (TMRM). 
 
In assessing the capability of TER to monitor mitochondrial redox status, hTERT 
immortalized human fibroblast cells were incubated with TER or MitoSox or TMRM, 
followed by treatment with either ROT or AMC. The changes in fluorescence intensity 
of TER upon the different treatment were recorded and presented as graphs of 
percentage change in fluorescence intensity relative to non-treated sample, against 
concentration of mitochondrial toxins.  
 
Initially experiments were carried out to optimize the incubation time of PFN probe to 
be used in assessing the ability to incorporate the application of PFN probes with flow 
cytometry techniques. Details of the experiment are described below.  
 
4.2 Optimizing flow cytometry experiment  
hTERT immortalized human fibroblast cells were incubated with 1 µM TER over 
range of time period as described below. Upon incubation, the fluorescence of the 
TER treated cells was recorded via flow cytometry.  
 
Experimental 
A stock culture of hTERT immortalized human fibroblast cells was prepared as 
described in research objective. From the stock culture, hTERT immortalized human 
fibroblast cells were seeded at an initial concentration of approximately 5x10
4
 cells per 
mL in 6-well plates. The cells were cultured in DMEM, supplemented with fetal calf 
serum (final concentration 12% v/v), penicillin streptomycin antibiotics (final 
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concentration 1% v/v) and phenol red over a period of approximately 48 hours (final 
cell concentration approximately 2x10
5
 cells per mL).  
 
The cells were initially incubated with TER (1 µM) for 15, 30, 45, 120, 240, 360, 720 
and 1440 minutes at 37
o
C, 5% CO2, in 1 mL of DMEM [supplemented with fetal calf 
serum (final concentration 12% v/v), penicillin streptomycin antibiotics (final 
concentration 1% v/v) and phenol red].  Upon treatment, the cells were washed with 1 
mL of 10% v/v versene, treated with a stock solution of trypsin (adding 0.5 mL of 
0.5% v/v trypsin) and centrifuged (speed- 1200rpm, time- 4 mins and temperature- 
37
o
C). Supernatant was removed and cells were resuspended in 1 mL 1xPBS. 
Fluorescence readings for approximately 10000 cells were subsequently obtained via 
the BD LSRFortessa flow cytometer. Cells incubated with TER were excited around 
wavelength 556 nm and emission collected at wavelength 575 nm. 
 
Results and discussion 
In attempt to provide an environment that mirrors the actual conditions within 
biological systems, experiments to monitor the mitochondrial redox sensing capability 
of TER were carried out on sub-confluent cells (cell concentration of approximately 
2x10
5
 cells per mL) (Figure 4.2.1). The sub-confluent state ensures cells have adequate 
space for replication and are actively respiring. 
 
    
______________________________________________________________ 
Figure 4.2.1: Sub-confluent hTRERT immortalized human fibroblast cells used in experiment. 
Image was taken using the Olympus CKx41 microscope equipped with QImaging 
MicroPublisher 3.3 RTV camera.  
 
Changes in TER fluorescence intensity upon subjecting TER treated cells to different 
ROT and AMC treatment were analysed via flow cytometry.  
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_____________________________________________________________________ 
Figure 4.2.2: Change in fluorescence intensity of TER treated hTERT immortalized 
human fibroblast cells with varying TER (1 µM) incubation time. 
_____________________________________________________________________ 
 
Based on Figure 4.2.2, a general trend where increasing incubation period, increases 
fluorescence intensity of TER treated cells was observed. Such a trend was expected 
as increasing TER incubation period among cells, increases the uptake of TER probe 
into the mitochondria of the cells. This in turn increases the fluorescence intensity of 
the cells.  
 
The fluorescence intensity reaches peak fluorescence at time point 360 minutes or 6 
hours. In an attempt to minimize incubation time, studies were subsequently carried 
out to compare the fluorescence changes between incubating hTERT immortalized 
cells for 45 minutes and subsequently treating the TER treated cells with ROT and 
AMC to induce ROS production within the mitochondria. Experimental setup and 
details are described as below. 
 
Experimental 
A stock culture of hTERT immortalized human fibroblast cells were prepared as 
described in Cell Preparation and Analysis chapter. From the stock culture hTERT 
immortalized human fibroblast cells were seeded at an initial concentration of 
approximately 5x10
4
 cells per mL in 6-well plates. The cells were cultured in DMEM, 
supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
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streptomycin antibiotics (final concentration 1% v/v) and phenol red over a period of 
approximately 48 hours (final cell concentration approximately 2x10
5
 cells per mL). 
Within different wells, the cells were treated differently as follows:   
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with TER (1 µM) either for 45 minutes or 360 
minutes (6 hours)  at 37
o
C, 5% CO2, in 1 mL of DMEM [supplemented with fetal calf 
serum (final concentration 12% v/v), penicillin streptomycin antibiotics (final 
concentration 1% v/v) and phenol red].  The medium containing TER was 
subsequently removed by pipette and a fresh batch of DMEM containing 1 µM of 
ROT in a final volume of 1 mL was added to each of the 6 well respectively. The cells 
were incubated with ROT for 15 minutes at 37
0
C under an atmosphere of 5% CO2 in 
air.  
 
ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of AMC treatment. Upon treatment with TER, the cells were incubated with 1 µM of 
AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a final volume of 1 mL of 
DMEM for 15 minutes.  
 
Blanks were carried out by replacing ROT or AMC with DMSO in a final volume of 1 
mL of DMEM, followed by15 minutes incubation at 37
0
C under an atmosphere of 5% 
CO2 in air. 
  
Upon treatment, the cells were washed with 1 mL of 10% v/v versene, treated with a 
stock solution of trypsin (adding 0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 
1200xg, time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells 
were resuspended in 1 mL 1xPBS. Fluorescence readings for approximately 10000 
cells were subsequently obtained via the BD LSRFortessa flow cytometer. The cells 
incubated with TER were excited around wavelength 556 nm and emission collected 
at wavelength 575 nm. 
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Results and discussion 
    
__________________________________________________________________ 
Figure 4.2.3.: Percentage reduction in fluorescence intensity of treated  hTRET immortalized 
human fibroblast cells, Fs [cells incubated with 1 µM probes for 45 or 360 minutes, followed 
by treatment with 1 µM of A) rotenone (ROT) or B) antimycin (AMC)] for 15 minutes relative 
to blank, Fc [cells incubated with  1 µM probes for 45 or 360 minutes, followed by treatment 
with DMSO for 15 minutes] . (Each data point are mean values. Result were not significantly 
different with P values > 0.05 under different treatment conditions, as determined by T-test). 
 
Figure 4.2.3 shows that under both experimental setup namely 45 minutes incubation 
or 360 minutes incubation with TER, followed by 15 minutes treatment with ROT and 
AMC in both cases, similar reduction in TER fluorescence response was detected. 
B 
A 
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Subsequent experimental setup was hence based on 45 minutes incubation time with 
TER, followed by 15 minutes incubation with mitochondrial ROS inducer, ROT and 
AMC. 
 
In an attempt to further assess the capability of TER along with flow cytometry 
techniques to assess mitochondrial redox status, TER treated hTERT immortalized 
human fibroblast cells were subjected to increasing concentration of ROT and AMC. 
Changes in fluorescence response with increasing ROT and AMC dose response was 
analysed. Details of the described experiment are detailed below.  
 
4.3 Assessing redox status within cells via flow cytometry 
The incorportation of PFN with flow cytometry technique promises an efficient yet 
accurate method for assessing the redox status within biological system via 
fluorescence. Upon optimizing the flow cytometry setup in the preivous section 
(Section 4.2), redox status within cells subsjected to increasing ROT and AMC dose 
response was analysed. 
 
Experimental 
hTERT immortalized human fibroblast cells were cultured in 6-well plates as 
previously described (page 124). The cells were cultured in DMEM, supplemented 
with fetal calf serum (final concentration 12% v/v), penicillin streptomycin antibiotics 
(final concentration 1% v/v) and phenol red over a period of approximately 48 hours 
(final cell concentration approximately 2x10
5
 cells per mL). Within different wells, the 
cells were treated differently as follows:   
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with TER (1 µM) or MitoSox (1 µM) for 45 minutes 
at 37
o
C, 5% CO2, in 1 mL of DMEM [supplemented with fetal calf serum (final 
concentration 12% v/v), penicillin streptomycin antibiotics (final concentration 1% 
v/v) and phenol red].  The medium containing TER was subsequently removed by 
pipette and a fresh batch of DMEM containing varying concentrations of ROT (0, 
0.01, 0.1, 1, 10 and 100 µM) in a final volume of 1 mL was added to each of the 6 well 
respectively. The cells were incubated with ROT for 15 minutes at 37
0
C under an 
atmosphere of 5% CO2 in air.  
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ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of AMC treatment. Upon treatment with TER, the cells were incubated with varying 
concentrations of AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a final 
volume of 1 mL of DMEM for 15 minutes.  
 
Blanks were carried out by replacing ROT or AMC with DMSO in a final volume of 1 
mL of DMEM, followed by15 minutes incubation at 37
0
C under an atmosphere of 5% 
CO2 in air. 
 
 Upon treatment, the cells were washed with 1 mL of 10% v/v versene, treated with a 
stock solution of trypsin (adding 0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 
1200xg, time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells 
were resuspended in 1 mL 1xPBS. Fluorescence readings for approximately 10000 
cells were subsequently obtained via the BD LSRFortessa flow cytometer. Cells 
incubated with TER was excited around wavelength 556 nm and emission collected at 
wavelength 575 nm, while cells incubated with MitoSox was excited around 
wavelength 510 nm and emission collected at wavelength 580 nm.  
 
Results and discussion 
During oxidative phosphorylation, electrons escape from the ETC. This results in the 
generation of free radicals especially O2•
-
. Superoxide (O2•
-
) is converted to H2O2 by 
manganese superoxide dismutase (Mn-SOD). Subsequently, some of the H2O2 is 
detoxified by glutathione peroxidise to water (H2O), while others are converted to the 
highly reactive hydroxyl radicals (HO•) via Fenton reaction.93,160  
 
The O2•
-
 generated during the ETC can be categorized into two main pools i) the 
mitochondrial matrix and ii) the mitochondrial intermembrane space. Each O2•
-
 pool 
arises from electron leakage within Complex I and Complex III of the ETC 
respectively.
105
  
 
Altering the concentration of O2•
- 
generated from both Complex I and III will affect 
the overall redox status within the mitochondria. Two mitochondrial toxins were used 
to induce oxidative stress in cells, rotenone (ROT) and antimycin (AMC) (Figure 
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4.1.2). ROT affects ROS generation within Complex I while AMC affects that of 
Complex III. 
92,94,105,160,161 
ROT inhibits the transfer of electrons from the iron-sulfur 
centre of Complex I to ubiquinones (Coenzyme Q). This subsequently alters the flow 
of electrons within the whole electron chain complex. Such alteration gives rise for the 
reduction of oxygen (O2) to ROS, instead of the generation of water molecules. In the 
case of AMC, it binds to Complex III preventing the transfer of electrons from 
ubiquinol (reduced ubiquinones) to Complex IV. This in turn disrupts the electron 
transfer as in the case of ROT treatment, resulting in ROS production.
162  
  
Both ROT and AMC treatments of cells pre-incubated with TER results in a reduction 
of fluorescence as displayed in Figures 4.3.1 and 4.3.2. 
 
 
_____________________________________________________________________ 
Figure 4.3.1: Histrogram representation of hTERT immortalized human fibroblast cells treated 
with antimycin (AMC) (similar trend was observed in the case of rotenone, ROT treatment) 
upon incubation with tetraethylrhodamine nitroxide (TER). Black - blank (DMSO treatment); 
Red - cells + TER; Blue - cells + TER + AMC. 
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_____________________________________________________________________ 
Figure 4.3.2: Percentage reduction in fluorescence intensity of treated  hTRET immortalized 
human fibroblast cells, Fs [cells incubated with 1 µM probes for 45 minutes, followed by 
treatment with varying concentrations of rotenone (ROT) or antimycin (AMC)] for 15 minutes 
relative to blank, Fc [cells incubated with  1 µM probes for 45 minutes, followed by treatment 
with DMSO for 15 minutes] . A) Cells treated with 1 µM TER. B) Cells treated with 1 µM 
MitoSox. (Each data point are mean values. Data set in A were analysed using Kruskal Wallis 
test with pos hoc testing using the Dunn’s multiple comparison test. Data set in B were 
analysed using One-way ANOVA with pos hoc testing using the Dunn’s multiple comparison 
test. In both cases A and B, relative to blank, all treatment showed P values < 0.05. Results are 
therefore significantly different to blank). 
 
MitoSox upon reacting with ROS forms hydroxyl triphenylphosphonium ethidium 
which fluoresces with an emission wavelength of 580 nm. MitoSox was used as a 
control to confirm if increasing the concentration of ROT and AMC increases ROS 
production within the mitochondria.
105,106,107
 Figure 4.3.2B displayed MitoSox acting 
as a positive fluorescence probe where an increasing ROT and AMC concentration, 
increases MitoSox fluorescence intensity. The increasing fluorescence intensity of 
MitoSox hence confirmed that ROS production within the mitochondria of hTERT 
cells increases with increasing ROT and AMC treatment.   
 
Due to the reducing environment within the mitochondria, the localized TER 
nitroxides are reduced to hydroxylamines (Figure 4.3.3).
163
 The reduction gives rise to 
an initial increase in fluorescence intensity upon the uptake of TER nitroxides into the 
A B 
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mitochondria. Subsequent treatment with ROT or AMC, increases ROS production 
within the mitochondria,
105,162
 where this was confirmed via the increasing 
fluorescence intensity of MitoSox with increasing concentration of ROT and AMC. 
The ROS in turn oxidises the hydroxylamines to nitroxides, resulting in a drop in TER 
fluorescence intensity. Dose response studies by increasing the concentration of ROT 
and AMC, therefore results in simultaneous reduction in TER fluorescence intensity 
(Figure 4.3.2). Results therefore shows that TER acts as a negative probe (opposite to 
MitoSox which acts as a postive probe), where increasing ROT and AMC 
concentration, decreases TER fluorescence intensity.  
 
_____________________________________________________________________ 
Figure 4.3.3: Change in fluorescence intensity of tetraethylrhodamine nitroxide (TER) upon 
uptake into mitochondria followed by treatment with rotenone (ROT) and antimycin (AMC). 
 
Recent studies by Zorov et al.
164
 suggest that the opening of mitochondrial 
permeability transition pore (mPTP) plays an important role in the regulation of 
mitochondrial ROS. In situations of increasing ROS, mPTP opens and releases a burst 
of ROS from within the mitochondria. This mPTP opening-asscoiated ROS release or 
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termed ROS-induced ROS release (RIRR) is reversible in nature. It serves as a 
defensive response to minimize the accumulation of potential toxic levels of ROS 
within the mitochondria. Although such a defense mechanism is vital, in conditions of 
excessive ROS, the prolonged opening of mPTP may disrupt the mitochondrial 
membrane in addition to an increase burst of ROS. Both increase burst of ROS and 
disruption of the mitochondrial membrane potentially affects the functionality of the 
mitochondria.  
 
In an attempt to assess the mitochondrial membrane potential under the described 
ROT and AMC treatment, cells were incubated with tetramethylrhodamine methyl 
ester (TMRM) (Figure 4.3.4).  
 
 
_____________________________________________________________________ 
Figure 4.3.4: Chemical structure of tetramethylrhodamine methy ester (TMRM). 
 
TMRM is a widely used commercial probe to assess mitochondrial membrane 
potential and was used alongside TER and MitoSox as a means to assess the effect of 
ROT and AMC treatment on the mitochondrial membrane potential in the treated 
cells.  
 
TMRM being positively charged is taken into the mitochondria. As aforementioned, 
increasing ROS production may lead to a loss of mitochondrial membrane potential.
164
 
Such loss in membrane potential will result in the leakage of TMRM out of the 
mitochondria and subsequently out of the cell. A reduction in TMRM fluorescence 
intensity, hence is an indication of a loss of mitochondrial membrane potential.  
 
In addition of TMRM, carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (Figure 
4.3.5) was used as a positive control to induce disruption of the mitochondrial 
membrane potential. CCCP being an ionophore is capable of disrupting the 
electrochemical gradient generated during the ETC within the mitochondria. The 
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disruption of the electrochemical gradient susbsequently results in a loss of membrane 
potential.
165 
 
 
_____________________________________________________________________ 
Figure 4.3.5: Chemical structure of carbonyl-cyanide m-chlorophenyl hydrazone (CCCP). 
 
Experimental procedures to assess the mitochondrial membrane potential within ROT 
and AMC treated cells were detailed as below.  
 
Experimental 
hTERT immortalized human fibroblast cells at an initial concentration of 
approximately 5x10
4
 cells per mL were cultured in 6-well plates as described on page 
124. 
 
Similar experimental procedures to that of TER and MitoSox treatment, followed by 
ROT and AMC treatment were carried in assessing the effect of ROT and AMC 
treatment on the membrane potential of hTERT immortalized human fibroblast cells. 
However, instead of treatment with TER and MitoSox, the cells were incubated with 
TMRM as decribed below.  
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with TMRM (20 nM) for 30 minutes in 1 mL of 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red]. The medium 
containing TMRM was subsequently removed by pipette and a fresh batch of DMEM 
containing varying concentrations of ROT (0, 0.01, 0.1, 1, 10 and 100 µM) in a final 
volume of 1 mL was added to each of the 6 well respectively. The cells were incubated 
with ROT for 15 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
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ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of AMC treatment. Upon treatment with TMRM, the cells were incubated with 
varying concentrations of AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a 
final volume of 1 mL of DMEM for 15 minutes.  
  
iii) Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of CCCP treatment. Upon treatment with TMRM, the cells were incubated with CCCP 
(100 µM) instead of ROT, in a final volume of 1 mL of DMEM for 15 minutes. 
  
Blanks were carried out by replacing the ROT or AMC or CCCP treatment with 
DMSO.  
  
Upon treatment, cells were washed with 1 mL of 10% v/v versene, treated with a stock 
solution of trypsin (adding 0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 
1200xg, time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells 
resuspended in 1 mL 1xPBS containing 20 nM TMRM. Fluorescence readings were 
subsequently obtained for 10000 cells via flow cytometry (BD LSRFortessa). 
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Results and discussion 
 
_____________________________________________________________________ 
Figure 4.3.6: Percentage reduction in mean fluorescence intensity of treated hTRET 
immortalized human fibroblast cells, Fs [cells incubated with 20 nM tetramethylrhodamine 
methyl ester (TMRM) for 30 minutes, followed by treatment with varying concentrations of 
rotenone (ROT) / antimycin (AMC) / carbonyl cyanide m-chlorophenyl hydrazone (CCCP)  
for 15 minutes] relative to blank, Fc [cells incubated with 20 nM TMRM for 30 minutes, 
followed by treatment with DMSO for 15 minutes] . (Each data point are mean values. Data 
were analysed using Kruskal Wallis test with pos hoc testing using the Dunn’s multiple 
comparison test. In all cases a P value of < 0.05 was obtained relative to blank, 0%. Results 
are therefore significantly different to blank). 
 
Figure  4.3.6 shows a decrease in TMRM fluorescence intensity with increasing ROT 
and AMC concentration. Results from CCCP treatment, which serve as a positive 
control to incur loss of membrane potential, also shows a reduction in TMRM 
fluorescence intensity. This observation incidates a loss of membrane potential with 
increasing ROT and AMC concentrations.  
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The loss of membrane potential with increasing ROT and AMC concentrations, hence 
raised the question that the previous drop in TER fluorescence intensity under these 
ROT and AMC treatments, may possibly be due to the leaking of the TER out of the 
cells. In an attempt to assess such deduction, the non-radical alkylated derivative of 
TER, also known as methyl trap tetraethylrhodamine (MT-TER) (Figure 4.3.7) was 
used. 
 
 
 
_____________________________________________________________________ 
Figure 4.3.7: Comparing chemical structures of A) tetraethylrhodamine nitroxide (TER) and 
B) its non-radical alkylated derivative or methyl trap tetraethylrhodamine (MT-TER). 
 
MT-TER has similar structure to TER but has an extra coupled methyl group (Figure 
4.3.7). The coupling of an extra methyl group at the nitroxide radical centre of MT-
TER, renders MT-TER non-reactive and has its fluorescence fully switched on. Any 
decrease in fluorescence intensity observed upon incubating cells with MT-TER 
followed by subsequent treatment with ROT and AMC, therefore confirms the 
leaching of TER out of cells under the ROT and AMC treatment conditions. 
Experimental procedures carried out for assessing the mitochondrial membrane 
potential using MT-TER are as follows. 
    
Experimental 
Similar cell preperation steps along with similar experimental procedures as detailed 
on page 129 for the treatment of TER treated cells with ROT and AMC treatment was 
carried out. However, instead of TER, hTERT immortalized human fibroblast cells 
were incubated with MT-TER. Details of the experimental procedures are described 
below.  
 
A B 
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i) Rotenone (ROT) treatment 
The cells were initially incubated with ME-TER (1 µM) for 30 minutes in 1 mL of 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red]. The medium 
containing ME-TER was subsequently removed by pipette and a fresh batch of 
DMEM containing varying concentrations of ROT (0, 0.01, 0.1, 1, 10 and 100 µM) in 
a final volume of 1 mL was added to each of the 6 well respectively. The cells were 
incubated with ROT for 15 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
 
ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment was carried out in the case 
of AMC treatment. Upon treatment with ME-TER, the cells were incubated with 
varying concentrations of AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a 
final volume of 1 mL of DMEM for 15 minutes.  
  
Blanks were carried out by replacing the ROT or AMC or CCCP treatment with 
DMSO.  
  
Upon treatment, cells were washed with 1 mL of 10% v/v versene, treated with a stock 
solution of trypsin (adding 0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 
1200xg, time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells 
resuspended in 1 mL 1xPBS. Fluorescence readings were subsequently obtained for 
10000 cells via flow cytometry (BD LSRFortessa). 
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Results and discussion 
 
______________________________________________________________ 
Figure 4.3.8: Percentage change in mean fluorescence intensity of treated  hTRET 
immortalized human fibroblast cells, Fs [cells incubated with 1 µM non-radical alkylated 
derivative of TER or methyl trap tetraethylrhodamine (MT-TER) for 45 minutes, followed by 
treatment with varying concentrations of rotenone (ROT) / antimycin (AMC) for 15 minutes] 
relative to blank, Fc [cells incubated with 1 µM MT-TER for 45 minutes, followed by 
treatment with DMSO for 15 minutes] . (Each data point are mean values. Data were analysed 
using Kruskal Wallis test with pos hoc testing using the Dunn’s multiple comparison test. 
Relative to blank, all treatment showed a P value of > 0.05. Results are therefore not 
significantly different to blank). 
 
Based on Figure 4.3.8, increasing ROT and AMC concentration does not result in 
subsequent decrease in fluorescence intensity of MT-TER, as observed in the case of 
TMRM (Figure 4.3.6). This indicates that changes in TER fluorescence intensity 
previously observed upon treatment with ROT and AMC were a result of changes in 
mitochondrial redox condition and not due to a leakage of TER out of cells.  
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As a further confirmation, imaging experiment of hTERT immortalized human 
fibroblast cells incubated with  MT-TER, followed by treatment with ROT, AMC and 
CCCP of varying concentrations was carried out as follows. 
 
Experimental  
hTERT immortalized human fibroblast cells were prepared in IBIDI slides as 
described on page 97. The cells were subjected to different treatment as follows. 
 
i) Incubation with MT-TER  
1 µM of MT-TER was incubated with hTERT cells for 45 minutes in 200 µL of 
phenol red free DMEM [supplemented with fetal calf serum (final concentration 12% 
v/v), penicillin streptomycin antibiotics (final concentration 1% v/v)] at 37
0
C under an 
atmosphere of 5% CO2 in air. The cells were subsequently washed once with 200 µL 
of phenol red free DMEM [supplemented with fetal calf serum (final concentration 
12% v/v), penicillin streptomycin antibiotics (final concentration 1% v/v)].  
 
ii) Incubation with mitochondrial specific probe, MitoTracker Green 
Upon incubation with MT-TER, the cells were subsequently incubated with 100 nM of 
MitoTracker Green probe in 200 µL of phenol red free DMEM [supplemented with 
fetal calf serum (final concentration 12% v/v), penicillin streptomycin antibiotics (final 
concentration 1% v/v)] for 30 minutes at 37
0
C under an atmosphere of 5% CO2 in air. 
After which, the cells were washed once with phenol red free DMEM [supplemented 
with fetal calf serum (final concentration 12% v/v), penicillin streptomycin antibiotics 
(final concentration 1% v/v)] and subjected to ROT or AMC or CCCP treatment. 
 
iii) ROT / AMC / CCCP treatments 
The previously treated with MT-TER and MitoTracker Green were subsequently 
treated with ROT or AMC (1, 10 and 100 µM) or CCCP (100 µM) in 200 µL phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v), 
penicillin streptomycin (final concentration 1% v/v)] for 15 minutes at 37
0
C under an 
atmosphere of 5% CO2 in air.  
 
Blanks were carried out by replacing ROT or AMC or CCCP treatment with DMSO.  
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Upon ROT/AMC /CCCP treatments, cells were washed once with phenol red free 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. The localization of MT-TER and 
MitoTracker Green was imaged under an Applied Precision Deltavision microscope 
(excited at wavelength 515-569 nm and emission detected at wavelength 549-639 nm 
in the case of MT-TER and excited at wavelength 447-503 nm and emission detected 
at wavelength 487-559 nm in the case of MitoTracker Green). Imaging conditions 
were maintained at 37
0
C under an atmosphere of 5% CO2 in air in phenol red free 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. 
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Results and discussion 
   
 
A 
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______________________________________________________________ 
Figure 4.3.9: Comparing localization of non-radical alkylated derivative of TER, methyl trap 
tetraethylrhodamine (MT-TER) within hTRET immortalized human fibroblast cells upon 
treatment with varying concentration of A) rotenone, ROT  (1,10 and 100 µM) and B) 
antimycin, AMC (1, 10 and 100 µM) as well as carbonyl cyaninde m-chlorophenyl hydrazone, 
CCCP (100 µM). (Triplicate life cell images were taken, only one image is being displayed). 
 
Figure 4.3.9 shows that MT-TER remains within cells despite treatment with varying 
concentrations of ROT and AMC as compared to control. This differs from that 
observed with CCCP treatment. CCCP disrupts the cell membrane, resulting in the 
leakage of both MitoTracker Green and MT-TER out of the mitochondria and 
subsequently out of the cell. Analysis observation made from Figure 4.3.9 hence 
confirms that the changes in fluorescence intensity upon treatment with TER was not 
due to leakage of probe out of the cells. Instead, it was due to changes in redox status 
within mitochondria. This renders TER as an effective probe for assessing 
mitochondrial redox status.  
 
Previous studies by Hirosawa (2012) reported of a TEMPO-conjugated profluorescent 
probe for monitoring redox reactions within the mitochondria, MitoRP.
123
 MitoRP 
consists of a TEMPO (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl moiety coupled to the 
monocationic fluorophore coumarin 343 (Figure 1.36). It was reported that MitoRP is 
able to assess redox changes within Complex I of the mitochondria reversibly. 
However, an increase in ROS production increases the fluorescence intensity of 
MitoRP, unlike a decrease in fluorescence intensity within TER.  
 
The difference in fluorescence response in relation to ROS production between 
MitoRP and TER could be the fact that MitoRP is a tetramethyl-based system but TER 
is a tetraethyl-based system. As described earlier, methyl-based system has a higher 
reduction rate compared to that of ethyl-based system. In this regard, the whole 
oxidation and reduction process occurring for both MitoRP and TER may be of a 
different mechanism. In addition to that, the experiments carried out by Hirosawa et al. 
(2012) were with isolated mitochondria and not intact viable cells as in the case of 
TER.  
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Despite the ability of TER to assess redox status within biological systems, it is vital 
that the PFN probes do not affect the normal physiological functioning of the system. 
The cytotoxic effect of TER in cells is therefore crucial. An understanding on the 
cytotoxic effect of TER provides a greater understanding on the applicability of the 
PFN probe. The commonly used assay for assessing the cytotoxicity of compounds, 
MTT or (3,-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was 
carried out to assess the cytotoxicity effect of TER. 
 
Experimental 
hTRET immortalized human fibroblast cells were cultured in 96-well plate at a 
concentration of 2x10
4
cells per mL over a period of 24 hours. The cells were then 
incubated with 1 µM of compounds namely, TER, MT-TER and MitoSox. DMSO was 
used in place of the compounds as blank.  
 
Cells were incubated with the compounds for 45 minutes, washed and replaced with 
100 µL of fresh phenol red free DMEM supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin (final concentration 1% v/v).   
 
A 12 mM stock solution of MTT was prepared by adding 1 mL of 1xPBS to a 5 mg 
vial of MTT (commercially available). 10 µL of the 12 mM MTT stock solution was 
added to each well within the 96-well plate. A negative control was prepared by 
adding of 10 µL of the 12 mM MTT stock solution to 100 µL media.  
 
The mixtures were incubated at 37
o
C for 4 hours. After which, 85 µL of the solution 
was removed and 50 µL of DMSO was added to each well. The mixtures were 
thoroughly mixed and incubated for a further 10 minutes at 37
o
C. 
 
The mixtures within the 96-well plate were subsequently mixed to form a homogenous 
solution and absorbance within each well was obtained at 540 nm using the BioTek 
Synergy plate reader.  
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Results and discussion  
 
 
_____________________________________________________________________ 
Figure 4.3.10: MTT cell proliferation assay upon incubating cells with different compounds 
[tetraethylrhodamine nitroxide, TER; its non-radical alkylated derivative, methyl trap 
tetraethylrhodamine (MT-TER) and MitoSox] for 45 mins. Cells were left to grow over a 
period of 1, 12, 24, 48 and 72 hours. Results were normalized to DMSO blank as percentage 
change in absorbance intensity of sample, FS relative to DMSO blank, FB. (GraphPad prism 
was used to compare times within each treatment using a two-way repeat measure ANOVA 
with Tukey’s mulptile comparisons test used for pairwise comparisons.  The standard errors to 
conduct pairwise comparisons between treatments were calculated manually, with the t-
statistic used for the comparisons. P values of > 0.05 were obtained between different 
treatments. Hence, results were considered non-significant between treatments). 
 
Under all the treatments described in Figure 4.3.10, the percentage change in 
absorbance intensity of sample, FS relative to DMSO blank, FB were similar. Figure 
4.3.10 hence indicated that TER, MT-TER as well as MitoSox were not significantly 
toxic to cells for periods up to 3 days and do not affect normal functioning of the 
mitochondria. Results therefore enable TER to be used over extensive time period to 
assess biological redox status.  
 
In summary, experiments described demonstrated that TER has a slow reduction rate. 
It was also shown that the probe has good pH stability at biologically relevant pH ( 6-
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7). In addition, microscopy indicated that TER localizes significantly into the 
mitochondria. The potential of the probe to assess the redox changes within the 
mitochondria of hTERT immortalized human fibroblast cells was demonstrated using 
flow cytometry. 
 
Despite the demonstrated value of TER as a mitochondrially targeted probe, the lack 
of complete localization of TER into the mitochondria potentially remains an issue. As 
aforementioned, due to the occurance of ETC within the mitochondria, the 
mitochondria have a net negative charge across the mitochondrial membrane. The net 
negative charge across the mitochondrial membrane increases the uptake of cationic 
group into the mitochondria.
136,137
 Subsequent effort was hence carried out to increase 
the overall positive charge of TER, with the aim to increase uptake of TER within the 
mitochondria.  
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 CHAPTER 5 
Improved Cellular Response of PFNs by 
Esterification 
 
Previous studies by Hardy et al. (2007),
94
 Dikalov et al.,
96,97,98
 Cocheme and Murphy 
et al. (2011),
104
 Hirosawa et al. (2012),
125
 as well as Trnka and Murphy (2008),
163,166
 
reported that cationic probes show an increased localization within the mitochondria. 
Having the objective to increase the localization of TER into the mitochondria, an 
attempt was made to increase the overall positive charge of TER. This was carried out 
through esterification of the carboxylic group within the rhodamine moiety of TER, 
giving rise to the PFN, methyl ester tetraethylrhodamine nitroxide (ME-TER) with 
increase positive charge (Figure 5.1). Synthesis was carried out by Dr. Benjamin 
Chalmers based on synthesis developed by Morrow.
126
 
 
 
_____________________________________________________________________ 
Figure 5.1: Comparing the chemical structures between A) tetraethylrhodamine nitroxide 
(TER) and B) methyl ester tetraethylrhodamine nitroxide (ME-TER). 
 
Compared to TER, ME-TER has an overall positive charge (Figure 5.1). Theoretically, 
ME-TER should show increased mitochondrial localization compared to TER. This 
was confirmed by repeating the previously described mitochondrial localization 
experiment using ME-TER as the PFN. Details of the experiment are described below.  
 
 
 
A B 
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5.1 Localization of methyl ester tetraethylrhodamine nitroxide (ME-TER) 
Experimental  
Similar cell preparation and experimental procedures as detailed in Chapter 2 for 
assessing the localization of PFN probes within cells were carried out. However, 
hTERT human fibroblast cells were incubated with 1 µM of ME-TER instead of TER. 
  
Cells within IBIDI slides were incubated with 1 µM of ME-TER by replacing previous 
medium within each well with 2 mL of phenol red free DMEM [supplemented with 
fetal calf serum (final concentration 12% v/v) and penicillin streptomycin antibiotics 
(final concentration 1% v/v). The cells were incubated for 45 minutes at 37
0
C under an 
atmosphere of 5% CO2 in air. Care was taken to avoid any detachment of cells from 
the slide.  
 
Upon incubation, the cells were washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and were subsequently co-
stained with 100 nM of MitoTracker Green and 50 nM of LysoTracker Blue in 2 mL 
of phenol red free medium [supplemented with fetal calf serum (final concentration 
12% v/v) and penicillin streptomycin antibiotics (final concentration 1% v/v)]. The 
cells were incubated for 30 minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
  
The cells were subsequently washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and a new batch of 2 mL phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to each 
well prior imaging. 
 
The localization of ME-TER, MitoTracker Green and LysoTracker Blue were imaged 
under an Applied Precision Deltavision microscope. An excitation at wavelength 515-
569 nm and emission detection at wavelength 549-639 nm was applied in the case of 
ME-TER, while in the case of MitoTracker Green, an excitation at wavelength 447-
503 nm and emission detection at wavelength 487-559 nm was applied. In the case of 
LysoTracker Blue, an excitation wavelength of 372-408 nm and an emission 
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wavelength of 417-453 nm were applied. Imaging conditions were maintained at 37
0
C 
under an atmosphere of 5% CO2 in air in phenol red free DMEM [supplemented with 
fetal calf serum (final concentration 12% v/v), penicillin streptomycin (final 
concentration 1% v/v)]. 
 
Results and discussion 
 
 
_____________________________________________________________________ 
Figure 5.1.1: Localization of 1 µM methyl ester tetraethylrhodamine (ME-TER) within 
hTERT immortalised human fibroblast cells. Cells were co-stained with MitoTracker Green 
(100 nM) and LysoTracker Blue (50 nM). (Triplicate life cell images were taken, only one 
image is being displayed). 
 
Based on Figure 5.1.1, it can be observed that incubating hTERT cells with 1 µM of 
ME-TER cause clumping of the mitochondria into spherical structures instead of 
remaining as a filamentous network as observed previously in the case of 1 µM TER. 
Such observation could possibly indicate the disruption of the mitochondrial 
membrane which could possibly be due to an increased uptake of ME-TER into the 
mitochondria, owing to the increased positive charge of ME-TER. The increased 
uptake in turn could have possibly perturbed the ETC within the mitochondria by 
disrupting the transfer of electrons along the mitochondrial membrane. The disruption 
in electron transfer along the mitochondrial membrane results in loss of membrane 
potential, observed as the rounding up of the mitochondrial filamentous network and 
subsequently apoptosis or cell death.  
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The experiment was hence repeated using lower concentrations of ME-TER, in the 
nanomolar (nM) range and localization of ME-TER imaged accordingly under the 
Deltavision microscope. The localization of ME-TER was compared with that of TER. 
 
 hTERT immortalized human fibroblast cells were incubated separately with 5 nM 
TER and ME-TER along with their respective non-radical alkylated derivatives. The 
localizations of the TER and ME-TER as well as their respective non-radical alkylated 
derivatives within the mitochondria were subsequently compared. 
 
 
 
_____________________________________________________________________ 
Figure 5.1.2: Comparing localization of 5 nM of tetraethylrhodamine nitroxiede (TER) with 5 
nM methyl ester tetraethyhylrhodamine nitroxide (ME-TER), along with the non-radical 
alkylated derivatives of both nitroxide probes, within hTERT immortalized human fibroblast 
cells. (Triplicate life cell images were taken, only one image is being displayed). 
 
Observations made based on Figure 5.1.2 shows that at 5 nM concentration, the 
fluorescence intensities given off by TER and its non-radical alkylated derivative were 
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too weak to be observed. ME-TER and its non-radical alkylated derivative on the other 
hand, showed significant signal. Overlay image between MitoTracker Green and ME-
TER (Figure 5.1.3) confirmed significant increase of ME-TER localization within the 
mitochondria.  
 
 
 
 
                            
 
 
 
 
A 
B 
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Figure 5.1.3: A) Comparing the localization of 1 µM of tetraethylrhodamine (TER) and 5 nM 
of methyl ester tetraethyhylrhodamine nitroxide (ME-TER) within hTERT immortalized 
human fibroblast cells. B) Colocalization plot between ME-TER (5 nM) and MitoTracker 
Green (100 nM) within mitochondria. (Triplicate life cell images were taken, only one image 
is being displayed). 
 
Based on Figure 5.1.3, the localization of ME-TER within the mitochondria has a 
coefficient of correlation of 0.9217.  The coefficient correlation is much higher than 
that of TER with MitoTracker Green (0.7269) as described in Figure 3.3.4. The 
increase ME-TER / MitoTracker Green coefficient correlation confirmed an increased 
localization of ME-TER into the mitochondria compared to TER. The increased 
mitochondrial localization of ME-TER is evident through Figure 5.1.3A where the 
endosomal localization of TER is absent in the case of ME-TER. Compared to TER 
which only displayed approximately 73% colocalization with MitoTracker Green 
(Figure 3.3.4B), ME-TER displayed approximately 90% colocalization within the 
mitochondria (Figure 5.1.3B) as shown by the coefficient of correlation. 
 
The increased localization of ME-TER within the mitochondria therefore renders ME-
TER possibly a better probe for assessing mitochondrial redox status relative to TER. 
Only a small quantity of ME-TER is required for assessing mitochondrial redox status. 
 
In an attempt to determine if esterification of TER giving rise to ME-TER affects the 
ability of ME-TER to assess mitochondrial redox status, the previously described flow 
cytometry redox experiment was repeated using ME-TER as probe. ME-TER treated 
hTERT immortalized human fibroblast cells were treated with ROT / AMC and the 
subsequent change in fluorescence intensity of ME-TER within cells were monitored 
via flow cytometry techniques. 
 
5.2 Methyl ester tetraethylrhodamine nitroxide (ME-TER) as mitochondrial 
redox probe 
 
Similar cell preparation and experimental procedures as detailed on page 129 for 
assessing the capability of TER to monitor redox changes within the mitochondria as 
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was carried out. However, instead of TER, cells were incubated with ME-TER. Details 
of the experimental procedures are as follows. 
 
Experimental  
Cells cultured within 6-well plates were subjected to different treatment as detailed 
below.   
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with ME-TER (5 nM) or MitoSox (1 µM) for 45 
minutes at 37
o
C, 5% CO2, in 1 mL of DMEM [supplemented with fetal calf serum 
(final concentration 12% v/v), penicillin streptomycin antibiotics (final concentration 
1% v/v) and phenol red].  The medium containing ME-TER was subsequently 
removed by pipette and a fresh batch of DMEM containing varying concentrations of 
ROT (0, 0.01, 0.1, 1, 10 and 100 µM) in a final volume of 1 mL, was added to each of 
the 6 well respectively. The cells were incubated with ROT for 15 minutes at 37
0
C 
under an atmosphere of 5% CO2 in air.  
 
ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment were carried out in the case 
of AMC treatment. Upon treatment with ME-TER, the cells were incubated with 
varying concentrations of AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a 
final volume of 1 mL of DMEM for 15 minutes.  
 
Blanks were carried out by replacing ROT or AMC with DMSO in a final volume of 1 
mL of DMEM, followed by15 minutes incubation at 37
0
C under an atmosphere of 5% 
CO2 in air. 
  
Upon treatment, the cells were washed with 1 mL of 10% v/v versene, treated with a 
stock solution of trypsin (0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 1200xg, 
time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells resuspended 
in 1 mL 1xPBS. Fluorescence readings for approximately 10000 cells were 
subsequently obtained via the BD LSRFortessa flow cytometer.  
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ME-TER was excited around wavelength 556 nm and emission collected at 
wavelength 575 nm, while MitoSox was excited around wavelength 510 nm and 
emission collected at wavelength 580 nm.  
 
Results and discussion 
 
 
Figure 5.2.1: Percentage reduction in fluorescence intensity of treated  hTRET immortalized 
human fibroblast cells, Fs [cells incubated with 5 nM methyl ester tetraethyrhodamine 
nitroxide (ME-TER) for 45 minutes, followed by treatment with varying concentrations of 
rotenone (ROT) or antimycin (AMC)] for 15 minutes relative to blank, Fc [cells incubated 
with  5 nM ME-TER for 45 minutes, followed by treatment with DMSO for 15 minutes] . 
(Each data point are mean values. Data were analysed using Kruskal Wallis test with pos hoc 
testing using the Dunn’s multiple comparison test. Relative to blank, all treatment showed a P 
value < 0.05, results are therefore significantly different to blank). 
 
As indicated in Figure 5.2.1, ME-TER showed similar results to the parent TER 
(Figure 4.3.2A). As described in Chapter 4 (Figure 4.3.3), due to the reducing 
environment within the mitochondria, the localized ME-TER nitroxides are reduced to 
hydroxylamines.
163
 The reduction give rise to an initial increase in fluorescence 
intensity upon the uptake of ME-TER nitroxides into the mitochondria. Subsequent 
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treatment with ROT or AMC, increases ROS production within the 
mitochondria.
105,162
 An increase in ROS production within the mitochondria oxidises 
the hydroxylamines to nitroxides, resulting in a drop in ME-TER fluorescence 
intensity (Figure 5.2.1). Increasing the level of ROT and AMC present, increases ROS 
production within the mitochondria of ME-TER treated cells. Such an increase in ROS 
production in turn decreases the fluorescence intensity of ME-TER present in the cells.  
  
Analysis made from observation based on Figure 5.2.1, concluded that modification 
made on the parent TER structure to give the ester ME-TER still provides a 
fluorescence response that is sensitive to mitochondrial redox changes.  
 
In an attempt to confirm if ME-TER fluorescence changes observed with ROT and 
AMC treated ME-TER incubated cells were due to changes in redox status within 
cells, the experiment above was repeated with the non-radical alkylated derivative of 
ME-TER or also known as methyl trap methyl ester tetraethylrhodamine, MT-ME-
TER (Figure 5.2.2). MT-ME-TER served as a control to examine the role of radical 
reduction compared to probe retention in governing the fluorescence response detected 
by flow cytometry. 
  
 
 
Figure 5.2.2: Comparing chemical structures between A) methyl ester tetraethylrhodamine 
nitroxide (ME-TER) and its B) non-radical alkylated derivative or methyl trap methyl ester 
tetraethylrhodamine (MT-ME-TER). 
 
A B 
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hTERT immortalized human fibroblast cells were incubated with MT-ME-TER 
instead of ME-TER and subjected to different ROT or AMC treatment as detailed 
below. 
 
Experimental 
hTERT immortalized human fibroblast cells were seeded at an initial concentration of 
approximately 5x10
4
 cells per mL in 6-well plates as described on page 124. Within 
different wells, the cells were treated differently as follows.   
 
i) Rotenone (ROT) treatment 
The cells were initially incubated with MT-ME-TER (5 nM) for 45 minutes at 37
o
C, 
5% CO2, in 1 mL of DMEM [supplemented with fetal calf serum (final concentration 
12% v/v), penicillin streptomycin antibiotics (final concentration 1% v/v) and phenol 
red)].  The medium containing ME-TER was subsequently removed by pipette and a 
fresh batch of DMEM containing varying concentrations of ROT (0, 0.01, 0.1, 1, 10 
and 100 µM) in a final volume of 1 mL was added to each of the 6 well respectively. 
The cells were incubated with ROT for 15 minutes at 37
0
C under an atmosphere of 5% 
CO2 in air.  
 
ii) Antimycin (AMC) treatment 
Similar experimental procedures to that of ROT treatment were carried out in the case 
of AMC treatment. Upon treatment with ME-TER, the cells were incubated with 
varying concentrations of AMC (0, 0.01, 0.1, 1, 10 and 100 µM) instead of ROT, in a 
final volume of 1 mL of DMEM for 15 minutes.  
 
Blanks were carried out by replacing ROT or AMC with DMSO in a final volume of 1 
mL of DMEM, followed by15 minutes incubation at 37
0
C under an atmosphere of 5% 
CO2 in air.  
  
Upon treatment, the cells were washed with 1 mL of 10% v/v versene, treated with a 
stock solution of trypsin (0.5 mL of 0.5% v/v trypsin) and centrifuged (speed- 1200xg, 
time- 4 mins and temperature- 37
o
C). Supernatant was removed and cells resuspended 
in 1 mL 1xPBS. Fluorescence readings for approximately 10000 cells were 
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subsequently obtained via the BD LSRFortessa flow cytometer. MT-ME-TER was 
excited around wavelength 556 nm and emission collected at wavelength 575 nm.  
 
Results and discussion 
 
 
 
Figure 5.2.3: Percentage reduction in fluorescence intensity of treated  hTRET immortalized 
human fibroblast cells, Fs [cells incubated with 5 nM methyl trap methyl ester 
tetraethyrhodamine nitroxide (MT-ME-TER) for 45 minutes, followed by treatment with 
varying concentrations of rotenone (ROT) or antimycin (AMC)] for 15 minutes relative to 
blank, Fc [cells incubated with  5 nM MT-ME-TER for 45 minutes, followed by treatment 
with DMSO for 15 minutes] . (Each data point are mean values. Data were analysed using 
Kruskal Wallis test with pos hoc testing using the Dunn’s multiple comparison test. Relative 
to blank, all treatment showed P values > 0.05, results are therefore not significantly different 
to blank).  
 
Based on Figure 5.2.3, there was no significant reduction in fluorescence intensity of 
MT-ME-TER upon treating the cells with increasing level of ROT. A similar trend 
was observed in the case of AMC treatment of concentration 0.01 to 10 µM. The 
analysis made based on Figure 5.2.3 hence confirmed that the drop in ME-TER 
fluorescence intensity previously observed in cells treated with ROT and AMC 
(Figure 5.2.1) was due to changes in mitochondrial redox status and not leakage of the 
probe out of the mitochondria and the cell.  
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However, upon treating cells with AMC concentration of 100 µM, there was a 
significant drop in MT-ME-TER fluorescence intensity (Figure 5.2.3) upon running a 
One-way ANOVA with pos hoc testing using the Dunnett’s multiple comparison test 
(P value 0.0009). This suggests that at AMC concentration of 100 µM, the drop in 
fluorescence intensity of ME-TER (Figure 5.2.1) was possibly due to leakage of the 
probe out of the cell.  
 
A positive control experiment based on CCCP treatment to disrupt mitochondrial 
membranes within cells incubated with MT-ME-TER was subsequently carried out. A 
similar drop in MT-ME-TER fluorescence intensity upon 100 µM AMC treatment 
compare to 100 µM CCCP treatment would possibly confirm the leakage of the probe 
MT-ME-TER out of the cell. CCCP treatment experimental procedures carried out 
were described below. 
 
Experimental 
CCCP treatment 
hTERT immortalized human fibroblast cells were incubated with MT-ME-TER for 45 
minutes as previously described in the case of ME-TER. The cells were washed with 
fetal calf serum (final concentration 12% v/v), penicillin streptomycin (final 
concentration 1% v/v). Subsequently, the cells were treated with CCCP (100 µM) 
prepared in phenol red free media added with fetal calf serum (final concentration 12% 
v/v), penicillin streptomycin (final concentration 1% v/v) for 15 minutes. Incubation 
conditions were maintained at 37
0
C under an atmosphere of 5% CO2 in air. 
 
Upon treatment, cells were washed with 1 mL of 10% v/v versene, treated with a stock 
solution of trypsin (adding 0.5 ml of 0.5% v/v trypsin) and centrifuged (speed- 1200 
rpm, time- 4 mins, temperature- 37
o
C). Supernatant was removed and cells 
resuspended in 1 mL 1xPBS. Fluorescence readings for approximately 10000 cells 
were subsequently obtained via the BD LSRFortessa flow cytometer. MT-ME-TER 
was excited around wavelength 556 nm and emission collected at wavelength 575 nm. 
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Results and discussion  
 
 
 
Figure 5.2.4: Percentage reduction in fluorescence intensity of treated  hTRET immortalized 
human fibroblast cells, Fs [cells incubated with non-radical alkylated derivative of methyl ester 
tetraethyrhodamine nitroxide (MT-ME-TER) for 45 minutes, followed by treatment with 
varying concentrations of rotenone (ROT) or antimycin (AMC) or carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) ] for 15 minutes relative to blank, Fc [cells incubated with  5 
nM MT-ME-TER for 45 minutes, followed by treatment with DMSO for 15 minutes] . (Each 
data point are mean values. Data were analysed using Kruskal Wallis test with pos hoc testing 
using the Dunn’s multiple comparison test. Relative to blank, CCCP  and AMC 100 µM 
treatment showed P values < 0.05, results are therefore significantly different to blank). 
 
A decrease in MT-ME-TER fluorescence intensity was observed at 100 µM CCCP 
treatment (Figure 5.2.4). Compared to 100 µM AMC, it is apparent that a greater 
decrease in MT-ME-TER was observed in the case of 100 µM CCCP treatment. 
Nevertheless, a decrease in MT-ME-TER fluorescence intensity was observed in both 
cases, 100 µM AMC and CCCP treatment. The decrease in MT-ME-TER fluorescence 
intensity in both 100 µM AMC and CCCP treatment could possibly confirm the 
leakage of MT-ME-TER out of the mitochondria and subsequently out of the cell. The 
leakage of MT-ME-TER out of the mitochondria and cell was possibly due to the 
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disruption of the mitochondrial membrane potential under both 100 µM AMC and 
CCCP treatments.   
 
In an attempt to confirm the possibility that the leakage of MT-ME-TER out of the cell 
under both 100 µM AMC and CCCP treatment is due to disruption of the 
mitochondrial membrane, imaging studies were carried out. The condition of MT-ME-
TER incubated cells upon treatment with varying concentrations of ROT, AMC and 
CCCP were imaged based on the following experimental procedures.  
 
Experimental  
Cells were cultured within IBIDI slides as decribed on page 97 and were subjected to 
different treatment as follows. 
 
i) Incubation with MT-ME-TER  
5 nM of MT-ME-TER was incubated with hTERT cells for 45 minutes in 200 µL of 
phenol red free DMEM [supplemented with fetal calf serum (final concentration 12% 
v/v), penicillin streptomycin antibiotics (final concentration 1% v/v)] at 37
0
C under an 
atmosphere of 5% CO2 in air. The cells were subsequently washed once with 200 µL 
of phenol red free DMEM [added with fetal calf serum (final concentration 12% v/v), 
penicillin streptomycin antibiotics (final concentration 1% v/v)].  
 
ii) Incubation with mitochondrial specific probe, MitoTracker Green 
Upon incubation with MT-ME-TER, the cells were subsequently incubated with 100 
nM of MitoTracker Green probe in 200 µL of phenol red free DMEM [supplemented 
with fetal calf serum (final concentration 12% v/v), penicillin streptomycin antibiotics 
(final concentration 1% v/v)] for 30 minutes at 37
0
C under an atmosphere of 5% CO2 
in air. After which, the cells were washed once with phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and subjected to ROT or AMC 
or CCCP treatment. 
 
iii) ROT / AMC / CCCP treatments 
The previously treated with MT-ME-TER and MitoTracker Green cells were 
subsequently treated with ROT or AMC (1, 10 and 100 µM) or CCCP (100 µM) in 
 163 
200 µL phenol red free DMEM [added with fetal calf serum (final concentration 12% 
v/v), penicillin streptomycin (final concentration 1% v/v)] for 15 minutes at 37
0
C 
under an atmosphere of 5% CO2 in air. 
 
Blanks were carried out by replacing ROT or AMC or CCCP treatment with DMSO. 
Upon ROT / AMC / CCCP treatments, cells were washed once with phenol red free 
DMEM [supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. The localization of MT-ME-TER and 
MitoTracker Green was imaged under an Applied Precision Deltavision microscope 
(excited at wavelength 515-569 nm and emission detected at wavelength 549-639 nm 
in the case of MT-ME-TER and excited at wavelength 447-503 nm and emission 
detected at wavelength 487-559 nm in the case of MitoTracker Green). Imaging 
conditions were maintained at 37
o
C and 5% CO2 in phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. 
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Figure 5.2.5: Comparing localization of non-radical alkylated derivative of ME-TER, methyl 
trap methyl ester tetraethylrhodamine (MT-ME-TER) within hTRET immortalized human 
fibroblast cells upon treatment with varying concentrations of A) rotenone, ROT (1, 10 and 
100 µM) and B) antimycin, AMC (1, 10 and 100 µM) as well as carbonyl cyaninde m-
chlorophenyl hydrazone, CCCP (100 µM).  (Triplicate life cell images were taken, only one 
image is being displayed). 
 
It can be observed from Figure 5.2.5, that upon treatment with 100 µM of AMC and 
CCCP, there was a lost of the filamentous network within the cells. The loss in 
filamentous network was absent in the case of ROT (1, 10, 100 µM) and AMC (1, 10 
µM) treatments. Such loss of the filamentous network as aforementioned (Figure 
5.1.1) is possibly an indication of disruption towards the mitochondrial membrane 
potential.  
 
The disruption of the mitochondrial membrane potential possibly leads to leakage of 
MT-ME-TER out of the mitochondria and the cell which can be observed by lower 
fluorescence intensity among the MT-ME-TER incubated cells treated with 100 µM 
AMC and CCCP. Such a decrease of fluorescence intensity among MT-ME-TER 
incubated cells with 100 µM of AMC and CCCP was prominent through Figure 5.2.5 
upon comparing the fluorescence intensity of MT-ME-TER incubated cells treated 
with 100 µM of AMC and CCCP relative to the other ROT (1, 10, 100 µM) and AMC 
(1, 10 µM) treatments.  In addition, cells treated MT-ME-TER and 100 µM CCCP 
resulted in lower MT-ME-TER fluorescence intensity compared to that of 100 µM 
AMC treatment, agreeing with previous flow cytometry results (Figure 5.2.4).  
 
Upon analysing the images in Figure 5.2.5, it can therefore be concluded that 100 µM 
AMC and CCCP treatments could possibly results in the disruption of mitochondrial 
membrane potential. The disruption of the mitochondrial membrane leads to the 
leakage of PFN probes out of the mitochondria and subsequently out of the cell. A 
high concentration of AMC (in this case 100 µM) therefore could possibly lead to 
disruption of mitochondrial membrane potential in ME-TER treated cells. Despite of it 
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all, ME-TER still has the capacity to serve as a potential probe to monitor redox 
changes at lower ROT and AMC concentrations.   
 
Upon confirming the redox sensing capability of ME-TER, cytotoxicity of ME-TER 
and MT-ME-TER remained a crucial factor in determining the potential use of ME-
TER and MT-ME-TER in biological system. An ideal redox sensing probe does not 
affect the normal physiological functioning of the cells over prolong incubation 
period. The cytotoxicity level of ME-TER and MT-ME-TER was therefore assessed.  
 
5.3 Cytotoxicity of Methyl Ester Tetraethylrhodamine (ME-TER) 
In assessing the cytotoxicity of ME-TER and MT-ME-TER, the previously described 
MTT assay assessment (Figure 4.3.10) was repeated for ME-TER and MT-ME-TER 
treated cells. In addition, the effect of ME-TER within cells was imaged over a period 
of more than 24 hours using the spinning disk fluorescence microscope, so as to assess 
the potential use of ME-TER to monitor changes in mitochondrial redox status within 
cells over extended time periods.  
 
Conventional fluorescence microscopy involves exciting the sample under observation 
with a broad stream of light. The fluorescence given off by the sample, both within 
and out of focal plane is subsequently collected and imaged. In the case of confocal 
fluorescence microscopy, a pinhole is used to block out light which is out of focus. 
This improves the resolution of image.  
 
A commonly used confocal fluorescence microscopic technique is the confocal laser 
scanning microscope. Such a laser scanning microscope uses a laser of distinct 
wavelength governed by the nature of the sample to rapidly scan the sample at several 
different points. The light returning from each point is quantified by a photomultiplier 
tube and a digital image is reconstructed.
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Although the confocal laser scanning microscope is able to provide a fast response, the 
microscope however suffers from a trade off between image resolution and imaging 
speed. In order to obtain a significantly good resolution in a short period of time, 
relatively intense laser power has to be used. Such intense power can result in 
photobleaching and even phototoxicity in live cell imaging.
168
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Another technology that has the potential to overcome this limitation is a spinning disk 
instrument where the microscope is equipped with multiple pin holes. A spinning disk 
containing rapidly rotating pinhole disk enables thousands of light points to scan the 
sample simultaneously and can achieve frame rates up to 1000 frames per second. This 
enables the use of a lower intensity laser power and multiple point detection 
simultaneously, giving high resolution images in a short period of time.
168
 
 
Due to its sensitivity and low phototoxicity, spinning disk microscopic techniques 
along with MTT assay were carried out to assess the cytotoxicity level of ME-TER. 
The experimental procedures were detailed below. 
  
Experimental 
i) MTT assay 
Similar MTT assay experimental procedures as described for assessing the 
cytotoxicity of TER (page 146) were repeated for assessing the cytotoxicity level of 
ME-TER and MT-ME-TER. 
   
hTRET immortalized human fibroblast cells were cultured in 96-well plate at a 
concentration of 2x10
4
cells per mL over a period of 24 hours. Upon incubation, the 
cells were incubated with 25 nM of compounds namely, ME-TER and MT-ME-TER. 
DMSO blank was used in place of the compounds as blank.  
 
Cells were incubated with the compounds for 45 minutes, washed and replaced with 
100 µL of fresh phenol red free DMEM added with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin (final concentration 1% v/v).   
 
A 12 mM stock solution of MTT was prepared by adding 1 mL of 1xPBS to a 5 mg 
vial of MTT (commercially available). 10 µL of the 12 mM MTT stock solution was 
added to each well within the 96-well plate. A negative control was prepared by 
adding of 10 µL of the 12 mM MTT stock solution to 100 µL media.  
 
The mixtures were incubated at 37
o
C for 4 hours. After which, 85 µL of the solution 
was removed and 50 µL of DMSO was added to each well. The mixtures were 
thoroughly mixed and incubated for a further 10 minutes at 37
o
C. 
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The mixtures within the 96-well plate were subsequently mixed to form a homogenous 
solution and absorbance within each well was obtained at 540 nm using the BioTek 
Synergy plate reader.  
 
ii) Imaging using spinning disk fluorescence microscopy 
4x10
5
cells per mL of hTERT immortalized human fibroblast cells were cultured in 
IBIDI slides overnight in DMEM media [supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin (final concentration 1% v/v)]. The 
cells were subsequently incubated with 25 nM of ME-TER (prepared in 2 mL of 
phenol red free DMEM media supplemented with fetal calf serum (final concentration 
12% v/v) and penicillin streptomycin (final concentration 1% v/v) and localization of 
probe was imaged under the CV1000 spinning disk microscope every 3 minutes for 
over 24 hours. Imaging conditions were maintained at 37
o
C and 5% CO2. The probe 
was excited at wavelength 561 nm and emission detected at wavelength 582 nm.  
 
 Results and discussion 
 
 
 
 
A 
B 
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Figure 5.3.1: A) hTERT immortalized human fibroblast cells were incubated with varying 
compounds (25 nM) for varying time point. Cells were then washed and cytotoxicity of 
compounds on cells were determined via MTT assay. Results were expressed as percentage 
absorbance change of sample, Fs relative to blank, FB (DMSO treatment). (Each data point are 
mean values of replicated experiment. Data were analysed using Kruskal Wallis test with pos 
hoc testing using the Dunn’s multiple comparison test. Relative to blank, all treatment showed 
P values > 0.05, results are therefore not significantly different to blank). B) hTERT 
immortalized human fibroblast cells were incubated with 25nM of methyl ester 
tetraethylrhodamine nitroxide (ME-TER) over 24 hours. Cells were imaged every 3 minutes 
for over 24 hours. Image of cells before and after treatment period was shown. (Triplicate life 
cell images were taken, only one image is being displayed). 
 
Based on Figure 5.3.1A, both ME-TER and MT-ME-TER have similar change in 
absorbance relative to the non-treated and DMSO control up to 3 days (72 hours) of 
incubation with the probes. The similar change in absorbance relative to the non-
treated and DMSO control indicates that both ME-TER and MT-ME-TER have 
limited impact on the normal mitochondrial function in the cells studied. Both ME-
TER and MT-ME-TER hence have low cytotoxic effect towards the treated cells.  
 
The low toxicity effect of ME-TER towards cells was further confirmed through 
images of cell imcubated with ME-TER observed in Figure 6.3.1B. Cells incubated 
with ME-TER for more than 24 hour incubation, undergone normal mitosis or cell 
division and increased in cell number. ME-TER therefore, has the potential to be used 
as a mitochondrial redox monitoring probe over extended time period.  
 
Although the coupling of an extra methyl group at the nitroxide radical centre of MT- 
ME-TER, renders it non-reactive, MT-ME-TER could possibly serve as a probe to 
stain mitochondria as it has its fluorescence fully switched on, in addition to showing 
good mitochondrial localization (Figure 5.2.5) and low cytotoxicity within cells 
(Figure 5.3.1A).   
 
Having established the potential use of ME-TER as a mitochondrial redox probe due 
to its increase mitochondrial localization and low cytoxocitiy within cells, studies were 
 171 
carried out to determine the capability of ME-TER to compare differential redox status 
within normal and Ataxia Telangiectasia, A-T diseased cells, which as previously 
described suffers from oxidative stress. 
 
5.4 Comparing redox status between normal and Ataxia Telangiectasia, A-T 
diseased cells  
The first step in determining the capability of ME-TER to assess the redox status 
within normal and A-T diseased cells, was to determine if ME-TER localizes within 
the mitochondria of both normal and A-T diseased cells. Imaging experiments as 
described in Figure 5.1.3 were carried out. Normal and A-T diseased fibroblast cells 
were incubated with 10 nM ME-TER and MT-ME-TER. Details of the experimental 
procedures are described below. 
   
A) Localization of ME-TER within normal and A-T diseased cells 
Experimental 
Primary (non-immortalized) normal human fibroblast and A-T diseased human 
fibroblast cells were cultured overnight in IBIDI slides in DMEM media 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red] at an initial 
concentration of 1.5x10
5
 cells per mL.  
 
The cells were subsequently incubated with 10 nM of ME-TER and MT-ME-TER by 
replacing previous medium within each well with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)]. The cells were incubated for 45 
minutes at 37
0
C under an atmosphere of 5% CO2 in air and care was taken to avoid 
any detachment of cells from the slide.  
 
Upon incubation, the cells were washed once with 2 mL of phenol red free DMEM 
(supplemented with 12% fetal calf serum and 1% penicillin streptomycin antibiotics) 
and were subsequently co-stained with 100 nM of MitoTracker Green in 2 mL of 
phenol red free medium [supplemented with fetal calf serum (final concentration 12% 
v/v) and penicillin streptomycin antibiotics (final concentration 1% v/v)]. The cells 
were incubated for 30 minutes at 37
0
C under an atmosphere of 5% CO2 in air. 
 172 
The cells were subsequently washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and a new batch of 2 mL phenol 
red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to each 
well prior imaging. 
 
The localization of ME-TER, MT-ME-TER and MitoTracker Green were imaged 
under an Applied Precision Deltavision microscope. An excitation at wavelength 515-
569 nm and emission detection at wavelength 549-639 nm was applied in the case of 
ME-TER and MT-ME-TER, while in the case of MitoTracker Green, an excitation at 
wavelength 447-503 nm and emission detection at wavelength 487-559 nm was 
applied. Imaging of LysoTracker Blue was based on an excitation wavelength of 372-
408 nm and an emission wavelength of 417-453 nm. Imaging conditions were 
maintained at 37
0
C under an atmosphere of 5% CO2 in air in phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 173 
Results and discussion 
  
 
 
 
 
 
    
A-T diseased Normal 
A 
C 
B 
 174 
_____________________________________________________________________ 
Figure 5.4.1: Localization of tetraethylrhodamine nitroxide (ME-TER) (10 nM, 45 minutes 
incubation) and MitoTracker Green (100 nM, 30 minutes incubation) within A) normal and B) 
Ataxia Telangiectasia, A-T diseased human fibroblast cells. C) Correlation plots of 
mitochondrial localization of ME-TER relative to MitoTracker Green in normal human 
fibroblast cell line (left) and Ataxia Telangiectasia, A-T diseased human fibroblast cell line 
(right) were shown. (Triplicate life cell images were taken, only one image is being displayed). 
 
Figure 5.4.1A and B shows that both ME-TER and MT-ME-TER showed significant 
mitochondrial localization within normal and A-T diseased cells. Colocalization plots 
between ME-TER and MitoTracker, displayed a correlation coefficients of 0.8902 and 
0.8767 for the localization of ME-TER within the mitochondria of normal and A-T 
diseased cells, respectively. This correlates with previous results on the localization of 
ME-TER and MT-ME-TER within the mitochondria of hTERT immortalized cells 
(Figure 5.1.3 and Figure 5.2.5). 
 
Having established significant uptake of ME-TER and MT-ME-TER into the 
mitochondria of normal and A-T diseased cells, subsequent flow cytometry 
experiments were carried out to assess the capability of ME-TER to compare 
differential redox status within normal and Ataxia Telangiectasia, A-T diseased cells. 
 
B) Assessing redox status of normal and A-T diseased cells with ME-TER via flow 
cytometry techniques 
Experimental 
Primary (non-immortalized) normal and A-T diseased human fibroblast cells were 
grown in cell culture flasks and treated with a stock solution of trypsin (adding 0.5 mL 
of 0.5% v/v trypsin) and centrifuged (speed- 1200xg, time- 4 mins and temperature- 
37
o
C) in 10 mL FALCON tube. Cells were subsequently count to a concentration of 2 
x 10
5
 cells per mL in a final volume of 0.3 mL. The cells were incubated with varying 
concentrations of compounds for varying periods of time as listed below, in a final 
volume of 2 mL of DMEM [supplemented with fetal calf serum (final concentration 
12% v/v), penicillin streptomycin antibiotics (final concentration 1% v/v) and phenol 
red]. 
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i)  10 nM ME-TER and MT-ME-TER for 45 minutes 
ii) 5 µM MitoSox for 45 minutes  
iii) 100 nM MitoTracker Green for 30 minutes  
iv) 20 nM TMRM for 30 minutes 
 
Upon incubation cells were centrifuged (1200 rpm, 4 minutes at 37
o
C). The 
supernatant was removed and cells resuspended in 1 mL of 1xPBS in the case of ME-
TER, MT-ME-TER, MitoSox and MitoTracker Green treatment, but 1 mL of 20 nM 
TMRM (prepared in 1xPBS) in the case TMRM treatment. Fluorescence readings 
were subsequently obtained for 5000 cells via flow cytometry (BD LSRFortessa). 
 
Results and discussion 
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Figure 5.4.2: Figures showing percentage changes in fluorescence intensity of sample, Fs 
(compounds) relative to control, Fc (DMSO) upon treatment with A) 45 minutes incubation 
with 10 nM ME-TER; B) 45 minutes incubation with 5µM MitoSox; C) 30 minutes 
incubation with 10 nM of MT-ME-TER; D) 30 minutes incubation with 20 nM TMRM probe. 
Results were normalized to mitochondrial density as measured by 30 minutes incubation with 
Mitotracker Green (100 nM). (Result were significantly different between normal and A-T 
diseasesd cells with P values < 0.1 under different treatment conditions, as determined by T-
test. Cells were taken from a minimum of 3 different patients). 
 
Subsequent flow cytometry studies based on analysis from Figure 5.4.2 affirmed the 
capability of ME-TER to compare the redox status between normal and A-T diseased 
cells. MitoSox serves as a positive control, confirming that A-T diseased cells have a 
higher fluorescence intensity signifying a higher oxidative stress level (higher ROS 
level) compared to that of normal cells (Figure 5.4.2B). Similar result was portrayed 
by ME-TER where the oxidative stressed A-T diseased cells have lower fluorescence 
intensity compared to that of normal cells (Figure 5.4.2A). These results align with our 
previous observation where ROT / AMC stressed ME-TER incubated hTERT cells 
portrayed decreasing fluorescence intensity with increasing ROT / AMC concentration 
(Figure 5.2.1).   
 
Further studies with MT-ME-TER and TMRM, confirmed that the difference in ME-
TER fluorescence intensity between normal and A-T diseased cells reflects a 
difference in oxidative status between both cell lines and not due to difference in 
uptake of probe into cells. Figure 5.4.2D (treatment with commercially available 
TMRM to assess mitochondrial membrane potential) shows that A-T diseased cells 
(higher fluorescence response) have higher mitochondrial membrane potential 
compared to normal cells (lower fluorescence response). The higher membrane 
potential should therefore lead to an increased uptake of ME-TER and MT-ME-TER 
into the mitochondria of the A-T diseased cells relative to normal cells. The increased 
uptake therefore should lead to a higher ME-TER fluorescence response within A-T 
diseased cells relative to normal cells. Such response was prominent in the case of 
MT-ME-TER treatment (Figure 5.4.2C) but missing from ME-TER treatment (Figure 
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5.4.2A). Instead of a higher fluorescence response, ME-TER treated A-T diseased 
cells displayed a lower fluorescence response relative to ME-TER treated normal cells 
(Figure 5.4.2A). Such reduction hence confirmed that the difference in ME-TER 
fluorescence intensity was due to difference in redox status between both normal and 
A-T diseased cells, where A-T diseased cells are under oxidative stress.   
 
Results obtained coincide with previously reported findings from other research 
groups. Studies carried out by Reichenbach et al. reported of an increase in lipid H2O2 
content in 33 A-T patients compared to normal patients.  In addition to that, they have 
also analysed the content of 8-oxodeoxyguanosine (8-OHdG) formed from the 
addition of OH• to the C-8 position of guanine. A-T patients were found having 
increased 8-OHdG levels, indicating an increase in OH• radicals within A-T diseased 
patients.
151
 
 
A more recent experiment carried out by Sharma et al. also coincided with the findings 
shown on Figure 5.4.2. They treated normal and A-T fibroblast cells with H2O2 and 
subsequently measured the oxidative stress level via the use of MitoSox. A-T cells 
were seen to exhibit a higher fluorescence compared to normal cells.
153
 
 
Results hence confirmed the capability of ME-TER to assess redox status within 
immortalized, normal as well as A-T diseased human fibroblast cells. However, an 
effective redox probe should have the potential to be used over a wide range of cell 
types. As all the studies carried out thus far were based mainly on human fibroblast 
cells, the capability of ME-TER to assess redox status within other cell lines was 
subsequently assessed.  
 
5.5 Versatility of ME-TER in other cell lines  
The versatility of a redox probe to monitor the redox status of a variety of cell lines is 
desirable. This enables the redox probe to be used to compare the redox status within 
different cell lines, which in turn provides a better understanding of the biochemical 
response of oxidative damage over a variety of cell lines.   
 
Studies on the redox sensing capability of ME-TER carried out thus far were based 
mainly on human fibroblast cells. In an attempt to assess the versatility of ME-TER 
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within other cell lines, four different cells lines ranging from normal to diseased states 
were incubated with ME-TER. The mitochondrial localization of ME-TER within the 
different cell lines was assessed. The cell lines used were: 
i)  Healthy normal cell- immortalized retinal cells (mouse origin), cerebellum cell 
(DAOY, human origin)  
ii) Diseased cells- cervical cancer cells (HeLa, human origin), adenocarcinomic 
alveolar basal epithelial cells (A549, human origin) 
 
Experimental 
The above mentioned cells were cultured overnight in IBIDI slides in DMEM media 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red] at an initial 
concentration of 1.5x10
5
 cells per mL. The cells were cultured in 2 mL of DMEM, 
supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin antibiotics (final concentration 1% v/v) and phenol red within each well.  
 
The cells were subsequently incubated with 10 nM of ME-TER and MT-ME-TER by 
replacing previous medium within each well with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v). The cells were incubated for 45 
minutes at 37
0
C under an atmosphere of 5% CO2 in air and care was taken to avoid 
any detachment of cells from the slide.  
 
Upon incubation, the cells were washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and were subsequently co-
stained with 100 nM of MitoTracker Green in 2 mL of phenol red free medium 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)]. The cells were incubated for 30 
minutes at 37
0
C under an atmosphere of 5% CO2 in air.  
 
The cells were subsequently washed once with 2 mL of phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)] and a new batch of 2 mL phenol 
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red free DMEM [supplemented with fetal calf serum (final concentration 12% v/v) and 
penicillin streptomycin antibiotics (final concentration 1% v/v)] was added to each 
well prior imaging. 
 
The localization of ME-TER and MT-ME-TER as well as MitoTracker Green was 
imaged under an Applied Precision Deltavision microscope. An excitation at 
wavelength 515-569 nm and emission detection at wavelength 549-639 nm was 
applied in the case of MT-TER and MT-ME-TER, while in the case of MitoTracker 
Green, an excitation at wavelength 447-503 nm and emission detection at wavelength 
487-559 nm was applied. Imaging conditions were maintained at 37
0
C under an 
atmosphere of 5% CO2 in air in phenol red free DMEM [supplemented with fetal calf 
serum (final concentration 12% v/v), penicillin streptomycin (final concentration 1% 
v/v)]. 
 
Results and discussion 
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Figure 5.5.1: Localization of 10 nM methyl ester-tetraethylrhodamine nitroxide (ME-TER) 
and its non-radical alkylated derivative, methyl trap methyl ester tetraethylrhodamine (MT-
ME-TER) along with 100 nM MitoTracker Green in A) immortalized retinal cells; B) DAOY, 
cerebellum cell; C) HeLa, cervical cancer cell; D) A549, adenocarcinomic alveolar basal 
epithelial cells. Pearson Coefficient of Correlation plots between nitroxide and MitoTracker 
Green were shown. (Triplicate life cell images were taken, only one image is being displayed). 
 
Figure 5.5.1 showed that ME-TER and MT-ME-TER localizes into the mitochondria 
of a range of different cell lines, both normal and diseased states as well as from 
different origins (human and animal). This extends the application of ME-TER as 
redox probe to a wider range of cell types and cell lines, not limiting only towards 
human fibroblast cells as previous described.  
 
Due to the fast growth rate of the immortalized mouse retinal cells, along with an 
attempt to assess the capability of ME-TER to monitor the redox status within animal 
cell model, the previously described ME-TER redox monitoring flow cytometry 
experiment (Figure 5.2.1) was repeated by incubating immortalized mouse retinal cells 
with ME-TER.  
              
A B 
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_____________________________________________________________________ 
Figure 5.5.2: Percentage reduction in fluorescence intensity of treated immortalized 
mouse retinal cells, Fs [cells incubated with probes for 45 minutes, followed by 
treatment with varying concentrations of rotenone (ROT) or antimycin (AMC)] for 15 
minutes relative to blank, Fc [cells incubated with  probes for 45 minutes, followed by 
treatment with DMSO for 15 minutes] . A) Cells treated with 10 nM ME-TER. B) 
Cells treated with 10 nM MT-ME-TER. C) Cells treated with 1 µM MitoSox. [Each 
data point are mean values. Data were analysed using Kruskal Wallis test with pos hoc 
testing using the Dunn’s multiple comparison test where P < 0.05 means results are 
significantly different to blank. Results in both Figures A and C showed a P value < 
0.05 (significantly different to blank), while Figure B showed a P value > 0.05 (non-
significantly different to blank)]. 
 
Figure 5.5.2A shows that ME-TER responded to ROT / AMC-stimulated ROS 
production in a dose respond manner over a ROT and AMC concentration range of 
0.01 to 100 µM. Similar trend was observed in the case of MitoSox treatment (Figure 
5.5.2C).  As aforementioned, MitoSox reacts with ROS giving rise to hydroxyl 
triphenylphosphonium ethidium. Hydroxyl triphenylphosphonium ethidium fluoresce 
with an emission wavelength of 580 nm. An increase in  MitoSox fluorescence was 
therefore used as a control to detect possible increase in ROS concentration.
105,106,107
 
Under the ROT and AMC treatments described in Figure 5.5.2, increasing the 
concentration of ROT and AMC increases fluorescence of MitoSox. The increasing 
C 
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MitoSox fluorescence hence indicates an increase in ROS production under those 
ROT and AMC treatment conditions.  
 
The drop in ME-TER fluorescence intensity (Figure 5.5.2A) was due to the changes in 
ROS production with increasing ROT and AMC concentrations. ME-TER nitroxides 
are reduced to hydroxylamine upon uptake into the mitochondria of the retinal cells. 
The reduction of ME-TER occur as a result of the reducing environment within the 
mitochondria (Figure 4.3.3).
163
 The reduction give rise to an initial increase in ME-
TER fluorescence intensity within the mitochondria. Subsequent dose  response 
treatment with ROT or AMC, increases ROS production within the 
mitochondria.
105,162
 The increasing ROS oxidises the hydroxylamines to nitroxides, 
resulting in a drop in ME-TER fluorescence intensity (Figure 5.5.2A).  
 
Interestingly, no significant decrease in fluorescence intensity of was observed 
between ROT treatment concentration of 10 µM and 100 µM. This deviates from 
reported evidence for rotenone-stimulated O2•
-
 production in human fibroblast cells.
169
 
Although the reason for such an observation remains unknown, it has been proposed 
that retinal cells have in place a mechanism which decreases O2•
-
 production within 
Complex I. Such mechanism serve to prevent aberrant signalling as O2•
-
 serves as an 
intracellular messenger to trigger the initiation of apoptosis or cell death.
170
   
 
Based on analysis from Figures 5.5.1 and 5.5.2, it can be concluded that ME-TER has 
the capability to localize into the mitochondria and assess the redox status within a 
variety of cell types and cell lines. The versatility of ME-TER possibly enables it to be 
used as a universal redox sensing probe.  
 
In an attempt to further explore the capability of ME-TER, further studies were carried 
to assess the potential use of ME-TER as a potential probe to monitor the efficacy of 
antioxidant therapy in reducing oxidative stress. 
 
5.6 The use of ME-TER as potential probe to monitor the efficacy of lutein as 
antioxidant therapy in reducing oxidative stress 
Lutein (Figure 4.6.1) has been reported to be an effective antioxidant in reducing 
oxidative damage. Studies have suggested the ability of lutein to function as a reactive 
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oxygen species scavenger in the reducting free radicals in eye diseases such as age-
related macular degeneration (AMD) and cataract.
171
 Placebo-controlled intervention 
trials have found that ingestion of lutein containing food or supplements increased 
macular pigment optical density (which indirectly measures lutein concentration) 
which possibly helps improve visual function.
172,173
 Lutein consumption was found to 
be inversely related to eye diseases such as AMD and cataract.
171 
  
 
 
_____________________________________________________________________ 
Figure 5.6.1: Chemical structure of lutein.
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In assessing the potential use of ME-TER as probe to monitor the efficacy of lutein as 
antioxidant therapy in reducing oxidative stress, hTERT human fibroblast cells treated 
with ME-TER were subjected to AMC as well as lutein treatment. Changes in ME-
TER fluorescence intensity was subsequently monitored via spinning disk microscopy. 
Details of experiment are described below. 
 
Experimental  
4x10
5
 cells per mL of hTERT immortalized human fibroblast cells were cultured in 
IBIDI slides overnight in DMEM media [supplemented with fetal calf serum (final 
concentration 12% v/v) and penicillin streptomycin antibiotics (final concentration 1% 
v/v)]. The cells were subsequently incubated with 300 µL of 25 nM ME-TER 
(prepared from a 10 mM DMSO stock,  in 2 mL of phenol red free DMEM media 
supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v) for 45 minutes. The media was 
then replaced with a fresh batch of media (300 µL) that does not contain ME-TER [but 
supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v)]. The ME-TER treated cells were 
subsequently imaged and the change in fluorescence intensity was imaged every 
minute for 3 minutes.  
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During imaging, the cells were then subjected to different treatments as follow. 
Different compounds were added to the cells within IBIDI slides between imaging 
intervals. 
 
a) 45 minutes incubation with 25 nM of ME-TER (as described above), followed by a 
20 µM AMC treatment (prepared from a 100 mM DMSO stock) in a final volume of 
300 µL. In addition to ME-TER, cells were also incubated with 100 nM MitoTracker 
Green (prepared from a 100 µM DMSO stock, in 2 mL of phenol red free DMEM 
media supplemented with fetal calf serum (final concentration 12% v/v) and penicillin 
streptomycin antibiotics (final concentration 1% v/v) for 30 minutes. 
 
b) 45 minutes incubation with 25 nM of ME-TER (as described above), followed by a 
2 mM lutein treatment (prepared from  a 0.6 M DMSO stock) in a final volume of 300 
µL.  
 
c) 45 minutes incubation with 25 nM of ME-TER (as described above), followed by a 
20 µM AMC treatment (prepared from a 100 mM DMSO stock) and 2 mM lutein 
treatment (prepared from  a 0.6 M DMSO stock) in a final volume of 300 µL.  
 
d) A blank solution was prepared where upon 45 minutes incubation with 25 nM of 
ME-TER (as described above), cells were incubated with DMSO in place of AMC and 
lutein, in a final volume of 300 µL. 
 
Fluorescence intensity of ME-TER treated cells subjected to the different treatment 
were imaged and compared accordingly. An excitation at wavelength 515-569 nm and 
emission detection at wavelength 549-639 nm was applied in the case of ME-TER, 
while in the case of MitoTracker Green, an excitation at wavelength 447-503 nm and 
emission detection at wavelength 487-559 nm was applied. Imaging conditions were 
maintained at 37
0
C under an atmosphere of 5% CO2 in air in phenol red free DMEM 
[supplemented with fetal calf serum (final concentration 12% v/v), penicillin 
streptomycin (final concentration 1% v/v)]. 
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Results and discussion 
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Figure 5.6.2: A) Spinning disk microscopy images of 25 nM ME-TER treated cells 
upon subjection to different treatments; B) Spinning disk microscopy overlay images 
of 25 nM ME-TER with 100 nM MitoTracker Green. (Triplicate life cell images were 
taken, only one image is being displayed). 
 
Based on Figure 5.6.2, it can be observed that despite the treatment, all ME-TER cells 
shows similar response. ME-TER incubated cells have increased fluorescence at time 
point 0 hour. However, upon 6 hours incubation, cells show a reduction in 
fluorescence intensity. Subsequent incubation up to 13 hours shows an increase in 
fluorescence intensity. Both AMC and lutein treatment does not affect the cell 
response.  
 
A possible deduction could be due to the detachment of cells from the culture slide 
upon treatment during imaging intervals. The detachment of cells from the culture 
slide results in a lost of focus within the spining disk microscope. Further incubation 
period, helps the cells to acclimatize and reattach themselves to the culture dish. This 
in turn, puts the cells back into focal plane, restoring the focus within the spinning disk 
and hence increasing fluorescence intensity. A similar observation was prominent in 
the case of overlay image between ME-TER and MitoTracker Green treated with 
DMSO (Figure 4.6.2B), confirming such deduction. 
 
As a solution to the above experimental setup, the use of animal model was looked 
into as an alternative. In collaboration with the Queensland Eye Institute (QEI), the 
potential use of ME-TER to monitor in vivo oxidative status within an acute ischaemia 
/ reperfusion injury rat model along with antioxidant treatment was assessed by Dr. 
B 
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Nigel Barnett and Miss Cassie Rayner. This study was published and the following 
provides a brief discussion with reference to the results and findings reported.   
 
5.7 Asessing redox status within animal model using ME-TER as redox probe 
The rat retinal ischemia / repurfusion (I/R) model has been reported to be an 
established animal model for monitoring retinal responses upon the induction of an 
ischaemic insult. The I/R model mimics clinical situations such as glaucoma (increase 
pressure in eye) and retinal vascular occlusion disease.
,25,174
  
 
To investigate the potential application of ME-TER as a redox probe for studying the 
redox condition within the glaucoma model, Barnett and Rayner administered ME-
TER through injection into the vitreous of rat eyes. The rat was subsequently subjected 
to ischaemia / reperfusion and changes in ME-TER fluorescence intensity within the 
rat eyes were imaged.  
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_____________________________________________________________________ 
Figure 5.7.1: The change in methyl ester tetraethylrhodamine nitroxide (ME-TER, 2 
µM) fluorescence intensity in the retina during reperfusion following an acute 
ischaemic insult in Sprague-Dawley rats. A) Fluorescent fundus images. B) 
Quantification of ME-TER fluorescence: Comparing fluorescence intensity between 
control and ischaemic reperfusion (I/R) treatment. (The data was fitted with a linear 
model and subsequently ANOVA statistical test was carried out. Relative to control, P 
values < 0.05 were obtained. Results are therefore significantly different to control). 
(Figure was taken from Nigel
175
 with permission). 
 
The obstruction followed by reflow of blood is known as ischaemia / reperfusion. It is 
known to result in a burst of ROS generation.
176
 Both Figures 5.7.1A and B show a 
drop in fluorescence intensity of ME-TER upon reperfusion following an acute 
ischaemic insult. In addition, the intensity reduces with increase reperfusion period 
(Figure 5.7.1B). The observed results coincide with that observed in cell-based 
experiments. 
 
Further studies by Rayner et al. (2014)
175
 investigated the possible toxic effect of ME-
TER on the retina. Immunohistochemistry analysis revealed that ME-TER treated 
B 
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retina has similar morphology to that of the non-treated control retina. This confirmed 
that ME-TER does not result in or has minimal toxic effect in animal retina models. 
Such observation agrees with previous ME-TER imaging and MTT toxicity results 
(Figure 5.7.1).  
 
Subsequently studies by Rayner et al. (2014)
175
 also shows that the ROS-induced 
change in ME-TER probe was ameliorated with lutein treatment. It was observed that 
with upon inducing reperfusion, the fluorescent intensity declined during the first 60 
minutes. Such decline in fluorescence intensity however, was significantly less in 
lutein treated retina.  No decline in fluorescence response was observed in the case of 
control (non-ischaemic) and lutein (non-ischaemic) treated retinas.   
 
The capability of ME-TER to detect the changes in ME-TER fluorescence intensity 
within lutein treated ischaemic retina, suggest the potential of ME-TER to serve as a 
tool for testing antioxidant therapies in reducing retinal oxidative damage.  
 
It can therefore be concluded that ME-TER serve as a verstatile redox probe. The 
application of ME-TER ranges from cell based model of varying cell lines and cell 
conditions (normal or diseased) to animal based model.   
 
In an attempt to further explore the capability of ME-TER, further studies were 
subsequently carried to assess the potential use of ME-TER as a potential probe to 
monitor the efficacy of antioxidant therapy in reducing oxidative stress. 
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CHAPTER 6 
Conclusion & Future Work 
 
Studies within this project focus on assessing the capabilities of fluorescein and 
rhodamine-based profluorescent nitroxides (PFN) to monitor mitochondrial redox 
state. In achieving this, several factors play an important role, namely the reduction 
rate of the PFN, the influence of changing pH conditions on the fluorescence stability 
of the PFN, the intracellular localization of the PFN as well as the applicability of the 
PFN within biological systems.  
 
Findings from comparing the reduction rate between tetraethylfluorescein (TEF) and 
tetramethylfluorescein (TMF) shows that ethyl-based probe (TEF) provides a better 
representation of biological redox status within intracellular organelle relative to 
methyl-based probe (TMF). This is due to the slower reduction rate of TEF compared 
to TMF. Such slower reduction rate prevents the probe from undergoing reaction prior 
reaching the mitochondria. The assessment of redox status provided is therefore, a 
better reflection of the oxidative condition within the mitochondria.  
 
A possible reason for the decreased reduction rate of TEF compared to its methyl 
counterpart, TMF, is thought to be due to the increased steric bulk around the nitroxide 
radical centre within TEF. The increased steric bulk is contributed by the ethyl groups 
around the radical centre within TEF. Such an increase in steric bulk slows down the 
rate at which the radical centre within TEF is being reacted upon, hence decreasing the 
reduction rate. In addition, the ethyl groups within TEF also contribute to an increase 
in the electron donating effect around the nitroxide centre of TEF. Such increase in the 
electron donating effect, increases the shielding around the radical centre within TEF. 
This subsequently slows down the rate of reaction around the radical centre within 
TEF. Both the increase in steric bulk and the shielding effect around the nitroxide 
centre within TEF contibute to a decrease in the reduction rate of the PFN.
 
 
Subsequent studies concluded that fluorescein-based probes such as the tetramethyl- 
(TMF) and tetraethyl- (TEF) system suffer from pH instability. Such pH instability 
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arises due to the nature of the chromophore fluorescein, which exhibits drastic changes 
in fluorescence intensity with slight changes in pH.  
 
In addition, fluorescein-based PFN shows lysosomal localization instead of 
mitochondrial localization. These factors limit the potential use of TMF and TEF as 
redox probes for assessing redox status within the mitochondria.  
 
Follow up studies were hence carried out to incorporate the chromophore rhodamine 
within the PFN. Rhodamine has been used as an effective probe for staining 
mitochondria since the 1980’s. Coupling a tetraethylisoindoline nitroxide with 
rhodamine has successfully gave rise to an effective redox probe, tetraethylrhodamine 
nitroxide (TER) for assessing the redox status within the mitochondria. Apart from 
showing relatively good mitochondrial localization (73% colocalization with 
MitoTracker Green), TER showed increased pH stability relative to TEF around 
biologically relevant pH. 
 
Further studies reveal TER exhibits a reversible sensing nature and via flow cytometry 
along with microscopy imaging, the capability of TER to assess redox status within 
ROT / AMC oxidative stressed hTERT immortalized human fibroblast cells was 
confirmed. The use of flow cytometry along with TER presents a sensitive tool for 
assessing mitochondrial redox status, where an increase in oxidative stress results in a 
reduction in the fluorescence intensity of TER treated cells. Via MTT assay, it was 
concluded that TER does not affect the normal functioning of treated cells. 
 
Despite the proven functionality of TER, the lack of complete localization of TER into 
the mitochondria remains an issue. Subsequent effort was hence carried out to increase 
the overall positive charge of TER. Esterification of TER was carried out giving rise to 
a PFN probe, methyl ester tetraethylrhodamine (ME-TER) with increased overall 
postive charge.  
 
ME-TER showed increased mitochondrial localization (approximately 90% 
colocalization with MitoTracker Green). Subsequent imaging and flow cytometry 
experiments confirmed the redox sensing capacity of ME-TER within a wide range of 
cell lines ranging from human to animal origin as well as normal and diseased cells. 
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ME-TER has the capacity to differentiate the redox condition within normal and 
Ataxia Telangiectasia (A-T) diseased cells.  
 
Further studies reveal that ME-TER does not affect normal functioning of cells up to 
72 hours incubation. Subsequent spinning disk microscopy techniques reveal that cells 
undergo normal mitosis and growth in the presence of ME-TER. 
 
The application of ME-TER within rat retinal ischaemia / repurfusion (I/R) model 
concluded that ME-TER serves as a verstatile redox probe. The application of ME-
TER ranges from cell based model of varying cell lines and cell conditions (normal or 
diseased) to animal based model.   
 
Comparing different mitochondrial redox sensing probes, TER and ME-TER has 
several advantages as follow.  
 
 TMF TEF TER ME-TER MitoSox 
Nature Methyl 
species 
Ethyl species Ethyl species Ethyl species - 
Chromophore Fluorescein Fluorescein Rhodamine Rhodamine Benzimidazole 
pH stability Not Not Yes Yes - 
Reduction 
Rate 
Fast Slow Slow Slow - 
Localization Non-specific Non-specific Mitochondria 
 
Mitochondria 
 
Mitochondria 
 
Reversibility Yes Yes Yes Yes No 
 
In conclusion, this study is a proof of concept that ethyl based rhodamine nitoxide 
system has the capacity to act as an effective mitochondrial redox sensing probe. 
 
Althought ME-TER shows great potential as a mitochondrial redox sensing probe, 
much still remains to be discovered. Among the future works that could be carried out 
are: 
1) Further understanding of the mechanism by which ME-TER assesses redox status 
within the mitochondria. This can be achieved via the use of different inhibitors 
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apart from rotenone and antimycin such as buthionine sulphoximine (BSO) which 
alters intracellular antioxidant and glutathione level.   
  
2) Administration and assessment of the efficacy of potential antioxidant drug 
treatments apart from lutein, based on the use of ME-TER within both cell-based 
and animal-based models could also be looked into. 
 
3) The application of ME-TER in other animal-based models apart from the 
glaucoma rat acute ischaemic / reperfusion (I/R) model also serve as an important 
further work to contribute to the development of an effective mitochondrial redox 
probe. 
 
4) The development of different variation of ME-TER could also be explored. An 
example being the attachment of another non-reactive chromophore into the 
existing probe. This has the potential of enabling a ratio metric analysis of the 
intracellular redox status to be carried out. 
 
5) Futher experiments to assess the applicability of TER within pure or mitochondrial 
enriched cell fraction could also be looked into.  
 
6) In addition, colocalization of cells treated with the PFN probes with other 
mitochondrial markers apart from Mitotracker Green could be carried out to serve 
as further confirmation of the localization of the probes within mitochondria. 
 
7) MTT studies could also be complemented with other assays such as assessing 
cellular ATP (adenosine triphosphate)  level within cells for a better assessment of 
mitochondrial redox status. 
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